<SEC-DOCUMENT>0001493152-25-018839.txt : 20251022
<SEC-HEADER>0001493152-25-018839.hdr.sgml : 20251022
<ACCEPTANCE-DATETIME>20251021193033
ACCESSION NUMBER:		0001493152-25-018839
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20251022
DATE AS OF CHANGE:		20251021

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AGRIFORCE GROWING SYSTEMS LTD.
		CENTRAL INDEX KEY:			0001826397
		STANDARD INDUSTRIAL CLASSIFICATION:	FINANCE SERVICES [6199]
		ORGANIZATION NAME:           	09 Crypto Assets
		EIN:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-266722
		FILM NUMBER:		251408319

	BUSINESS ADDRESS:	
		STREET 1:		800-525 WEST 8TH AVENUE
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V5Z 1C6
		BUSINESS PHONE:		1-866-226-3514

	MAIL ADDRESS:	
		STREET 1:		800-525 WEST 8TH AVENUE
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V5Z 1C6
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>form424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
pursuant to Rule 424(b)(5)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
No. 333-266722</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS
SUPPLEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(to
prospectus dated August 18,2022)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AgriForce
Growing Systems, Ltd.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Up
to</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B> $3,457,461</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into a Sales Agreement, or sales agreement, with Yorkville Securities, LLC and Cohen &amp; Company Capital Markets,
a division of Cohen &amp; Company Securities, LLC (the &ldquo;Sales Agents&rdquo;) relating to shares of our common stock offered
by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the sales agreement, we may offer and
sell shares of our common stock having an aggregate offering price of up to $3,457,461 from time to time through or to the
Sales Agents,
acting as our sales agents or principals pursuant to this prospectus supplement and the accompanying prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is traded on the Nasdaq Capital Market, or Nasdaq, under the symbol &ldquo;AGRI.&rdquo; The last reported sale price of
our common stock on October 20, 2025 was $3.67 per share. On August 28, 2025, we effected a 1 for 9 reverse split
of our issued and outstanding common shares (the &ldquo;Reverse Split&rdquo;). All share numbers in this prospectus supplement reflect
share numbers post Reverse Split unless indicated otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently subject to General Instruction I.B.6 of Form S-3, which limits the amounts of securities that we may sell under the registration
statement of which the prospectus supplement and the accompanying prospectus form a part. The aggregate market value of our outstanding
common stock held by non-affiliates pursuant to General Instruction I.B.6 of Form S-3, or public float, is $20,684,818, which is based
on 3,609,916 shares of our outstanding common stock held by non-affiliates as of the date of this prospectus supplement, at a price of
$5.73 per share, which was the closing sale price of one share of our common stock on Nasdaq on September 22, 2025. Pursuant to General
Instruction I.B.6 of Form S-3, in no event will we sell shares pursuant to this prospectus supplement with a value of more than one-third
of the aggregate market value of our common stock held by non-affiliates in any 12-month period. We have not offered any securities pursuant
to General Instruction I.B.6 of Form S-3 during the prior 12 calendar month period, except for $2,116,741 pursuant to a sales agreement
with Maxim Group, LLC in November 2024 and $1,320,737 &nbsp;pursuant to a sales agreement with Maxim Group, LLC in August and September
2025 .</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
of our common stock, if any, under this prospectus supplement and the accompanying prospectus will be made by any method permitted that
is deemed an &ldquo;at the market offering&rdquo; as defined in Rule 415 under the Securities Act of 1933, as amended, or the Securities
Act, including sales made directly on or through Nasdaq or any other existing trading market in the United States for our common stock,
directly to the Sales Agents, as principals, and/or in any other method permitted by law. If we and the Sales Agents agree on any method
of distribution other than sales of shares of our common stock on or through Nasdaq or another existing trading market in the United
States at market prices, we will file a further prospectus supplement providing all information about such offering as required by Rule
424(b) under the Securities Act. The Sales Agents are not required to sell any specific number or dollar amount of securities, but will
act as our sales agent using commercially reasonable efforts consistent with its normal trading and sales practices. There is no arrangement
for funds to be received in any escrow, trust or similar arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sales Agents will be entitled to compensation at a commission rate equal to up to 3.0% of the gross sales price per share sold. In connection
with the sale of the common stock on our behalf, the Sales Agents will be deemed to be &ldquo;underwriters&rdquo; within the meaning
of the Securities Act and the compensation of the Sales Agents will be deemed to be underwriting commissions or discounts. We have also
agreed to provide indemnification and contribution to the Sales Agents with respect to certain liabilities, including liabilities under
the Securities Act or the Exchange Act of 1934, as amended, or the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in our common stock involves significant risks. Please read the information contained in or incorporated by reference under the heading
&ldquo;<U>Risk Factors</U>&rdquo; beginning on page S-4 of this prospectus supplement and page 23 of the accompanying prospectus, and
under similar headings in other documents filed after the date hereof and incorporated by reference into this prospectus supplement and
the accompanying prospectus.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities, or determined
if this prospectus supplement is accurate or complete. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: center; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Yorkville
  Securities</B></FONT></TD>
  <TD STYLE="text-align: center; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cohen &amp; Company Capital Markets</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
date of this prospectus supplement is October 21, 2025.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"><A HREF="#Da_013" STYLE="font-weight: bold">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="Da_013"></A>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Prospectus
Supplement</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 0.5in; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Da_001">ABOUT THIS PROSPECTUS SUPPLEMENT</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Da_002">PROSPECTUS SUPPLEMENT SUMMARY</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Da_003">THE OFFERING</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Da_004">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-3</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Da_005">RISK FACTORS</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-4</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Da_006">USE OF PROCEEDS</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-5</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Da_007">DIVIDEND POLICY</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-5</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Da_008">DILUTION</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-6</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Da_009">PLAN OF DISTRIBUTION</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-7</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Da_010">LEGAL MATTERS</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-8</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Da_011">EXPERTS</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-8</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Da_012">WHERE YOU CAN FIND MORE INFORMATION</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-8</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ta_001">INCORPORATION BY REFERENCE</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-8</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prospectus</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT THIS PROSPECTUS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">1</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SUMMARY</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">1</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">23</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">23</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RATIO OF EARNINGS TO FIXED CHARGES</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">37</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">37</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF COMMON STOCK</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">37</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF PREFERRED STOCK</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">38</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF WARRANTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">39</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF UNITS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">40</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">40</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">42</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">42</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_014"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">43</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"><A HREF="#Da_013" STYLE="font-weight: bold">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="Da_001"></A>ABOUT
THIS PROSPECTUS SUPPLEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document is part of the registration statement that we filed with the Securities and Exchange Commission, or the SEC, using a &ldquo;shelf&rdquo;
registration process and consists of two parts. The first part is this prospectus supplement, which describes the specific terms of this
offering. The second part, the accompanying prospectus, gives more general information, some of which may not apply to this offering.
Generally, when we refer only to the &ldquo;prospectus,&rdquo; we are referring to both parts combined. This prospectus supplement may
add to, update or change information in the accompanying prospectus and the documents incorporated by reference into this prospectus
supplement or the accompanying prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
information in this prospectus supplement is inconsistent with the accompanying prospectus or with any document incorporated by reference
that was filed with the SEC before the date of this prospectus supplement, you should rely on this prospectus supplement. This prospectus
supplement, the accompanying prospectus and the documents incorporated into each by reference include important information about us,
the securities being offered and other information you should know before investing in our securities. You should also read and consider
information in the documents we have referred you to in the sections of this prospectus supplement entitled &ldquo;Where You Can Find
More Information&rdquo; and &ldquo;Incorporation by Reference.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should rely only on this prospectus supplement, the accompanying prospectus, the documents incorporated or deemed to be incorporated
by reference herein or therein and any free writing prospectus prepared by us or on our behalf. We have not, authorized anyone to provide
you with information that is in addition to or different from that contained or incorporated by reference in this prospectus supplement
and the accompanying prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. We are
not offering to sell these securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information
contained in this prospectus supplement, the accompanying prospectus or any free writing prospectus, or incorporated by reference herein
or therein, is accurate as of any date other than as of the date of this prospectus supplement or the accompanying prospectus or any
free writing prospectus, as the case may be, or in the case of the documents incorporated by reference, the date of such documents regardless
of the time of delivery of this prospectus supplement and the accompanying prospectus or any sale of our securities. Our business, financial
condition, liquidity, results of operations and prospects may have changed since those dates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to any document
that is incorporated by reference in this prospectus supplement or the accompanying prospectus were made solely for the benefit of the
parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreements, and should
not be deemed to be a representation, warranty or covenant to you. Moreover, such representations, warranties or covenants were accurate
only as of the date when made. Accordingly, such representations, warranties and covenants should not be relied on as accurately representing
the current state of our affairs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated in this prospectus supplement or the context otherwise requires, all references to &ldquo;we,&rdquo; &ldquo;us,&rdquo;
&ldquo;our,&rdquo; &ldquo;the Company,&rdquo; and &ldquo;AgriFORCE&rdquo; refer to AgriFORCE Growing Systems, Ltd. and its subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
action is being taken in any jurisdiction outside the United States to permit a public offering of the common stock or possession or
distribution of this prospectus supplement or the accompanying prospectus in that jurisdiction. Persons who come into possession of this
prospectus supplement or the accompanying prospectus in jurisdictions outside the United States are required to inform themselves about
and to observe any restrictions as to this offering and the distribution of this prospectus supplement or the accompanying prospectus
applicable to that jurisdiction.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"><A HREF="#Da_013" STYLE="font-weight: bold">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="Da_002"></A>PROSPECTUS
SUPPLEMENT SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
summary highlights information contained elsewhere or incorporated by reference in this prospectus supplement. This summary does not
contain all of the information that you should consider before deciding to invest in our common stock. You should read this entire prospectus
supplement and accompanying base prospectus carefully, including the &ldquo;Risk Factors&rdquo; section contained in this prospectus
supplement, the accompanying base prospectus and under the section &ldquo;Risk Factors&rdquo; in our Annual Report on Form 10-K for the
year ended December 31, 2024, , as amended, in our subsequent Quarterly Reports on Form 10-Q and any amendment or update thereto reflected
in subsequent filings with the SEC, along with our consolidated financial statements and the related notes thereto and the other documents
incorporated by reference in this prospectus supplement and accompanying base prospectus.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overview</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgriFORCE&trade;
was incorporated as a private company by Articles of Incorporation issued pursuant to the provisions of the Business Corporations Act
(British Columbia) on December 22, 2017. The Company&rsquo;s registered and records office address is at 800 &ndash; 525 West 8<SUP>th
</SUP>Avenue, Vancouver, BC, Canada, V5Z 1C6.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an innovative sustainable technology focused company that strives to innovate and deliver sustainable technology solutions
across a wide array of vertical utilization of our proprietary intellectual property to businesses and enterprises through our AgriFORCE&trade;
Solutions division (&ldquo;Solutions&rdquo;) and deliver innovative flour products through our AgriFORCE&trade; Brands division (&ldquo;Brands&rdquo;).
In 2024, the Company bought the assets of the Radical Clean Solutions (&ldquo;RCS&rdquo;) business for which it had bought an exclusive
license to the agricultural industry in 2023. During 2023, the Company commenced efforts to launch its UN(THINK) Awakened Flour&trade;,
which is a nutritious flour that we believe provides health advantages over traditional flour.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
Solutions&rsquo; legacy focus was to operate in the plant based pharmaceutical, nutraceutical, and other high value crop markets using
its unique proprietary facility design and hydroponics based automated growing system that enable cultivators to effectively grow crops
in a controlled environment (&ldquo;FORCEGH+&trade;&rdquo;). The Company has designed FORCEGH+&trade; facilities to produce in virtually
any environmental condition and to optimize crop yields to as near their full genetic potential possible whilst substantially eliminating
the need for the use of pesticides and/or irradiation. The Company has changed its focus to broaden the use of its proprietary intellectual
property across multiple industries. For instance, the Company through its RCS purchase, is now able to utilize that technology to deliver
solutions across multiple industries, including not only agriculture, but other industries including hospitality, commercial applications,
education institutions, residential real estate and transportation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brands
is focused on the development and commercialization of plant-based ingredients and products that deliver healthier and more nutritious
solutions. We strive to market and commercialize both branded consumer product offerings and ingredient supply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2024, the Company entered into the sustainable Bitcoin mining industry and has completed two acquisitions since late November 2024 pursuant
to which the Company now owns and operates three Bitcoin mining facilities, one in Alberta, Canada and two in Ohio, for a total of 1120
BITMAIN Antminer S19j units. The facility is powered by sustainable energy, advancing AgriFORCE&rsquo;s mission to integrate innovative
technologies that promote environmental stewardship while generating significant financial returns. The Company is proud to announce
the launch of sustainable agricultural operations at its newly acquired Bitcoin mining facility in Sturgeon County, Alberta, Canada.
By harnessing the excess heat and carbon emissions from Bitcoin mining, AgriFORCE is pioneering a novel approach to promote agricultural
productivity while reducing environmental impact.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Business Including Recent AVAX Treasury Strategy</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 22, 2025, the Company entered into subscription agreements (each, a &ldquo;Subscription Agreement&rdquo; and collectively,
the &ldquo;Subscription Agreements&rdquo;) with certain institutional and accredited investors (each, an &ldquo;Investor&rdquo; and collectively,
the &ldquo;Investors&rdquo;), pursuant to which the Company, subject to the restrictions and upon satisfaction of the conditions in the
Subscription Agreements, agreed to sell in one or more private placement transactions exempt from registration pursuant to Section 4(a)(2)
of the Securities Act of 1933, as amended (the &ldquo;Offering&rdquo;), to the Investors Company common shares, no par value per share
(in generality, the &ldquo;Common Shares&rdquo;, and the aggregate number thereof referenced in this sentence, the &ldquo;Shares&rdquo;),
in an aggregate amount of $292.4 million. The per Share purchase price is $2.36 (the &ldquo;Share Price&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of
the aggregate $292.4 million purchase price for the Shares, an aggregate of (i) $146.4 million is expected to be paid in cash, the cryptocurrency
stablecoin commonly referred to as USDC (&ldquo;USDC&rdquo;) based on a purchase price of $1.00 per USDC, and the cryptocurrency stablecoin
commonly referred to as USDT (&ldquo;USDT&rdquo; and together with USDC, &ldquo;Stablecoins&rdquo;) based on a purchase price of $1.00
per USDT, and (ii) $146.0 million is expected to be paid in the native cryptocurrency of the Avalanche Network, referred to as AVAX Tokens
(&ldquo;AVAX Tokens&rdquo;), which will be valued for purposes of the Subscription Agreements at the volume-weighted average price of
an AVAX Token (rounded to two decimal places) during the 14 consecutive calendar days ending on the Funding Payment Deadline (as defined
in the Subscription Agreements) based on midnight UTC, calculated by using the hourly volume and the Messari Price as reported on messari.io
(the &ldquo;Specified AVAX Token Value&rdquo;). Because the Specified AVAX Token Value will not be set until the Funding Payment Deadline,
the aggregate number of Shares to be issued in the Offering is not currently known. Based on an indicative value of $33.82 per
AVAX Token, which was the Messari Price of AVAX Tokens at 4:00 pm on September 19, 2025, as reported on messari.io (the &ldquo;Illustrative
AVAX Token Price&rdquo;), the aggregate number of Shares that are expected to be issued is 112 million. Such amount is preliminary and
subject to change based on changes in AVAX Token prices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscription Agreements contain representations and warranties of the Company and the Investors which are typical for transactions of
this type. In the Subscription Agreements, the Company has granted to the Investors, and the Investors have granted to the Company, customary
indemnification rights. The Subscription Agreements also contain conditions precedent to closing, including but not limited to, shareholder
approval pursuant to Nasdaq Listing Rules 5635(b)-(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cohen
&amp; Company Securities, LLC acted as the sole placement agent in connection with the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Offering is expected to close promptly after the satisfaction of customary closing conditions, including approval of the Offering by
the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company intends to use up to $10 million of the cash net proceeds from the Offering for general corporate purposes initiated after the
closing and for pre-existing working capital commitments or obligations, and the remaining cash net proceeds for the acquisition of AVAX
Tokens. The AVAX Tokens so acquired, together with the remaining net proceeds, will be used for the establishment of the Company&rsquo;s
cryptocurrency treasury operations to the extent consistent with the Company&rsquo;s investment policy as amended or otherwise modified
from time to time. In connection with the announcement of the Offering, the Company announced the launch of its digital asset treasury
reserve strategy, to be effective upon the closing of the Offering, pursuant to which the Company plans to use AVAX Tokens as its primary
treasury reserve asset on an ongoing basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Status
as an Emerging Growth Company and Smaller Reporting Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>On
April 5, 2012, the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, was enacted. Section 107 of the JOBS Act provides that
an &ldquo;emerging growth company&rdquo; can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities
Act of 1933, as amended, or the Securities Act, for complying with new or revised accounting standards. In other words, an &ldquo;emerging
growth company&rdquo; can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.
We have irrevocably elected to avail ourselves of this extended transition period and, as a result, we will adopt new or revised accounting
standards on the relevant dates on which adoption of such standards is required for private companies.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
are in the process of evaluating the benefits of relying on other exemptions and reduced reporting requirements provided by the JOBS
Act. Subject to certain conditions set forth in the JOBS Act, as an &ldquo;emerging growth company,&rdquo; we intend to rely on certain
of these exemptions from, without limitation, (i) providing an auditor&rsquo;s attestation report on our system of internal controls
over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act and (ii) complying with any requirement that may be adopted
by the Public Company Accounting Oversight Board (PCAOB) regarding mandatory audit firm rotation or a supplement to the auditor&rsquo;s
report providing additional information about the audit and the financial statements, known as the auditor discussion and analysis. We
will remain an &ldquo;emerging growth company&rdquo; until the earliest of (a) the last day of our fiscal year following the fifth anniversary
of the closing of the initial public offering, (b) the last day of the first fiscal year in which our annual gross revenues exceed $1.07
billion, (c) the last day of our fiscal year in which we are deemed to be a &ldquo;large accelerated filer&rdquo; as defined in Rule
12b-2 under the Securities Exchange Act of 1934, or Exchange Act (which would occur if the market value of our equity securities that
is held by non-affiliates exceeds $700 million as of the last business day of our most recently completed second fiscal quarter), or
(d) the date on which we have issued more than $1 billion in nonconvertible debt during the preceding three-year period.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also a &ldquo;smaller reporting company&rdquo; as defined in Rule 12b-2 of the Exchange Act of 1934, as amended, as our public float
as of October 20, 2025 was under $75 million and have elected to follow certain scaled disclosure requirements available to smaller
reporting companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"><A HREF="#Da_013" STYLE="font-weight: bold">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="padding-right: 0.1in; padding-left: 0.1in; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="Da_003"></A>THE
OFFERING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock
    offered by us pursuant to this prospectus</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    of our common stock having an aggregate offering price of $3,457,461.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock to be outstanding
    after this offering</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">5,066,246 shares, assuming
    a price of $3.67 per share which was the closing price on the Nasdaq Capital Market on October 20, 2025. The actual
    number of shares issued and outstanding will vary depending on the price at which shares may be sold from time to time during this
    offering.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manner of offering</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;At
    the market offering&rdquo; that may be made from time to time on the Nasdaq Capital Market or other trading market for our common
    stock in the U.S. through or to Yorkville Securities, LLC and Cohen &amp; Company Capital Markets, a division of Cohen &amp; Company
    Securities, LLC, acting as our sales agent or principal. See the section entitled &ldquo;Plan of Distribution&rdquo; on page
    S-7 of this prospectus supplement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of proceeds</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We intend to use all
    proceeds of this offering for general corporate purposes, mainly the purchase of AVAX tokens. See the section entitled &ldquo;Use
    of Proceeds&rdquo; on page S-5 of this prospectus supplement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk factors</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See &ldquo;Risk Factors&rdquo;
    beginning on page S-4 of this prospectus supplement and page 23 of the accompanying prospectus and the other information included
    in, or incorporated by reference into, this prospectus supplement and accompanying prospectus for a discussion of certain factors
    you should carefully consider before deciding to invest in shares of our common stock.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq Capital Market symbol</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGRI (for common stock)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares of our common stock to be outstanding immediately after this offering is based on 4,128,089 shares of common stock outstanding
as of October 20, 2025, and excludes the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99,821
    Warrants outstanding to purchase common stock, 59 stock options, and $1,501,102 of convertible debentures with a strike price
    of $2.36 per share.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"><A HREF="#Da_013" STYLE="font-weight: bold">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="Da_004"></A>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus supplement and the documents incorporated by reference herein contain forward-looking statements. Such statements include
statements regarding our expectations, hopes, beliefs or intentions regarding the future, including but not limited to statements regarding
our market, strategy, competition, development plans (including acquisitions and expansion), financing, revenues, operations, and compliance
with applicable laws. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from
those discussed in any such statement. Factors that could cause actual results to differ materially from such forward-looking statements
include the risks described in greater detail in the following paragraphs and in the Company&rsquo;s Annual Report on Form 10-K for the
year ended December 31, 2024, filed with the SEC on April 7, 2025 , as amended on April 29, 2025, in the Company&rsquo;s Quarterly Report
on Form 10-Q for the quarter ended March 31, 2025, filed with the SEC on May 15, 2025 and in the Company&rsquo;s Quarterly Report on
Form 10-Q for the quarter ended June 30, 2025, filed with the SEC on August 14, 2025. All forward-looking statements in this document
are made as of the date hereof, based on information available to us as of the date hereof, and we assume no obligation to update any
forward-looking statement. Market data used throughout this prospectus supplement is based on published third party reports or the good
faith estimates of management, which estimates are based upon their review of internal surveys, independent industry publications and
other publicly available information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should review carefully the section entitled &ldquo;Risk Factors&rdquo; within this prospectus supplement for a discussion of these and
other risks that relate to our business and investing in shares of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
forward-looking statements speak only as of the date of this prospectus supplement. We disclaim any obligation to update or revise these
statements unless required by law, and you should not place undue reliance on these forward-looking statements. Although we believe that
our plans, intentions and expectations reflected in or suggested by the forward-looking statements we make in this prospectus supplement
are reasonable, we can give no assurance that these plans, intentions or expectations will be achieved. We disclose important factors
that could cause our actual results to differ materially from our expectations under &ldquo;Risk Factors&rdquo; and elsewhere in this
prospectus supplement. These cautionary statements qualify all forward-looking statements attributable to us or persons acting on our
behalf.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"><A HREF="#Da_013" STYLE="font-weight: bold">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="Da_005"></A>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Investment
in our common stock involves risks. Before deciding whether to invest in our common stock, you should consider carefully the risk factors
discussed below and those contained in the section entitled &ldquo;Risk Factors&rdquo; contained in our Annual Report on Form 10-K for
the year ended December 31, 2024, as filed with the SEC on April 7, 2025, , as amended on April 29, 2025, and in our subsequent Quarterly
Reports on Form 10-Q, which are incorporated herein by reference in its entirety, as well as any amendment or update to our risk factors
reflected in subsequent filings with the SEC. If any of the risks or uncertainties described in our SEC filings actually occurs, our
business, financial condition, results of operations or cash flow could be materially and adversely affected. This could cause the trading
price of our common stock to decline, resulting in a loss of all or part of your investment. The risks and uncertainties we have described
are not the only ones facing our company. Additional risks and uncertainties not presently known to us or that we currently deem immaterial
may also affect our business operations.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Associated with this Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>We
have broad discretion in the use of the net proceeds of this offering and may not use them effectively.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to use the net proceeds of this offering for general corporate purposes. Our management will have broad discretion in the application
of the net proceeds from this offering and could spend the proceeds in ways that do not improve our results of operations or enhance
the value of our common stock. The failure by management to apply these funds effectively could result in financial losses that could
have a material adverse effect on our business or cause the price of our common stock to decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>You
will experience immediate and substantial dilution.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offering price per share in this offering may exceed the net tangible book value per share of our common stock outstanding prior to this
offering. Assuming that an aggregate of 942,087 shares of our common stock are sold at a price of $3.67 per share for aggregate
gross proceeds of $3,457,461 and after deducting commissions and estimated offering expenses payable by us, you will experience
immediate dilution of $4.80 per share, representing the difference between our as adjusted net tangible book value per share of
$(1.13) after giving effect to this offering and the assumed offering price. The exercise of outstanding stock options and warrants,
or the conversion of outstanding preferred stock into common stock, will result in further dilution of your investment. See the section
entitled &ldquo;Dilution&rdquo; below for a more detailed illustration of the dilution you would incur if you participate in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>You
may experience future dilution as a result of future equity offerings.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to raise additional capital, we may in the future offer additional shares of our common stock or other securities convertible into
or exchangeable for our common stock at prices that may not be the same as the price per share in this offering. We may sell shares or
other securities in any other offering at a price per share that is less than the price per share paid by investors in this offering,
and investors purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per
share at which we sell additional shares of our common stock, or securities convertible or exchangeable into common stock, in future
transactions may be higher or lower than the price per share paid by investors in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
common stock offered hereby will be sold in &ldquo;at the market offerings&rdquo;, and investors who buy shares at different times will
likely pay different prices.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investors
who purchase shares in this offering at different times will likely pay different prices, and so may experience different outcomes in
their investment results. We will have discretion, subject to market demand, to vary the timing, prices and numbers of shares sold, and
there is no minimum or maximum sales price. Investors may experience a decline in the value of their shares as a result of share sales
made at prices lower than the prices they paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>It
is not possible to predict the actual number of shares we will sell under the sales agreement, or the gross proceeds resulting from those
sales.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain limitations in the sales agreement and compliance with applicable law, we have the discretion to deliver a placement notice
to either Sales Agent or both Sales Agents at any time throughout the term of the sales agreement. The number of shares that are sold
through the applicable Sales Agent after delivering a placement notice will fluctuate based on a number of factors, including the limits
we set with such Sales Agent in any applicable placement notice and the demand for our common stock during the sales period. Because
the price per share of each share sold will fluctuate during the sales period, it is not currently possible to predict the gross proceeds
to be raised in connection with those sales, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"><A HREF="#Da_013" STYLE="font-weight: bold">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="Da_006"></A>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are issuing shares of our common stock having aggregate sales proceeds of $3,457,461 from time to time hereunder. Because there
is no minimum offering amount required as a condition to close this offering, the actual total public offering amount, commissions and
proceeds to us, if any, are not determinable at this time. We estimate that the net proceeds from the sale of the shares of common stock
that we are offering may be up to approximately $3.3 million, after deducting the Sales Agents&rsquo; commissions and estimated
offering expenses payable by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to use to use all proceeds for general corporate purposes, mainly the purchase of AVAX tokens.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company shall sell any shares of its Common Stock pursuant to any at-the-market offering or equity line of credit (however denominated),
the Company may use 25% of the net proceeds from any such sales to repay the principal on any outstanding Debentures (as such term is
defined in the June 30, 2022 Securities Purchase Agreement) in accordance with the terms of such Debentures, which as of this date is
approximately $1.5 million in principal amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="Da_007"></A>DIVIDEND
POLICY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid any cash dividends on our common stock. We currently intend to retain any future earnings and do not expect
to declare or pay any cash dividends in the foreseeable future. Any future determination to pay dividends will be at the discretion of
our board of directors, subject to applicable laws, and will depend on our financial condition, results of operations, capital requirements,
general business conditions and other factors that our board of directors considers relevant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"><A HREF="#Da_013" STYLE="font-weight: bold">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="Da_008"></A>DILUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you invest in our common stock, your interest will be diluted to the extent of the difference between the price per share you pay in
this offering and the net tangible book value per share of our common stock immediately after this offering. Our net tangible book value
deficit of our common stock as of June 30, 2025 was approximately $(4,925,573) million, or approximately $(11.70) per share of common
stock based upon 420,901 shares outstanding. Net tangible book value per share is equal to our total tangible assets, less our total
liabilities, divided by the total number of shares outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
giving effect to the sale of our common stock in the aggregate amount of $3,457,461 at an offering price of $3.67 per share, the
last reported sale price of our common stock on the Nasdaq Capital Market on October 20, 2025, and after deducting estimated
offering commissions and offering expenses payable by us, our net tangible book value deficit as of June 30, 2025 would have been
$(1,544,974) million, or $(1.13) per share of common stock. This represents an immediate increase in net tangible book
value of $10.57 per share to our existing stockholders and an immediate dilution in net tangible book value of $4.80 per
share to new investors in this offering.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table illustrates this calculation on a per share basis:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%">Offering price per share</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">3.67</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Net tangible book value (deficit) per share as of June 30, 2025</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(11.70</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Increase in net tangible book value per share attributable to the offering</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">10.57</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">As-adjusted net tangible book value (deficit) per share after giving effect to the offering</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(1.13</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Dilution in net tangible book value per share to new investors</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.80</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing table does not give effect to the exercise of any outstanding options or warrants or the conversion of indebtedness to common
stock. To the extent options and warrants are exercised, or to the extent preferred stock is converted to common stock, there may be
further dilution to new investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table above assumes for illustrative purposes that an aggregate of 942,087 shares of our common stock are sold at a price of $3.67
per share, the last reported sale price of our common stock on the Nasdaq Capital Market on October 20, 2025 for aggregate gross
proceeds of $3,457,461.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"><A HREF="#Da_013" STYLE="font-weight: bold">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="Da_009"></A>PLAN
OF DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have entered into a Sales Agreement, or sales
agreement, with Yorkville Securities, LLC and Cohen &amp; Company Capital Markets, a division of Cohen &amp; Company Securities, LLC
(the &ldquo;Sales Agents&rdquo;), under which we may issue and sell our common stock from time to time through or to the Sales Agents,
acting as sales agents or principals, subject to certain limitations, including the number of shares registered under the registration
statement to which the offering relates. The sales, if any, of shares made under the sales agreement will be made by any method that
is deemed an &ldquo;at the market offering&rdquo; as defined in Rule 415 promulgated under the Securities Act. If we and the Sales Agents
agree on any method of distribution other than sales of shares of our common stock on or through the Nasdaq Capital Market or another
existing trading market in the United States at market prices, we will file a further prospectus supplement providing all information
about such offering as required by Rule 424(b) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
time we wish to issue and sell common stock under the sales agreement, we will notify the applicable Sales Agent of the number of shares
to be issued, the dates on which such sales are anticipated to be made, any minimum price below which sales may not be made and other
sales parameters as we deem appropriate. Subject to the terms of the sales agreement, the Sales Agents have agreed to use commercially
reasonable efforts consistent with their normal trading and sales practices to sell shares of our common stock up to the amount specified
in the relevant placement notice on such terms. The obligations of the Sales Agents under the sales agreement to sell our common stock
are subject to a number of conditions that we must meet. We may instruct the Sales Agents not to sell common stock if the sales cannot
be effected at or above the price designated by us from time to time. We or the Sales Agents may suspend the offering of common stock
upon notice and subject to other conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will pay the Sales Agents commissions for their services in acting as agents in the sale of our common stock. Each Sales Agents will
be entitled to a commission in an amount equal up to 3.0% of the gross proceeds from the sale of common stock offered hereby. In
addition, we have agreed to reimburse the Sales Agents for fees and disbursements related to their legal counsel in an amount not to
exceed $75,000 in connection with the filing of the sales agreement, $5,000 per calendar quarter in connection with ongoing
diligence arising from the transactions contemplated by the sales agreement and $25,000 for each program &ldquo;refresh&rdquo;. We
estimate that the total expenses for the offering, excluding compensation payable to the Sales Agents under the terms of the sales
agreement, will be approximately $75,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Settlement
for sales of common stock will generally occur on the business day following the date on which any sales are made, or on some other date
that is agreed upon by us and the Sales Agents in connection with a particular transaction, in return for payment of the net proceeds
to us. There is no arrangement for funds to be received in an escrow, trust or similar arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the sale of the common stock on our behalf in this &ldquo;at the market offering&rdquo;, each of the Sales Agents will
be deemed to be an &ldquo;underwriter&rdquo; within the meaning of the Securities Act and the compensation of the Sales Agents will be
deemed to be underwriting commissions or discounts. We have agreed to provide indemnification and contribution to the Sales Agents against
certain civil liabilities, including liabilities under the Securities Act or the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offering of our common stock pursuant to the sales agreement will terminate upon the earlier of (i) the sale of all of our common stock
provided for in this prospectus or (ii) termination of the sales agreement as provided therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sales Agents and its affiliates may in the future provide various investment banking and other financial services for us and our affiliates,
for which services they may in the future receive customary fees. To the extent required by Regulation M, The Sales Agents will not engage
in any market making activities involving our common stock while the offering is ongoing under this prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"><A HREF="#Da_013" STYLE="font-weight: bold">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="Da_010"></A>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the common stock offered hereby will be passed upon for us by Farris LLP, our British Columbia counsel. Jolie Kahn, Esq.,
will be passing upon matters of United States law for us with respect to the common stock offered hereby. The Sales Agents are being
represented in connection with this offering by Duane Morris LLP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="Da_011"></A>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements incorporated in this Prospectus Supplement by reference to the Annual Report on Form 10-K for the year
ended December 31, 2024 have been audited by Marcum, LLP, an independent registered public accounting firm, as stated in their report
incorporated by reference herein, and have been so incorporated in this prospectus supplement in reliance upon such report and upon the
authority of such firm as experts in accounting and auditing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="Da_012"></A>WHERE
YOU CAN FIND MORE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
file reports with the SEC on an annual basis using Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. You may
read and copy any such reports and amendments thereto at the SEC&rsquo;s Public Reference Room at 100 F Street, N.E., Washington, D.C.
20549 on official business days during the hours of 10:00 a.m. to 3:00 p.m. Please call the SEC at 1-800-SEC-0330 for information on
the Public Reference Room. Additionally, the SEC maintains a website that contains annual, quarterly, and current reports, proxy statements,
and other information that issuers (including us) file electronically with the SEC. The SEC&rsquo;s website address is http://www.sec.gov.
You can also obtain copies of materials we file with the SEC from our Internet website found at www.agriforcegs.com. Our stock is quoted
on the Nasdaq Capital Market under the symbol &ldquo;AGRI.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus supplement is only part of a registration statement on Form S-3 that we have filed with the SEC under the Securities Act and
therefore omits certain information contained in the registration statement. We have also filed exhibits and schedules with the registration
statement that are excluded from this prospectus, and you should refer to the applicable exhibit or schedule for a complete description
of any statement referring to any contract or other document. You may inspect a copy of the registration statement, including the exhibits
and schedules, without charge, at the public reference room or obtain a copy from the SEC upon payment of the fees prescribed by the
SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="ta_001"></A>This
prospectus supplement is part of a registration statement filed with the SEC. The SEC allows us to &ldquo;incorporate by reference&rdquo;
into this prospectus supplement the information that we file with them, which means that we can disclose important information to you
by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus supplement,
and information that we file later with the SEC will automatically update and supersede this information. The following documents are
incorporated by reference and made a part of this prospectus supplement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual Report on <A HREF="https://www.sec.gov/Archives/edgar/data/1826397/000164117225002955/form10-k.htm" STYLE="-sec-extract: exhibit">Form 10-K</A> for the
    year ended December 31, 2024 filed on April 7, 2025 and as amended on <A HREF="https://www.sec.gov/Archives/edgar/data/1826397/000164117225006668/form10-ka.htm" STYLE="-sec-extract: exhibit">Form 10-K/A</A>, which amendment was filed on April 29, 2025 and
    Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025 and June 30, 2025, filed on <A HREF="https://www.sec.gov/Archives/edgar/data/1826397/000164117225010961/form10-q.htm" STYLE="-sec-extract: exhibit">May 15, 2025</A> and <A HREF="https://www.sec.gov/Archives/edgar/data/1826397/000164117225024019/form10-q.htm" STYLE="-sec-extract: exhibit">August 14, 2025</A>,
    respectively;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Definitive Proxy Statement on <A HREF="https://www.sec.gov/Archives/edgar/data/1826397/000164117225008444/formdef14a.htm" STYLE="-sec-extract: exhibit">Schedule 14A</A> and
    accompanying additional proxy materials filed with the SEC on May 5, 2025;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current Reports on Form 8-K (excluding any reports
    or portions thereof that are deemed to be furnished and not filed) filed <A HREF="https://www.sec.gov/Archives/edgar/data/1826397/000149315225002585/form8-k.htm" STYLE="-sec-extract: exhibit">January 16, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1826397/000149315225003505/form8-k.htm" STYLE="-sec-extract: exhibit">January 24, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1826397/000149315225004221/form8-k.htm" STYLE="-sec-extract: exhibit">January 30, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1826397/000149315225009709/form8-k.htm" STYLE="-sec-extract: exhibit">March 10, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1826397/000164117225002981/form8-ka.htm" STYLE="-sec-extract: exhibit">April 7, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1826397/000164117225006275/form8-k.htm" STYLE="-sec-extract: exhibit">April 25, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1826397/000164117225008121/form8-k.htm" STYLE="-sec-extract: exhibit">May 1, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1826397/000164117225009082/form8-k.htm" STYLE="-sec-extract: exhibit">May 7, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1826397/000164117225014101/form8-k.htm" STYLE="-sec-extract: exhibit">June 6, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1826397/000164117225022238/form8-k.htm" STYLE="-sec-extract: exhibit">August 5, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1826397/000149315225013992/form8-k.htm" STYLE="-sec-extract: exhibit">September 18, 2025</A> and <A HREF="https://www.sec.gov/Archives/edgar/data/1826397/000149315225014385/form8-k.htm" STYLE="-sec-extract: exhibit">September 22, 2025</A>; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our registration statement on <A HREF="https://www.sec.gov/Archives/edgar/data/1826397/000149315221015987/form-8a12b.htm" STYLE="-sec-extract: exhibit">Form 8-A</A> filed on July
    2, 2021.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also incorporate by reference all additional documents that we file with the Securities and Exchange Commission under the terms of Sections
13(a), 13(c), 14 or 15(d) of the Exchange Act that are made after the date of the initial registration statement but prior to effectiveness
of the registration statement and after the date of this prospectus supplement but prior to the termination of the offering of the securities
covered by this prospectus supplement. We are not, however, incorporating, in each case, any documents or information that we are deemed
to furnish and not file in accordance with Securities and Exchange Commission rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may request, and we will provide you with, a copy of these filings, at no cost, by calling us at (604) 757-0952 or by writing to us at
the following address:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgriFORCE
Growing Systems Ltd.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">800-525
    West 8th Avenue</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vancouver,
BC V5Z 1C6</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"><A HREF="#Da_013" STYLE="font-weight: bold">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AGRIFORCE
GROWING SYSTEMS, LTD.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Units</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may from time to time, in one or more offerings at prices and on terms that we will determine at the time of each offering, sell common
stock, preferred stock, warrants, units or a combination of these securities for an aggregate initial offering price of up to $150,000,000.
This prospectus provides you with a general description of the securities we may offer, which is not meant to be a complete description
of each of the securities. Each time we offer and sell securities, we will provide you with a prospectus supplement that will contain
specific information about the terms of that offering. Any prospectus supplement may also add, update, or change information contained
in this prospectus. You should carefully read this prospectus and the applicable prospectus supplement as well as the documents incorporated
or deemed to be incorporated by reference in this prospectus and the applicable prospectus supplement before you purchase any of the
securities offered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 32.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus may not be used to offer and sell securities unless accompanied by a prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 32.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is currently traded on the Nasdaq Capital Market under the symbol &ldquo;AGRI&rdquo;, and our Series A Warrants are currently
traded on the Nasdaq Capital Market under the symbol &ldquo;AGRIW&rdquo;. On August 8, 2022, the last reported sales price for
our common stock was $1.78 per share. We will apply to list any shares of common stock sold by us under this prospectus and any
prospectus supplement on the Nasdaq Capital Market. The prospectus supplement will contain information, where applicable, as to any other
listing of the securities on the Nasdaq Capital Market or any other securities market or exchange covered by the prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 32.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may offer the securities directly or through agents or to or through underwriters or dealers. If any agents or underwriters are involved
in the sale of the securities, their names, and any applicable purchase price, fee, commission or discount arrangement between or among
them, will be set forth, or will be calculable from the information set forth, in an accompanying prospectus supplement. We can sell
the securities through agents, underwriters or dealers only with delivery of a prospectus supplement describing the method and terms
of the offering of such securities. See &ldquo;Plan of Distribution&rdquo; section of this prospectus for further information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
securities offered by this prospectus involve a high degree of risk. See &ldquo;Risk Factors&rdquo; section of this prospectus.
We may also include specific risk factors in an applicable prospectus supplement under the heading &ldquo;Risk Factors.&rdquo; You should
carefully review these Risk Factors prior to investing in our securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined
if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is August 9, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT THIS PROSPECTUS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">1</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SUMMARY</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">1</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">23</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">23</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RATIO OF EARNINGS TO FIXED CHARGES</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">37</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">37</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF COMMON STOCK</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">37</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF PREFERRED STOCK</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">38</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF WARRANTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">39</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF UNITS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">40</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">40</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">42</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">42</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#ba_014"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">43</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 13; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="ba_001"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABOUT
THIS PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is a part of a registration statement that we filed with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;),
using a &ldquo;shelf&rdquo; registration process. Under this shelf registration statement, we may sell securities from time to time and
in one or more offerings up to a total dollar amount of $150,000,000, subject to limitations as set forth in General Instruction I.B.6.
of Form S-3, until such time as our unaffiliated market capitalization reaches $75 million. As allowed by SEC rules, this prospectus
does not contain all of the information included in the registration statement, including its exhibits. For further information, we refer
you to the registration statement, including its exhibits, the documents incorporated by reference therein and herein as well as any
accompanying prospectus supplements or any free writing prospectuses prepared by or on behalf of us or to which we have referred you.
Statements contained in this prospectus and any accompanying prospectus supplement or in any applicable free writing prospectus about
the provisions or contents of any agreement or other document are not necessarily complete. If the SEC&rsquo;s rules and regulations
require that an agreement or document be filed as an exhibit to the registration statement, please see that agreement or document for
a complete description of these matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>You
should rely only on the information incorporated by reference or provided in this prospectus, any accompanying prospectus supplement
or any applicable free writing prospectuses prepared by or on behalf of us or to which we have referred you. We have not authorized anyone
else to provide you with any other information. If anyone provides you with different or inconsistent information, you should not rely
on it. We are not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
PROSPECTUS MAY NOT BE USED TO CONSUMMATE A SALE OF SECURITIES UNLESS IT IS ACCOMPANIED BY A PROSPECTUS SUPPLEMENT.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
we, nor any agent, underwriter or dealer has authorized any person to give any information or to make any representation other than those
contained or incorporated by reference in this prospectus, any applicable prospectus supplement or any related free writing prospectus
prepared by us or on our behalf or to which we have referred you. This prospectus, any applicable supplement to this prospectus or any
related free writing prospectus do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the
registered securities to which they relate, nor does this prospectus, any applicable supplement to this prospectus or any related
free writing prospectus constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person
to whom it is unlawful to make such offer or solicitation in such jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should not assume that the information contained in this prospectus, any applicable prospectus supplement or any related free writing
prospectus is accurate on any date subsequent to the date set forth on the front of the applicable document. You should also not assume
that any information we have incorporated by reference is correct on any date subsequent to the date of the document incorporated by
reference, even though this prospectus, any applicable prospectus supplement or any related free writing prospectus is delivered, or
securities are sold, on a later date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus and the information incorporated by reference in this prospectus contain summaries of provisions of certain other documents,
but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual
documents. Copies of some of the documents referred to in this prospectus have been filed, will be filed or will be incorporated by reference
as exhibits to the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described
below under the heading &ldquo;Where You Can Find More Information.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>You
should only rely on the information contained or incorporated by reference in this prospectus, any prospectus supplement or any related
free writing prospectus. We have not authorized anyone to provide you with information different from what is contained or incorporated
by reference into this prospectus, applicable prospectus supplement or any related free writing prospectus. If any person does provide
you with information that differs from what is contained or incorporated by reference in this prospectus, applicable prospectus supplement
or any related free writing prospectus, you should not rely on it. No dealer, salesperson or other person is authorized to give any information
or to represent anything not contained in this prospectus, applicable prospectus supplement or any related free writing prospectus. You
should assume that the information contained in this prospectus, any prospectus supplement or any related free writing prospectus is
accurate only as of the date on the front of the document and that any information contained in any document we have incorporated by
reference therein is accurate only as of the date on its face, regardless of the time of delivery of this prospectus, any prospectus
supplement, any related free writing prospectus or any sale of a security under this registration statement. These documents are not
an offer to sell or a solicitation of an offer to buy these securities in any circumstances under which the offer or solicitation is
unlawful.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="ba_002"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary highlights selected information from this prospectus and does not contain all of the information that you should consider in
making your investment decision. You should carefully read the entire prospectus, the applicable prospectus supplement and any related
free writing prospectus, including the risks of investing in our securities discussed under the heading &ldquo;Risk Factors&rdquo; contained
in the applicable prospectus supplement and any related free writing prospectus, and under similar headings in the documents that are
incorporated by reference into this prospectus. You should also carefully read the information incorporated by reference into this prospectus,
including our financial statements, and the exhibits to the registration statement of which this prospectus is a component.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms &ldquo;AgriForce,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;our&rdquo; or &ldquo;us&rdquo; in this prospectus
refer to AgriForce Growing Systems, Ltd. and its wholly-owned subsidiaries, unless the context suggests otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OUR
BUSINESS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgriFORCE
Growing Systems Ltd. was incorporated as a private company by Articles of Incorporation issued pursuant to the provisions of the Business
Corporations Act (British Columbia) on December 22, 2017. The Company&rsquo;s registered and records office address is at <FONT STYLE="background-color: white">300
&ndash; 2233 Columbia Street, Vancouver, BC, Canada, V5Y 0M6</FONT>. On February 13, 2018, the Company changed its name from 1146470
B.C. Ltd to Canivate Growing Systems Ltd. On November 22, 2019 the Company changed its name from Canivate Growing Systems Ltd. to AgriFORCE
Growing Systems Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
AgriFORCE, our purpose is clear: to positively transform farm, food, and family every day, everywhere. With years of in-depth research
and development experience, we are pioneers, ready to deliver integrated, practical, and sustainable solutions that can be applied throughout
multiple verticals in AgTech. We drive our business through two operating divisions, AgriFORCE Solutions and AgriFORCE Brands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
two divisions&mdash;AgriFORCE Solutions and AgriFORCE Brands&mdash;work in partnership to address some of the existential challenges
being faced by the world today&mdash;climate change, extreme weather, food security and sovereignty, the environmental impact of industrial
and commercial farming&mdash;working towards providing better tasting, more nutritious plant-based foods and other products to consumers
on a global level.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AgriFORCE
Solutions:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgriFORCE
Solutions provides consulting services for AgTech knowledge, operational solutions, and research and development (R&amp;D), which is
augmented with patented and patent pending controlled-environment agriculture (CEA) and additional agriculture facilities and platforms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have taken a strategic and holistic view of agriculture to provide solutions that address the key challenges facing this important industry.
We develop and acquire innovative intellectual property (IP) and technology to improve farming. Our expertise goes from seed to table
and ranges through the life cycle of a plant&mdash;from micropropagation and tissue culture to cultivation&mdash;with a proprietary approach
that brings together all of the elements, including crops, operations, facilities, systems, and environment designed to allow the plant
to reach its full genetic potential.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
consulting to our innovative foundational intellectual property&mdash;our proprietary facility and growing systems&mdash;to the technology
and know-how that we have in our group of companies, we have integrated the key aspects of AgTech to create an outcome that is Clean.
Green. Better.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AgriFORCE
Brands:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgriFORCE
Brands division is focused on the development and commercialization of plant-based ingredients and products that deliver healthier and
more nutritious solutions. We will market and commercialize both branded consumer product offerings and ingredient supply. This started
with the acquisition of the MNG (Manna) intellectual property which is a patent-pending technology to naturally process and convert grains,
pulses, and root vegetables. The process results in low-starch, low-sugar, high-protein, fiber-rich baking flour products, and nutrition
liquid. The nutrition values of the flour have the potential to transform consumers&rsquo; diet in multiple verticals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MNG
Wheat flour has 30 times more fibers, up to 3 times more proteins and less than 15% of the starch as Regular All-Purpose Baking flour
as independently tested and conducted by Eurofins Food Chemistry Testing Madison, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><IMG SRC="forms-3_001.jpg" ALT="" STYLE="height: 192px; width: 670px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DIVISIONS:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AgriFORCE
Solutions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Understanding
Our Approach &ndash; The AgriFORCE Precision Growth Method</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Traditional
farming includes three fundamental approaches: outdoor, greenhouse and indoor. AgriFORCE introduces a unique fourth method, the AgriFORCE
precision growth method, which is informed by cutting-edge science and leveraging the latest advances in artificial intelligence (AI)
and Internet of Things (IoT).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a carefully optimized approach to facility design, IoT, AI utilization, nutrient delivery, and micro-propagation, we have devised an
intricate, scientific and high success-oriented approach designed to produce greater yields using fewer resources. This method is intended
to outperform traditional growing methods using a specific combination of new and traditional techniques required to attain this efficiency.
We call it precision growth. The AgriFORCE precision growth method focuses on addressing some of the most important legacy challenges
in agriculture: environmental impact, operational efficiency and yield volumes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
AgriFORCE precision growth method presents a tremendous opportunity to positively disrupt all corners of the industry. The size of just
the nutraceutical and plant-based pharmaceutical and vaccine/therapeutics market is over $500 billion. Including the traditional hydroponics
high value crops and controlled-environment food markets, the addressable market approaches nearly $1 trillion.<SUP>(1)(2)(3)</SUP>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
our patent pending intellectual property initially targeted the hydroponics sector of our customers high value crops to showcase its
efficacy in a growing market, we are currently expanding operations to refine our technology and methodology for vegetables and fruit
food crops. Hydroponics was identified as an ideal sector to demonstrate proof of concept However, management has decided that the Company
focus on evolving our intellectual property and applying our precision growth method to other agricultural areas so that we can be a
part of the solution in fixing the severe issues with the global food supply chain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
AgriFORCE Model &ndash; Managing the Difficulties of Agricultural Verticals with Modern Technology and Innovation</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
intellectual property combines a uniquely engineered facility design and automated growing system to provide a clear solution to the
biggest problems plaguing most agricultural verticals. It delivers a clean, self-contained environment that maximizes natural sunlight
and offers near ideal supplemental lighting. It also limits human intervention and &ndash; crucially &ndash; it was designed to provide
superior quality control. It was also created to drastically reduce environmental impact, substantially decrease utility demands, as
well as lower production costs, while delivering customers daily harvests and higher crop yields.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plants
grow most robustly and flavorfully in full natural sunlight. While it may seem counterintuitive to some, even the clearest of glass greenhouses
inhibit the full light spectrum of the sun. However, new translucent and transparent membrane materials have emerged that enable the
near-full-transmission of the sun&rsquo;s light spectrum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
https://home.kpmg/pl/en/home/insights/2015/04/nutraceuticals-the-future-of-intelligent-food.html</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
https://link.springer.com/article/10.1057/jcb.2010.37</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
https://medium.com/artemis/lets-talk-about-market-size-316842f1ab27</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlike
plastic or glass, these new transparent membranes can help crops achieve their full genetic (and flavor) potential. Natural light also
warms the microclimate, when necessary, dramatically reducing heating energy requirements. At times when natural light is not available,
advances in supplemental grow lighting can extend the plants&rsquo; photoperiod &ndash; to maximize crop growth, quality, and time to
harvest by up to 50% better.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greenhouses
and vertical farms are also compromised by outdoor and human-introduced contamination. The new model relies on creating a sealed, cleanroom-like
microclimate that keeps pests, pesticides, and other pollutants outside.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks
to AI, the IoT, and similar advances, farmers can now benefit from highly automated growing systems that reduce human intervention and
its associated costs. Finely tuned convective air circulation systems enable the microclimate to remain sealed and protected. Natural
temperature regulation using sunlight and organic foam-based clouds can significantly reduce air-conditioning electricity requirements.
Highly automated hydration, fertilization, and lighting are all continuously optimized by machine learning.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
new AgriFORCE model, which has been designed with more than four years of ongoing research and development, is set to be put into large
scale practice when the first of three new grow facilities complete construction in Coachella, California. This unique approach, which
included contributions from lighting experts who had previously worked at NASA sending plants into space, was developed to significantly
improve local food security in an environmentally friendly way. It uses the best aspects of the facility&rsquo;s operator&rsquo;s current
growing methods &ndash; outdoor, greenhouse and indoor &ndash; and replaces their shortcomings with better technology and processes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
solution whether in agriculture, industry, or consumer goods is typically the integration of various disparate parts which, in and of
themselves, require independent skill sets and levels of expertise to bring together the desired outcome. Controlled environment agriculture
solutions such as our patent pending proprietary facility and automated grow system are no different. Centered around four pillars: facility
and lighting; automation and AI; nutrients and fertigation and micropropagation and genetics, our business not only has a tremendous
opportunity to grow organically by virtue of our future pipeline of Growhouse contracts;, but also through accretive acquisitions for
our Agtech platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Our
Position in the Ag-Tech Sector</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Ag-Tech sector is severely underserved by the capital markets, and we see an opportunity to acquire global companies who have provided
solutions to the industry and are leading innovation moving forward. We are creating a separate corporate office to aggressively pursue
such acquisitions. The robustness of our engagement with potential targets has confirmed our belief and desire to be part of a larger
integrated Ag-Tech solutions provider, where each separate element of the business has its existing legacy business <I>and</I> can leverage
across areas of expertise to expand their business footprint. We believe that there is currently no one that we are aware of who is pursuing
this model in the US capital markets environment at this time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
AgriFORCE Grow House</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an agriculture-focused technology company that delivers innovative and reliable, financially robust solutions for high value
crops through our proprietary facility design and automation IP to businesses and enterprises globally. The Company intends to operate
in the plant based pharmaceutical, nutraceutical, and high value crop markets using its unique proprietary facility design and hydroponics
based automated growing system that enable cultivators to effectively grow crops in a controlled environment. The Company calls its facility
design and automated growing system the &ldquo;AgriFORCE grow house&rdquo;. The Company has designed its AgriFORCE grow house to produce
in virtually any environmental condition and to optimize crop yields to as near their full genetic potential possible while substantially
eliminating the need for the use of pesticides, fungicides and/or irradiation. The Company is positioning itself to deliver solutions
to a growing industry where end users are demanding environmentally friendly and sustainable, controlled growing environments and processes.
The initial market focus is the cultivation of food and other high value crops in California, and proof of concept may apply the IP to
biomass production of plant based vaccine materials. The Company believes that its IP may provide a lower cost cultivation solution for
the indoor production of crops due to a combination of higher crop quality and yields, and reduced operating costs. The Company has designed
its AgriFORCE grow house as a modular growing facility that it plans to build and license to licensed operators for the cultivation of
food and high value crops. The AgriFORCE grow house incorporates a design and technology that is the subject of a provisional patent
that the Company has submitted to the United States Patent and Trademark Office on March 7, 2019. On March 6, 2020, a New International
Patent Application No. PCT/CA2020/050302 Priority Claim United States 62/815, 131 was filed. The Company&rsquo;s IP can be adapted to
a multitude of crops and required growing conditions where exacting environmental control and pharma grade equivalent cleanliness and
processes are required to meet the highest cultivation standards. By delivering the first facility, the Company should be in a position
to demonstrate the performance and to target Good Manufacturing Practices standards compliance necessary to engage the pharma industry
as it moves into modifying its IP to meet the particular plant biomass requirements for vaccines and other pharma biomass.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the Company commences construction of its micropropagation facility and grow house, it is plannings to start developing its solution
for fruits and vegetables focusing on the integration of its current structure with a new form of vertical grow technology. Although
many of the components and elements may be the same or similar in nature, the automation and integration for going vertical and accommodating
lighting, circulation, climate control and humidity control may be somewhat different. Therefore, the Company intends to develop a small
working commercial facility as it moves to finalize design and engineering. The Company believes it can deliver new IP for various forms
of CEA with a view to constructing its first commercial facility to serve the Southern California market before rolling out its solution
to other crops and local markets in the United States and internationally.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Our
Intellectual Property Strategy</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s IP and business is focused on four (4) key elements:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FACILITY AND LIGHTING DESIGN</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-the
facility utilizes a proprietary building envelope system that allows virtually the full light spectrum and substantial portions of the
UV light spectrum through it. It is fully sealed and utilizes positive air pressure exchange to create a microclimate that optimizes
temperature, humidity, CO2, air velocity, filtration, and sanitation through the process of biomimicry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-Advanced
proprietary supplemental grow lighting technologies achieving optimal luminous efficacy, spectrum, distribution characteristics, automated
DLI management and fixture architecture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUTOMATION AND ARTIFICIAL INTELLIGENCE</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-Proprietary
automated grow system(s) and technology integrated through IOT and artificial intelligence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-Self
learning input factors to create the highest yield, lowest impact cultivation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FERTIGATION AND NUTRIENTS</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-white
label and proprietary organic based blends/products tailored and focused on improved yields and reduced impact cultivation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MICROPROPAGATION AND GENETICS</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Optimized
cellular cloning and tissue culture process tailored to facility environment optimization to ensure enhanced solution specific genetic
outcomes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
maximize the AgriFORCE grow house&rsquo;s production capacity, each AgriFORCE grow house is planned to incorporate its own tissue culture
laboratory for micropropagation into the Company&rsquo;s proprietary mechanized and automated growing system. AgriFORCE micropropagation
laboratories should enable the micropropagation of healthy plantlets to be transplanted and grown to maturity in its facilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>AGRIFORCE
SOLUTIONS BUSINESS PLAN</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company plans to develop its business by focusing on both an organic growth plan and through M&amp;A. The Company&rsquo;s organic growth
plan is focused on four distinct phases:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PHASE
1: COMPLETED: 2017-2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conceptualization,
    engineering, and design of facility and systems.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Completed selection process
    of key environmental systems with preferred vendors.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The signing
    of revenue contracts with the Exclusive Independent Operator (EIO) for the first three facilities completed.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The arrangement of three
    offtake agreements signed with Exclusive Independent Operator (EIO) for those three facilities when complete. (Subsequently these
    agreements were terminated in Q2 2021)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selection and Land Purchase
    agreement in Coachella, CA for 41.37-acre parcel subject to financing.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ForceFilm material ordered.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PHASE
2: 2022-2024:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase of
    a land parcel in Coachella, CA</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Complete new contracts&rsquo;
    structures for those first three facilities with new independent operators.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Site preparation and utilities
    infrastructure build out for the campus (up to eight facilities).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fit out and complete genetics
    lab for micropropagation, breeding, and R&amp;D to achieve near term revenue (8 months) of the sale of tissue culture clones for
    variant crops.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional raw materials
    procurement of AgriFORCE IP specific automated grow system, supplemental grow lighting and controls systems, and manufacture of the
    building envelope materials.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conceptualization and design
    of vertical grow solutions in order to develop a small-scale vertical grow house.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Focus on the delivery and
    installation of the first facility.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initiate the design of
    a R&amp;D facility for food solutions and plant-based pharma.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PHASE
3: 2024-2027:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compete construction
    of first facility and commence operations</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Focus on the delivery and
    installation of the second and third facilities. Proof of quantitative and qualitative benefits are expected to drive both sales
    pipeline acceleration for subsequent years.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Complete the design and
    construction of a R&amp;D facility for food solutions and plant-based pharma. Commence engagement with universities and pharmaceutical
    companies.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Construct small scale vertical
    grow house and operate successfully.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finalize the design and
    engineering of vertical grow solution with construction commencement late in the third year. Commence engagement with local restaurants
    and grocery stores and develop a vertical grow house branding strategy.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PHASE
4: 2027:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Focus on delivery
    and installation of additional facilities.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expand geographic presence
    into other states whilst also introducing the grow house to other international markets with a view to securing additional locations
    and markets by year four.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Targeted additional contracts
    of three facilities.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commence and complete first
    vertical grow commercial facility to serve Southern California market by end of year 4.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s initial AgriFORCE grow houses are planned to be constructed in California.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AgriFORCE
Brands</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company purchased Intellectual Property (&ldquo;IP&rdquo;) from Manna Nutritional Group, LLC (&ldquo;MNG&rdquo;), a privately held firm
based in Boise, Idaho on September 10, 2021. The IP encompasses patent-pending technologies to naturally process and convert grain, pulses
and root vegetables, resulting in low-starch, low-sugar, high-protein, fiber-rich baking flour produces as well as wide range of breakfast
cereals, juices, natural sweeteners and baking enhancers. The core process is covered under a pending patent application in the U.S.
and key international markets. The all-natural process is designed to unlock nutritional properties, flavor and other qualities in a
range of modern, ancient and heritage grains, pulses and root vegetables to create specialized All-Natural baking and all-purpose flours,
sweeteners, juices, naturally sweet cereals and other valuation products, providing numerous opportunities for dietary nutritional, performance
and culinary applications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As
of May 17, 2022, AgriForce Growing Systems, Ltd. (the &ldquo;Company&rdquo;) completed an amendment to its asset purchase agreement with
Manna Nutritional Group LLC, dated September 10, 2021. The amendment amends certain provisions of Section 2 thereof. Section 2.04(i)
was amended to provide for the issuance of prefunded warrants instead of shares, with the trigger valuation date for the first $3.5 million
of equity to be March 10, 2022 and the trigger valuation date for the next $1.5 million of equity to be the vwap of the Company&rsquo;s
common stock for the ten trading days immediately preceding the submission resubmission work date on the patents set forth in the asset
purchase agreement. Section 2.04(iv) was amended to also reflect issuance of pre funded warrants instead of common shares in two tranches
of $5 million on June 30, 2022 and $3 million on December 31, 2022, such that if a Patent (as defined in the asset purchase agreement)
is issued within 24 months of the Closing Date (as defined in the asset purchase agreement), then the aforementioned $8 million in prefunded
warrants will vest in four equal amounts on the date of issuance of the patent and then for the three subsequent three month anniversaries
thereof. If the aforementioned patent does not issue within 24 months of the Closing Date, then those prefunded warrants shall be returned
to the Purchaser, and the transaction purchase price shall be adjusted downward, dollar for dollar. The amendment also contains covenants
to obtain shareholder approval of the acquisition transactions before the prefunded warrants can be exercised into Company common shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company plans to rebrand the consumer products and innovative ingredient offering for food manufacturers under the brand (un)Think foods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Wheat
and Flour Market</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Modern
diet is believed to be a contributor to health risks such as heart disease, cancer, diabetes and obesity, due in part to the consumption
of highly processed foods that are low in natural fiber, protein and nutrition; and extremely high in simple starch, sugar and calories.
These &ldquo;empty carbs&rdquo; produce glycemic swings that may cause overeating by triggering cravings for food high in sugar, salt
and starch. As an example, conventional baking flour is low in natural fiber (about 2-3%), low-to-average in protein (about 9%), and
very high in starch (about 75%). Whole wheat flour is only marginally better. Similarly, gluten-free products are often produced with
sugar and starches such as potato flour, rice flour, tapioca, etc. Gluten-free products are typically low-fiber, low-nutrition, high-starch
and high-calorie.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
contrast, foods high in fiber help to satiate hunger, suppress cravings, raise metabolism and require more calories to digest. They also
assist in weight loss, lower cholesterol, and may reduce the risk of cancer, heart disease and diabetes.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Advantages
of the MNG IP</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
CERES-MNG process allows for the development and manufacturing of All-natural Fours that are significantly higher in Fibers, Nutrients
and Proteins and significantly lower in Carbohydrates and Calories than Standard Baking Flour.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
shown in the graph below, MNG Baking Flour produced from Soft White Wheat has 30 time more fiber, 3 times more protein, 80% less starch
and 50-60% less calories as compared to standard all- purpose baking flour.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><IMG SRC="forms-3_002.jpg" ALT="" STYLE="height: 273px; width: 600px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
CERES-MNG patent pending process is expected to help develop new flours and products from modern, ancient and heritage grains, seeds,
legumes and tubers/root vegetables.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Why
Manna NG versus Keto or Low Carb Flours and Sprouted Grains Flours?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><IMG SRC="forms-3_003.jpg" ALT="" STYLE="height: 322px; width: 630px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Versus Keto/Low Carb Flours, Manna NG has some clear
    positive distinctions:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9676;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simple and clean ingredient list</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9676;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significantly higher protein values</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9676;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Materially Higher Fiber content</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9676;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significantly lower carb content</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9676;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">More palatable and natural flavor without any additives</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9676;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Works and tastes like All Purpose Wheat Baking Flour</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Versus Sprouted Grains Flours</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9676;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Like Sprouted Grains Flours, Manna NG Nutrients are
    metabolized better;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9676;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significantly Higher Protein content</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9676;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Materially Higher Fiber content</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9676;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significantly Lower Carb content</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finally,
the CERES-MNG Process creates a Liquid by-product which is a High Fiber, High Protein, Maltose Sweet Juice (Power Juice) from which we
intend to develop Nutrition Drinks, Flavoured Drinks and to use as a base for Nutrition Bars.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Products
that AgriFORCE intends to develop for commercialization from the CERES/MNG Process:</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">High protein, High Fiber, Low Carb Modern, Heritage
    and Ancient grain flours (for use in breads, baked goods, doughs, pastry, snacks, and pasta)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Protein Flours and Protein Additives</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">High Protein, High Fiber, Low Carb cereals and snacks</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">High Protein, High Fiber, Low Carb oat based dairy
    alternatives</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Better Tasting, Cleaner Label High Protein, High Fiber,
    Low Carb nutrition bars</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">High Protein, High Fiber Low Carb nutrition juices
    and flavored drinks</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">High Protein, High Fiber, Low Carb pet foods and snacks</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
intend to commercialize these products behind 2 main Go-to-Market strategies:</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Branded Ingredients for B2B</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consumer Brand for Direct to Consumers and Retail</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Opportunity for AgriFORCE to successfully commercialize Premium Specialized Products from the Manna IP - by capturing a conservatively
very small percentage share of the category it is targeting to enter in the premium segments. We estimate these revenues to be between
$500 million and $1 Billion by 2025 (excluding any potential revenues from the Maltose-Power Juice applications).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Breads &amp;Bakery</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Functional Flours</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Pulse Flours</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Dairy Alternatives</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Nutrition Bars</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">TOTAL</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; font-weight: bold; text-align: left">Global Market Size of Target Categories</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;222B</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;48B</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17B</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6B</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;45B</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">Potential Market Share</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Sources:
Grand View Research Reports, San Francisco CA, 2018 Estimates.</I></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Products
from the MANNA IP address Consumer Trends in Health, Nutrition and Diet</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
benefits of plant-based proteins, low-carbohydrates (particularly &ldquo;empty&rdquo; carbs) and natural high- fiber diets are key to
good health and nutrition and are critically important in combating cancer, diabetes, digestive disorders, high-cholesterol, obesity
and heart disease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
High-Protein, High Fiber, Low Carb products from the CERES-MNG Process, allows to address these growing consumer needs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Importantly,
the Manna IP products would target primarily Millennials and Boomers, that increasingly look for healthier food alternatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="forms-3_004.jpg" ALT="" STYLE="height: 341px; width: 500px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Long-Term
Future Applications &ndash; Product Development; Medical Research &amp; Development</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following outlines future applications, research, and development. This may include controlled studies on Type II Diabetes, in addition
to a dedicated and completely independent Medical Research Organization (MRO) and research laboratory, supported by private and public
research grants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><IMG SRC="forms-3_005.jpg" ALT="" STYLE="height: 280px; width: 499px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>AGRIFORCE
BRANDS BUSINESS PLAN</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgriFORCE&rsquo;s
organic growth plan to actively establish and deploy the commercialization of products, following the acquisition of the MNG IP, is focused
on four distinct phases:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PHASE
1: COMPLETED: 2017-2020</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product
    and Process Testing and Validation (Completed)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing
    of US and International Patent (Completed)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conceptual
    Engineering and Preliminary Budgeting on Commercial Pilot Plant (Completed)</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PHASE
2: 2021-2022</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Design,
    Build, Start-up and Operation of the Pilot Plant</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
    Range of Finished Products in Wheat Grain Flours</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaborate
    with Nutritional Flour Medical Research Institute (an IRS section 501(c)(3) Medical Research Organization) funded by private &amp;
    public research grants</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PHASE
3: 2022-2023</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Launch
    First Range of Products in US/Canada</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Drive
    Business with Finished Products in direct to consumer (&ldquo;D2C&rdquo;), Retail, Food Service</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Drive
    Business as Ingredients for Bakery, Snack and Plant Based Protein Products Manufacturers</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
    Manufacturing Base through Partnerships and Licensing</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conceptual
    Engineering and Preliminary Budgeting on Large-Scale Processing Plant</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
    Range of Finished Products in other Grain Flours, Pulses/Protein Flours and Juices</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PHASE
4: 2024-2025</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expand
    Product Range in US/Canada</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expand
    Business to other Geographies (select Markets in Europe, Asia, Latin America)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Design,
    Build Start-up and Operation of Large-Scale Processing Plan</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger
and Acquisition (&ldquo;M&amp;A&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to M&amp;A growth, the Company is creating a separate corporate office to aggressively pursue acquisitions. The Company plans
to focus on identifying target companies, which help expand AgriFORCE Brand&rsquo;s mandate to deliver more nutritious (better for you)
crops, ingredients, and plant-based products that are sustainably produced. The Company believes that AgriFORCE Solutions platform of
IP and group of companies acquired through M&amp;A can identify opportunities to produce crops more sustainably and that offer unique
competitive advantages through the supply chain to ultimately have them converted into ingredients and plant based products or simply
sold to consumers through AgriFORCE Brands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Below
is a summary of the intended strategy with respect to the Company&rsquo;s M&amp;A strategy:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strategy</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><IMG SRC="forms-3_006.jpg" ALT="" STYLE="height: 158px; width: 670px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delphy
Groep BV Acquisition</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 10, 2022, the Company signed a definitive agreement to acquire Delphy Groep BV (&ldquo;Delphy&rdquo;), a Netherlands-based AgTech
consultancy firm, for $23.1 million through a combination of cash and stock. The closing of the transaction was expected to occur
within 60 days of the signing date but is subject to shareholder approval and completion of audited financials of Delphy. The definitive
agreement follows the binding letter of intent (&ldquo;LOI&rdquo;) as previously announced in the Company&rsquo;s press release in October
2021. Delphy, which optimizes production of plant-based foods and flowers, has multinational operations in Europe, Asia, Kazakhstan,
and Africa, with approximately 200 employees and consultants. Delphy&rsquo;s client list includes agriculture companies, governments,
universities, and leading AgTech suppliers, who turn to the company to drive agricultural innovation, solutions, and operational expertise.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Deroose
Plants NV Binding Letter of Intent</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 23, 2022, the Company signed a binding letter of intent (the &ldquo;LOI&rdquo;) with Deroose Plants NV (&ldquo;Deroose&rdquo;),
one of the largest tissue culture propagation companies in the world with a leadership position in horticulture, plantation crops, and
fruit and vegetables. Founded in 1980, Deroose has multi-national operations in Europe, North America, and Asia, and over 800 employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
LOI is subject to completion of standard due diligence and entry into a definitive purchase agreement, which shall include commercially
standard terms and conditions, including, but not limited to, representations and warranties, covenants, events of default and conditions
to closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net purchase price by the Company is expected to be approximately $59.8 million. The purchase price represents approximately $40.2
million for the Deroose business on a cash and debt free basis and $19.6 million for the genetic IP portfolio.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
Structure</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently has the following wholly-owned subsidiaries, which perform the following functions &ndash; AgriFORCE Investments handles
any investments in the U.S., West Pender Holdings holds real estate assets, West Pender Management manages those assets, and AGI IP holds
intellectual property in the U.S. and DayBreak is dormant:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of Subsidiary</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jurisdiction
    of Incorporation</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
    of Incorporation</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgriFORCE
    Investments Inc. (US)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    9, 2019</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">West
    Pender Holdings, Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    1, 2018</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGI
    IP Co.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevada</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    5, 2020</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">West
    Pender Management Co.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevada</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    9, 2019</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Un(Think)
    Food Company</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevada</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    20, 2022</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DayBreak
    Ag Systems Ltd.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">British
    Columbia</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    4, 2019</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary
Three Year History</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
the date of Incorporation (December 22, 2017) to the date of this filing, the Company has largely been engaged in completion of its initial
corporate organization, assembling its management team, completing the design and engineering of its IP and filing the appropriate intellectual
property protection and taking the initial steps to implement its business plan through the commencement of initial operations in California.
Significant milestones during this period are as follows:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company completed its initial seed round financings in early 2018.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
    November 2018 to August 2019, the Company engaged architectural, lighting design, engineering and tensile structure engineering consultants
    to advance &ldquo;Concept Solution&rdquo; to an &ldquo;Engineered Solution&rdquo; for the AgriFORCE grow houses, and the Company&rsquo;s
    consultants completed testing and verification of its proprietary solutions, as described below in detail under &ldquo;<I>Advancement
    from Concept Solution to Engineered Solution</I><B>&rdquo;.</B></FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    December 2018, the Company selected FabriTec as its primary contractor for the growing portion of the AgriFORCE grow houses, which
    is planned to be constructed of tensile steel and the high strength flexible covering material.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    January 2019, the Company received from FabriTec the initial engineering drawings for the greenhouse enclosure for the AgriFORCE
    grow house.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    February 2019, the Company arranged for PharmHaus, as its initial EIO, to enter into three offtake agreements with well-known California
    high value crop producers for the potential offtake purchase of an aggregate of 19,500 kilograms of production, which has since been
    increased to 21,878 kilograms of production per year under a replacement offtake agreement executed in September 2019 (terminated
    in April 2021 as per the below description).</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    March 7, 2019, the Company filed an initial provisional patent application for the original concept related to the AgriFORCE grow
    house.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    July 2019, the Company entered into a master &ldquo;Design/ Build&rdquo; construction contract with FabriTec for the construction
    of the greenhouse enclosure (subject to final agreement on pricing).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    August 2019, the Company submitted an amended provisional patent application for its Structure Technology that reflects the &ldquo;engineered
    solution&rdquo; and related technology and intellectual property developed by the Company through the testing and verification process
    with FabriTec and the Company&rsquo;s other architectural, engineering and technical consultants.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    March 6, 2020, a New International Patent Application No. PCT/CA2020/050302 Priority Claim United States 62/815, 131 was filed. The
    Company&rsquo;s IP can be adapted to a multitude of crops and required growing conditions where exacting environmental control and
    pharma grade equivalent cleanliness and processes are required to meet the highest cultivation standards.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    April 22, 2021, the Company terminated its agreement with PharmHaus, its initial exclusive Independent Operator, as PharmHaus failed
    to demonstrate the business wherewithal to serve in its capacity as an exclusive Independent Operator.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company has substantially finalized the final design and engineering drawings for the AgriFORCE grow house.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    November 30, 2021, the Company signed an offtake agreement with Humboldt Bliss, Ltd., a Barbadian limited company (&ldquo;Humboldt&rdquo;).
    Under the terms of the contract, AgriFORCE is responsible for constructing its proprietary facility and providing the full Standard
    Operating Procedures (SOPs) of the AgriFORCE Grow House and Humboldt is responsible for securing the project&rsquo;s land as well
    as operating the facility. Upon production, Humboldt has committed to remit an IP licensing, management services and equipment leasing
    fee to AgriFORCE for up to 14,300 pounds (6,500 kgs) of high value medical and agricultural crops per year. David Welch, a director
    of the Company, owns a controlling interest in Humboldt am dos this a related party. Mr. Welch recused himself from the final deliberation
    and approval of the agreement by the board.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    February 18, 2022, the Company signed a license agreement with Radical Clean Solutions Ltd (&ldquo;Radical&rdquo;), a New York corporation
    that has development an advanced product line consisting of &ldquo;smart hydroxyl generation systems&rdquo; focused on numerous industry
    verticals that is proven to eliminate 99.99+% of all pathogens, virus, mold, volatile organic compounds (VOCs) and allergy triggers,
    to commercialize their new proprietary hydroxyl generating devices within the controller environment agriculture (&ldquo;CEA&rdquo;)
    and food manufacturing industries. The patent pending system seeks out and destroys both airborne and surface-based mold, bacteria,
    virus, odorous and volatile organic compounds and allergy triggers, as well as other pathogens and pollutants in real-time. The license
    grants the rights to AgriFORCE in perpetuity as well as joint patent ownership rights for CEA.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt
Financing</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
2022 Debt Financing</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 30, 2022, AgriForce Growing Systems, Ltd. (the &ldquo;Company&rdquo;) entered into a Securities Purchase Agreement (&ldquo;SPA&rdquo;)
with two institutional investors (&ldquo;Investors&rdquo;) with an initial purchase of $14.025 million principal amount of debentures
(&ldquo;Debentures&rdquo;) and accompanying warrants (&ldquo;Warrants&rdquo;) and up to an additional $33 million principal amount of
Debentures and accompanying Warrants. Under the SPA, the Company expects to receive an initial amount of $12.75 million (gross of fees
which will be deducted from that amount) on July 6, 2022 and has the right to receive up to an additional aggregate of $33.0 million
at the discretion of each of the purchasers hereunder (the &ldquo;Investors&rdquo;), in one or multiple tranches, subject to certain
conditions, at then-current market prices in minimum tranches of $5 million each. The SPA contains industry standard representations
and warranties and negative covenants, including, but not limited to, limitations upon the amounts of indebtedness and other securities
which may be incurred and issued by the Company under certain circumstances as set forth in the SPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
initial conversion price of the Debentures is $2.22 per share. The Debentures are due in 2.5 years from June 30, 2022, which may be extended
for an additional six month period by the Company by paying, at the end of the 18<SUP>th</SUP> month of the term of the Debentures, six
months of interest at the rate of 8% per annum. The Debentures are subject to a 10% original issue discount and bear interest at 5% for
the first 12 months, 6% for the next 12 months and 8% until maturity. The Debentures amortize over a 25 month period commencing on September
1, 2022, and the monthly amortization of the Debentures are payable in cash only for the first 12 months of amortizations and in cash
or stock thereafter at the option of the Company. Once the monthly amortizations are payable in cash or stock, the Company can only elect
to pay the monthly amortization in stock if certain equity conditions, as set forth in the Debentures, are met, which include, but are
not limited to, for each Trading Day in a period of 20 consecutive Trading Days prior to the applicable date in question, the daily trading
volume for the Common Stock on the principal Trading Market exceeds $1,000,000 per Trading Day, the Company is not in default of any
of its obligations under the Debentures, there is an effective registration statement for the resale of shares issuable under the Debentures,
and the Company is in compliance with all Nasdaq listing requirements. The Debentures contain commercially standard events of default
and covenants and the like.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Investors have received 3.5-year Warrants with 65% warrant coverage at an initial exercise price of $2.442 per share, subject
to customary adjustments, including a price ratchet (to the price of the new issuance) if it issues its common shares at a price less
than the then in effect exercise price and are subject to standard pro rata dilution for reverse stock splits and the like. The Debentures
have the same dilution protection as the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
the Debentures and Warrants contain exercise limitations upon an Investor beneficially owning more than either 4.99% or 9.99% of the
Company&rsquo;s common shares and also contain caps upon the total amount of common shares issuable upon conversion of the Debentures
and exercise of the Warrants of 19.9% of the issued and outstanding shares of the Company at the time of the closing of the transactions,
until shareholder approval of both the financing transaction, including all subsequent tranches of the financing, and the Delphy acquisition
are received, consistent with Nasdaq rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has entered into a Registration Rights Agreement with the Investors to register the shares issuable upon conversion of the Debentures
and exercise of the Warrants with a registration statement to be filed on Form S-1 no later than 30 days from June 30, 2022 (or any subsequent
closing) and effective no later than 60 days from June 30, 2022 (or the date of any subsequent closing; or 90 days, if there is full
SEC review). Penalties for missing those deadlines are equal to 2% of the subscription amount per month up to 10% of the subscription
amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s subsidiaries have also entered into subsidiary guarantees pursuant to which each guarantees the performance of the Company
of its obligations under the SPA and related instruments. Each of the officers and directors has also entered into a lockup agreement
to not sell any common shares of the Company owned by each such person for one year from June 30, 2022 (subject to the ability to sell
shares received by each as the result of an employment agreement at any time, which ability to sell shares commences on January 1, 2023).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the Debentures and Warrants sold under the SPA are sold in private placement transactions exempt from registration under Section 4(a)(2)
of the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Micropropagation
Laboratories</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has undertaken the steps described below in connection with the design and deployment of the Company&rsquo;s micropropagation
laboratories. These laboratories are expected to be deployed at the Company&rsquo;s AgriFORCE grow houses. However, the Company has identified
a business opportunity to build out an existing warehouse facility in collaboration with a wholly owned subsidiary of Deroose Plants
N.V., to be established in the United States. The Company&rsquo;s previous potential arrangement with an existing micropropagation lab
which required additional capacity fell through as commercial terms could not be agreed. The advantage of the Company for pursuing this
opportunity is that it enables the Company to achieve initial revenues in advance of incurring the full construction expenditure required
for the initial AgriFORCE grow houses, thereby providing internally generated funding for the Company&rsquo;s expenditures and tests
of the micropropagation process with the selected crops:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Company has completed the evaluation of options for construction of the micropropagation facility;</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Company has completed the determination of the most suitable low capital expenditure option providing flexibility;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acquired
    in-house expertise through Dr. Laila Benkrima, the Company&rsquo;s Chief Scientific Officer, who has a PhD from the University of
    Paris in horticulture with a specialization in tissue culture and the hybridization and selection of plant varietals; and Deroose
    plants;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">completed
    the design of full facility and equipment scope and layout;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identified
    potential vendors and received final quotations; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">research
    and preparation for permitting and licensing requirements.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is currently working with Deroose Plants N.V. management to select a lab location and plan the commercialization of its future
micropropagation operation. Concurrently, the Company is engaging in discussions with respect to the commercial arrangement of providing
micropropagation services for another micropropagation lab&rsquo;s excess volume requirements as well as exploring opportunities to provide
such services to potential customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
Property</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s intellectual property rights are important to its business. In accordance with industry practice, the Company protects
its proprietary products, technology and its competitive advantage through a combination of contractual provisions and trade secret,
copyright and trademark laws in Canada, the United States and in other jurisdictions in which it conducts its business. The Company also
has confidentiality agreements, assignment agreements and license agreements with employees and third parties, which limit access to
and use of its intellectual property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Patent
Applications</I></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Date filed or Information received</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Registration Date</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Title</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Patent Application #</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Country</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Status</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Expiry, renewal, submission Date</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Applicant</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; width: 10%; text-align: center">26-Aug-2020</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 8%; vertical-align: top">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 20%; text-align: left">AUTOMATED GROWING SYSTEMS</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 8%; text-align: left">2001/2096</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 10%; vertical-align: top">Barbados</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 8%; vertical-align: top">Pending</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 10%; vertical-align: top">26-Feb-2023</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 12%; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: center">26-Aug-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AUTOMATED GROWING SYSTEMS</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">3151492</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Canada</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Pending</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">26-Aug-2023</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center">26-Aug-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AUTOMATED GROWING SYSTEMS</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">202080073940.7</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">China</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Pending</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">26-Aug-2022</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: center">26-Aug-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AUTOMATED GROWING SYSTEMS</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">20858811.1</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">European Patent Office</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Pending</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">06-Jan-2023</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center">26-Aug-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AUTOMATED GROWING SYSTEMS</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">TT/A/2022/00024</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Trinidad and Tobago</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Pending</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">26-Aug-2023</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: center">26-Aug-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AUTOMATED GROWING SYSTEMS</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">17/638668</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">United States</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Pending</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center; width: 10%">26-Aug-2020</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 8%; vertical-align: top">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; width: 20%">AUTOMATED GROWING SYSTEMS</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; width: 8%">PCT/CA2020/051161</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; width: 10%">Patent Cooperation Treaty</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 8%; vertical-align: top">Pending</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 10%; vertical-align: top">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; width: 12%">&nbsp;AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: center">06-Mar-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">STRUCTURES FOR GROWING PLANTS</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">17/436275</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">United States</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Pending</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">06-Oct-2022</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center">06-Mar-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">STRUCTURES FOR GROWING<BR> PLANTS</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">2001/2057</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Barbados</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Pending</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">06-Mar-2023</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: center">06-Mar-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">STRUCTURES FOR GROWING<BR> PLANTS</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">TT/A/2021/00093</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Trinidad and Tobago</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Pending</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">06-Mar-2023</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center">06-Mar-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">07-Jun-2022</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">STRUCTURES FOR GROWING<BR> PLANTS</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">3132672</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Canada</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">06-Mar-2023</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: center">06-Mar-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">STRUCTURES FOR GROWING<BR> PLANTS</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">CN202080033944.2</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">China</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Pending</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center">06-Mar-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">STRUCTURES FOR GROWING<BR> PLANTS</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">20765629.9</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">European Patent Office</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Pending</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">31-Mar-2023</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: center">06-Mar-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">STRUCTURES FOR GROWING<BR> PLANTS</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">PCT/CA2020/050302</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Patent Cooperation Treaty</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Pending</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Trademarks</I></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Date filed or Information received</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Registration Date</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Title</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Patent Application #</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Registration #</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Country</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Status</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Expiry, renewal, submission Date</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Applicant</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; width: 10%; text-align: center">26-Nov-2019</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 8%; text-align: center">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; width: 8%">AGRIFORCE</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 8%; text-align: left">1997835</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; width: 8%">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 10%; vertical-align: top">Canada</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 10%; text-align: left">Application filed</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 8%; text-align: center">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 14%; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: center">22-May-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">18-Sep-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">018243244</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">018243244</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">European Union Intellectual Property Office</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Registered</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">22-May-2030</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center">22-May-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">88/930218</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">United States</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Suspended</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">13-Nov-2022</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: center">22-May-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">18-Sep-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">UK00918243244</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">UK00918243244</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">United Kingdom</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Registered</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">22-May-2030</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center">20-Jul-2022</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AWAKENED GRAINS</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">2198964</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Canada</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">TM Application filed</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">20-Jan-2023</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: center">29-Jul-2022</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AWAKENED GRAINS</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">97/527128</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">United States</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Application filed</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center">06-Jul-2022</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">C2F</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">2196090</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Canada</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">TM Application filed</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">06-Jan-2023</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: center">08-Jul-2022</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">C2F</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">97/495313</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">United States</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Application filed</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center">30-Aug-2019</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">30-Aug-2019</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">CANIVATE</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">UK00801494234</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">UK00801494234</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">United Kingdom</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Registered</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">30-Aug-2029</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: center">30-Aug-2019</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">10-Nov-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">CANIVATE</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">79/270262</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">6191972</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">United States</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Registered</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">10-Nov-2026</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center">30-Aug-2019</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">30-Aug-2019</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">CANIVATE</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">1494234</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">1494234</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Madrid Protocol (TM)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Registered</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">10-Nov-2026</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: center">01-Mar-2019</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">CANIVATE</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">1949210</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Canada</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">TM Application filed</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center">07-Aug-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">FORCEFILM</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">2044675</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Canada</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">TM Application filed</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: center">19-Aug-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">FORCEFILM</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">90/124842</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">United States</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Suspended</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center">04-Feb-2021</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">21-Jun-2021</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">FORCEFILM</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">018389838</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">018389838</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">European Union Intellectual Property Office</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Registered</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">04-Feb-2031</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center; width: 10%">24-Jul-2019</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; width: 8%">25-Jul-2019</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; width: 8%">PLANET LOVE</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; width: 8%">UK00801942554</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; width: 8%">UK00801504091</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; width: 10%">United Kingdom</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 10%; vertical-align: top">Registered</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; width: 8%">24-Jul-2029</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; width: 14%">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: center">24-Jul-2019</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">17-Nov-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">PLANET LOVE</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">79/274347</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">6197554</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">United States</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Registered</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">17-Nov-2026</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center">24-Jan-2019</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">PLANET LOVE</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">1942554</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Canada</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Advertised</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: center">24-Jul-2019</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">25-Jul-2019</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">PLANET LOVE</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">1942554</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">1504091</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Madrid Protocol (TM)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Registered</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">17-Nov-2026</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center">01-Mar-2019</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">THE CANIVATE WAY</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">1949209</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Canada</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">TM Application filed</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: center">30-Aug-2019</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">30-Aug-2019</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">THE CANIVATE WAY</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">1494231</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">1494231</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Madrid Protocol (TM)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Registered</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">27-Oct-2026</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center">30-Aug-2019</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">27-Oct-2020</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">THE CANIVATE WAY</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">79/270261</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">6182017</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">United States</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Registered</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: center">30-Aug-2019</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">30-Aug-2019</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">THE CANIVATE WAY</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">UK00801494231</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">UK00801494231</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">United Kingdom</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Registered</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">30-Aug-2029</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center">18-Aug-2021</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">UN(THINK)</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">2127781</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Canada</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">TM Application filed</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: center">23-Aug-2021</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">UN(THINK)</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">90/897689</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">United States</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Application filed</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center">06-Oct-2021</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">25-Feb-2022</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">UN(THINK)</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">018572674</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">018572674</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">European Union Intellectual Property Office</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Application filed</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">06-Oct-2031</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: center">18-Feb-2022</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">UN(THINK)</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">1669126</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Madrid Protocol (TM)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Pending</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">AGRIFORCE GROWING SYSTEMS LTD.</TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Competitive Conditions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
indoor and greenhouse growing facilities have come to the forefront in recent years. With the advent of new business opportunities and
the necessity and demand for increasing efficiency and yields, the facility design for both indoor and greenhouse has been significantly
improved through advancing technologies and operational procedures, even more importantly in hybrid facility environments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
recent decades, the greenhouse industry has been transforming from small scale facilities used primarily for research and aesthetic purposes
(i.e. botanic gardens) to significantly more large-scale facilities that compete directly with land-based conventional food and ornamental
plant production. While indoor growing allows production throughout the year and in most geographical locations, the energy used for
lighting and climate control is costly while those systems are critical to the success, efficiency and yield of the operation. In large
part due to the recent improvements in growing technology, the industry is witnessing a blossoming like no time before. Greenhouses today
are increasingly emerging that are large-scale, capital-infused, more resource conscientious and urban-centered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
major part of this recent transformation in the greenhouse industry has been the rise of a technology-infused Smart Greenhouse Market.
Smart Greenhouses feature new levels of technology and automated control systems that allow for further optimization of growing conditions.
These technologies include LED grow-lights that provide energy efficient supplemental lighting during cloudy conditions and at night,
as well as an array of smart sensors that can detect issues with plants or the growing environment as they arise and trigger responses
from different control systems.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
matter the country or region, one universal trend is that modern greenhouses are being built closer to metropolitan areas and large transportation
hubs. One reason for this shift is to locate greenhouses closer to universities where research opportunities and skilled labor abound.
As greenhouses become more tech-heavy, having this proximity to research institutions is expected to be an important factor in location.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the market has grown dramatically, it has also experienced clear trends in recent years. Modern greenhouses are becoming increasingly
tech-intensive, using LED lights and automated control systems to tailor optimal growing environments. Successful greenhouse companies
are scaling significantly and locating their growing facilities near urban hubs to capitalize on the ever-increasing demand for local
(sustainable, conscientious, nutritious) food, no matter the season. To accomplish these feats, the greenhouse industry is also becoming
increasingly capital-infused, using venture funding and other sources to build out the infrastructure necessary to compete in the current
market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the smart greenhouse market continues to expand, new technologies are also coming online that are expected to shape the future of production.
Like before, many of these technologies are being developed for the greenhouse industry in particular. However, perhaps recently more
than ever, innovation is also coming from other sectors. From artificial intelligence to Solar PV, new technologies from a wide range
of industries are now finding their way into the modern greenhouse.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Past
and current deficiencies with indoor farming in general have already signaled two important messages. First, there is logical reasoning
to support the argument that indoor agriculture may become the norm and play a vital role to our current food (water intensive, non-grain)
landscape. It will not be an easy journey, but the industry is growing and evolving at a fascinating speed. Second, technology advancements
play a key role in leading the industry to continue to mature and reach greater efficiencies, production, and profitability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the global population continues to grow, and resources like land and water become more restricted, greenhouse (and hybrid) farming are
expected to be a dominant contributor for feeding global population that is just as important as land-based farming.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a whole, the solutions provided to the agriculture industry have been driven by the integration of disparate components predominately
lead by the client / farmer, major greenhouse vendors such as Kubo, Van der Hoeven, Certhon and Havecon or by major automation vendors
such as Codema Systems or Ridder Group. This has resulted in fragmentation and sub-optimal IP that has not been fully integrated in a
form as the Company is endeavoring to provide. Additionally, many solutions often are an amalgamation of disparate parts and vendors
that are not necessarily optimized for a particular crop. In the indoor growing space, this is even more pronounced as the facility is
often a simple warehouse which is in and of itself suboptimal and the draw backs are more pronounced. Often the integration is led by
the cultivators themselves, who often do not possess the necessary skills to effectively manage such a process or it is led by one of
the main vendors.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Technology</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
future: hardware, software, &amp; plant physiology</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently
innovation is steered by three main drivers: in-house development within companies, technology providers, and &ldquo;cross-industry pollination&rdquo;.
New and upcoming companies have great potential to create innovative products. When companies showcase how their innovative technology
can be applied, other companies can either adapt or further develop these ideas. There are also technology providers who specialize in
specific areas of Ag-Tech. Through cross-industry pollination, we can acquire existing technology from other industries for use in greenhouse
application.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Lighting/materials</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Energy
costs&mdash;primarily associated with lighting&mdash;are of major significance in the operation of a greenhouse facility. Lighting is
a critical component for growing plants in fully closed environments because it is the primary energy input used by plants for photosynthesis.
Light-emitting diodes (LEDs) were first adopted for indoor growing in the 1970s to supplement natural sunlight more efficiently than
previously used incandescent bulbs. With the advancement of LED technology, the cost has dropped significantly over the last 10 years&mdash;specifically,
LED lighting costs have halved, while their efficacy, or light energy, has more than doubled. We can expect costs to continue to drop
as technology develops and this trend continues. Additionally, precise control of lighting can enable the discovery and dissemination
of reproducible &ldquo;light recipes&rdquo; that are tailored to crops specifically grown indoors. These light recipes are being developed
and used by cultivators to manipulate how plants grow, what they taste like, and their nutrient composition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to lighting, improvements related to materials can also help further efficiency. Companies like Soliculture, are paving the
way for a revolution of greenhouse materials. Their LUMO solar panel contains a low density of silicon photovoltaic (PV) strips arranged
with space in between to allow light to transmit between the strips. A thin layer of luminescent material is adhered to the backside
of the glass, enhancing light quality by converting green light to red light. Red light has the highest efficiency for photosynthesis
in plants, and therefore this optimized light spectrum increases yield faster maturation rate, and has proven to contribute to more disease
resistant plants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Data/AI</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AI
is expected to grow significantly in the coming years, where humans are certainly not obsolete but essential in leading innovation to
significantly enhance results. AI-powered tools are gaining popularity across several industries including agriculture. In the future,
we expect AI to be used in operations by means of automation and for predictive analytics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robots
are increasingly replacing humans as we see more fully automated operations. Robots excel at repetitive, precision mundane tasks such
as seeding, weeding, and harvesting. Start-up Iron Ox uses robots every step of the way from seed to harvest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
allows allocation of resources elsewhere to focus on their overall production. Robotics also reduce labor costs while increasing efficiency.
Currently farming is facing a labor shortage for reasons ranging from immigration policy to a lack of desire to work in the industry.
Robots can help fill in the gaps in missing labor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AI
and machine learning technologies are developed to integrate and deliver more precise control of comprehensive growing operations. Ag-Tech
company, Autogrow, provides intelligent automation systems including pH sensors, irrigation, and climate control products. Both hardware
and software are improving to become more analytical and help detect and solve problems such as pest management, nutrient solution maintenance,
and disease prevention.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Automation
is expected to become more feasible and available as AI technology improves and becomes less expensive. Reduced labor costs should allow
product prices to decrease, making local food more accessible.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Biological
Development</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
improved environmental control and cultivation practices is expected to lead to greater crop yields, biological alterations can more
specifically tailor plants to growing environments and consumer needs. Indoor growing environments and processing facilities reduce the
need for plant traits which provide stability in the face of environmental fluctuations, pests, pathogens, and post-harvest injury. New
plant breeding techniques and genome-editing technologies such as CRISPR/Cas9 can be used to promote new plant traits focused on rapid
plant growth, performance in low-light environments, plant stature, nutrition, and flavor. Coupling heightened environmental control
with biological control also opens the door for variable gene expression under different growing conditions. This could lead to crop
varieties that are distinct from their outdoor counterparts for new culinary applications and create unique markets for produce grown
indoors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Industrial
synergies</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the rise of abundant tech providers and cross-disciplinary innovators, we can expect collaboration and knowledge sharing to become more
common. In addition to delivering more effective indoor growing technologies, collaboration may also substantiate partnerships between
companies which reduce their ecological footprints. For instance, co-locating greenhouses with industrial power plants can divert carbon
dioxide and heat&mdash;by products of combustion&mdash;from the atmosphere to crops for photosynthesis enhancement and climate control.
Furthermore, composted food waste may be diverted from landfills to fertilize crops in soil-based greenhouses. In the other direction,
transparent solar panels may enable greenhouses to become net producers of energy to supply nearby buildings without sacrificing crop
performance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
technologies and ideas are expected to better integrate agricultural businesses with the world around them, helping urban and industrial
communities become more productive and sustainable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Innovation
in technology and practice are believed to be the key drivers of new developments in indoor and greenhouse ag businesses. While these
developments may be diverse and multidimensional, their effects are expected to be focused on improvements to the potential scale and
efficiency of, and quality of food from, indoor agriculture. Following the greenhouse&rsquo;s historical trajectory, we believe it is
safe to assume its relevance to global food systems may continue to expand as we progress into the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Competitor
Comparison</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes that it has no direct competitors who provide a proprietary facility design and automated grow system as well as a system
of operational processes designed to optimize the performance of the Company&rsquo;s grow houses. On a broader basis, the competitive
landscape includes greenhouse vendors, agriculture systems providers, automated grow system vendors, and system/solutions consultants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Competitive
Differentiation</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes it has developed one of the world&rsquo;s most technologically advanced indoor agriculture systems by focusing on competitive
differentiators to deliver vastly improved results beyond conventional indoor approaches. By conceiving new IP, as well as utilizing
tried trued tested existing Ag-Tech and Bio-Tech solutions, the Company delivers integrated unique architectural design, intelligent
automation and advanced growing processes to create precisely controlled growing environments optimized for each nominated crop variety.
These precision ecosystems should enable the Company to cost-effectively produce the cleanest, greenest and most flavorful produce, as
well as consistent medical-grade plant-based nutraceuticals and pharmaceuticals, available. The key points of differentiation are as
follows:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Crops</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ops</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Optimized
    genetics through advanced tissue culture and micropropagation.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advanced
    propagation/cultivation/harvest SOP&rsquo;s.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Higher
    yields.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minimal
    workforce.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Improved
    nutrition/efficacy values.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enhanced
    automation.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lower
    production costs.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantive
    capital, resource, and operational savings.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents,
    future pending and provisional.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reduced
    ecological impacts.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade-marks,
    EU registered and Canada + US pending.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents,
    pending and provisional.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Facilities</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Systems</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Environment</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 28%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">High-tech
    high efficiency building envelope.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 28%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IoT
    to AI integrated facility/systems controls.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 31%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">High
    efficiency climate control equipment.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proprietary
    building engineering and materials.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Critical
    sensing and monitoring interface equipment.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Micro-climate
    delivery materials and systems.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Natural
    sunlight, indoors.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advanced
    Ag-tech Automated Grow Systems.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Automated
    chronological/meteorological/biological integrated controls.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proprietary
    supplemental grow lighting. Dynamic foam solar gain control. Significantly reduced utility demands. Alternative clean energy sourcing.
    Green Building Initiative/Green Globe certification. Patents, pending and provisional.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proprietary
    high efficiency grow channels.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sealed
    environment.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of August 9, 2022, the Company has 15 employees and five consultants. The Company also relies on consultants and contractors
to conduct its operations. The Company anticipates hiring additional employees to support its planned activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company primary operating activities are in California. The Company&rsquo;s head office is located in Vancouver, British Columbia, Canada
with a second office opening in the Rotterdam, Netherlands. The Company intends to open a project office near Coachella, CA. The Company
also plans to construct its initial micropropagation laboratories and its initial AgriFORCE grow houses in the State of California.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description
of Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently leases office space at 2233 Colombia Street, Suite 300, Vancouver, B.C., V5Y 0M6 as its principal office. The Company
believes the office is in good condition and satisfy its current operational requirements. The Company also leases an office space at
Weena 505 Rotterdam, Netherlands</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Litigation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the legal proceeding and claims described in detail in &ldquo;Note 16. Commitments and Contingencies&rdquo; to the audited
financial statements included in this filing. Although the results of litigation and claims cannot be predicted with certainty, as of
the date of this filing, we do not believe the outcome of such legal proceeding and claims, if determined adversely to us, would be reasonably
expected to have a material adverse effect on our business. Regardless of the outcome, litigation can have an adverse impact on us because
of defense and settlement costs, diversion of management resources and other factors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><A NAME="ba_003"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
in our securities involves a high degree of risk. Before making an investment decision, you should consider carefully the risks, uncertainties
and all risk factors set forth in the applicable prospectus supplement and the documents incorporated by reference in this prospectus,
including the risk factors discussed under the heading &ldquo;Risk Factors&rdquo; in our most recent Annual Report on Form 10-K for the
year ended December 31, 2021 and each subsequent filed quarterly report on Form 10-Q and current reports on Form 8-K, which may be amended,
supplemented or superseded from time to time by the other reports we file with the SEC in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><A NAME="ba_004"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains forward-looking statements. Such statements include statements regarding our expectations, hopes, beliefs or intentions
regarding the future, including but not limited to statements regarding our market, strategy, competition, development plans (including
acquisitions and expansion), financing, revenues, operations, and compliance with applicable laws. Forward-looking statements involve
certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. Factors that could
cause actual results to differ materially from such forward-looking statements include the risks described in greater detail in the following
paragraphs. All forward-looking statements in this document are made as of the date hereof, based on information available to us as of
the date hereof, and we assume no obligation to update any forward-looking statement. Market data used throughout this prospectus is
based on published third party reports or the good faith estimates of management, which estimates are based upon their review of internal
surveys, independent industry publications and other publicly available information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should review carefully the section entitled &ldquo;Risk Factors&rdquo; within this prospectus for a discussion of these and other risks
that relate to our business and investing in shares of our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
forward-looking statements speak only as of the date of this prospectus. We disclaim any obligation to update or revise these statements
unless required by law, and you should not place undue reliance on these forward-looking statements. Although we believe that our plans,
intentions and expectations reflected in or suggested by the forward-looking statements we make in this prospectus are reasonable, we
can give no assurance that these plans, intentions or expectations will be achieved. We disclose important factors that could cause our
actual results to differ materially from our expectations under &ldquo;Risk Factors&rdquo; and elsewhere in this prospectus. These cautionary
statements qualify all forward-looking statements attributable to us or persons acting on our behalf.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Relating to the Company&rsquo;s Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Company is an early stage company with little operating history, a history of losses and the Company cannot assure profitability.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently has no revenues and does not have any history of revenue generating operations. The Company has been involved to date
in the design and development of its AgriFORCE grow house which incorporates the Company&rsquo;s AgriFORCE micropropagation laboratories.
While the Company has invested considerably in this development and design process, no AgriFORCE grow house has been constructed to date
and accordingly, the commercial or operating viability of the AgriFORCE grow house has not been proven, or when, if ever, the Company
will generate revenue from its operations, and if those revenues, when and if generated, will be sufficient to sustain operations, nonetheless
achieve profitability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>There
is no assurance that the Company&rsquo;s AgriFORCE grow houses or micropropagation laboratories will operate as intended.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s initial state of business operations contemplates the construction and deployment of its initial AgriFORCE grow house
and micropropagation laboratories. However, the Company has yet to complete construction of any laboratories. Accordingly, this component
of the Company&rsquo;s business plan is subject to considerable risks, including:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there is no assurance that
    the laboratories will achieve the intended plantlet production rates;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the costs of constructing
    and operating the laboratories may be greater than anticipated;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the potential offtake partners
    who have indicated a willingness to deploy the laboratories at their existing cultivation operations may withdraw and determine not
    to deploy the laboratories;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there is no assurance that
    the facilities will deliver the intended benefits of high production yields, lower crop losses and reduced operation costs;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if the company is not able
    to fully develop the grow house or it does not operate as intended, it could prevent the company from realizing any of its business
    goals or achieving profitability;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the costs of constructing
    the AgriFORCE grow houses may be greater than anticipated and the Company may not be able to recover these greater costs through
    increases in the lease rates, license fees and services fees that it charges to its customers; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the costs of operating
    the AgriFORCE grow house may be greater than anticipated.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>COVID-19
or any pandemic, epidemic or outbreak of an infectious disease in the United States or elsewhere may adversely affect our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
COVID-19 virus has had unpredictable and unprecedented impacts in the United States and around the world. The World Health Organization
has declared the outbreak of COVID-19 as a &ldquo;pandemic,&rdquo; or a worldwide spread of a new disease. Many countries around the
world have imposed quarantines and restrictions on travel and mass gatherings to slow the spread of the virus. In the United States,
federal, state and local governments have enacted restrictions on travel, gatherings, and workplaces, with exceptions made for essential
workers and businesses. As of the date of this filing, we have not been declared an essential business. As a result, we may be required
to substantially reduce or cease operations in response to governmental action or decree as a result of COVID-19. We are still assessing
the effect on our business from COVID-19 and any actions implemented by the federal, state and local governments. We have implemented
safety protocols to protect our staff, but we cannot offer any assurance that COVID-19 or any other pandemic, epidemic or outbreak of
an infectious disease in the United States or elsewhere, will not materially and adversely affect our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Fluctuations
in the exchange rate of foreign currencies could result in losses.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incur a portion of our operating expenses in Canadian dollars, and in the future, as we expand into other foreign countries, we expect
to incur operating expenses in other foreign currencies. We are exposed to foreign exchange rate fluctuations as the financial results
of our international operations are translated from the local functional currency into U.S. dollars upon consolidation. A decline in
the U.S. dollar relative to foreign functional currencies would increase our non-U.S. revenue and improve our operating results. Conversely,
if the U.S. dollar strengthens relative to foreign functional currencies, our revenue and operating results would be adversely affected.
We have not previously engaged in foreign currency hedging. If we decide to hedge our foreign currency exchange rate exposure, we may
not be able to hedge effectively due to lack of experience, unreasonable costs or illiquid markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Company will require additional financing and there is no assurance that additional financing will be available when required.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will require substantial additional capital in order to acquire or lease the Coachella land, develop the Coachella lands for
use, develop the micropropagation laboratories and operate them, and complete construction of its initial AgriFORCE grow house. The funds
raised in this offering may not be sufficient and additional financing may be needed for this purpose and for other purposes. The Company
plans to achieve this additional financing through equity and/ or debt financing which may be dilutive to the position of then current
shareholders. However, there is no assurance that this financing will be available when required. Specifically, there is no assurance
that the Company will be able to raise any additional equity financing through its shares given that the viability of the Company&rsquo;s
AgriFORCE grow houses will not be demonstrated until after construction is complete. In addition, there is no assurance that the Company
will be able to secure debt financing given its low asset base and its current lack of revenues.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Company had negative cash flow for the period ended March 31, 2022.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had negative cash flows from operating activities for period ended March 31, 2022. To the extent that the Company has negative
cash flows from operating activities in future periods, it may need to allocate a portion of its cash reserves to fund such negative
cash flow. The Company may also be required to raise additional funds through the issuance of equity or debt securities. There can be
no assurance that the Company will be able to generate a positive cash flow from operating activities, that additional capital or other
types of financing will be available when needed or that these financings will be on terms favorable to the Company. The Company&rsquo;s
actual financial position and results of operations may differ materially from the expectations of the Company&rsquo;s management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Company&rsquo;s actual financial position and results of operations may differ materially from the expectations of the Company&rsquo;s
management.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s actual financial position and results of operations may differ materially from management&rsquo;s expectations. The process
for estimating the Company&rsquo;s revenue, net income and cash flow requires the use of judgment in determining the appropriate assumptions
and estimates. These estimates and assumptions may be revised as additional information becomes available and as additional analyses
are performed. In addition, the assumptions used in planning may not prove to be accurate, and other factors may affect the Company&rsquo;s
financial condition or results of operations. As a result, the Company&rsquo;s revenue, net income and cash flow may differ materially
from the Company&rsquo;s projected revenue, net income and cash flow.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Company expects to incur significant ongoing costs and obligations related to its investment in infrastructure, growth, regulatory compliance
and operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expects to incur significant ongoing costs and obligations related to its investment in its initial AgriFORCE grow houses. To
the extent that these costs may be greater than anticipated or the Company may not be able to generate revenues or raise additional financing
to cover these costs, these operating expenses could have a material adverse impact on the Company&rsquo;s results of operations, financial
condition and cash flows. In addition, future changes in regulations, more vigorous enforcement thereof or other unanticipated events
could require extensive changes to the design and operation of the Company&rsquo;s AgriFORCE grow houses, which could increase construction
costs and have a material adverse effect on the business, results of operations and financial condition of the Company. The Company&rsquo;s
efforts to construct its AgriFORCE grow houses and grow its business may be costlier than the Company expects, and the Company may not
be able to recover sufficient revenues to offset its higher operating expenses. The Company may incur significant losses in the future
for a number of reasons, including, unforeseen expenses, difficulties, complications and delays, and other unknown events. If the Company
is unable to achieve and sustain profitability, the market price of our securities may significantly decrease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>There
is no assurance the Company will be able to repatriate or distribute funds for investment from the United States to Canada or elsewhere.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that any of the Company&rsquo;s investments, or any proceeds thereof, any dividends or distributions there from, or any profits
or revenues accruing from such investments in the United States were found to be in violation of money laundering legislation or otherwise,
such transactions may be viewed as proceeds of crime under applicable federal laws, rules and regulations or any other applicable legislation.
This could restrict or otherwise jeopardize the ability of the Company to declare or pay dividends, effect other distributions or subsequently
repatriate such funds back to Canada or elsewhere.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Company may not be able to effectively manage its growth and operations, which could materially and adversely affect its business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company implements it business plan as intended, it may in the future experience rapid growth and development in a relatively short
period of time. The management of this growth may require, among other things, continued development of the Company&rsquo;s financial
and management controls and management information systems, stringent control of costs, the ability to attract and retain qualified management
personnel and the training of new personnel. The Company intends to utilize outsourced resources, and hire additional personnel, to manage
its expected growth and expansion. Failure to successfully manage its possible growth and development could have a material adverse effect
on the Company&rsquo;s business and the value of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Company may face significant competition from other facilities.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
other businesses in California engage in similar activities to the Company, leasing commercial space to agricultural producers generally,
and providing additional products and services to similar customers. The Company cannot assure you that it will be able to compete successfully
against current and future competitors. Competitive pressures faced by the Company could have a material adverse effect on its business,
operating results and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we are unable to protect our intellectual property, our business may be adversely affected.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
must protect the proprietary nature of the intellectual property used in our business. There can be no assurance that trade secrets and
other intellectual property will not be challenged, invalidated, misappropriated or circumvented by third parties. Currently, our intellectual
property includes provisional patents, patent applications, trademarks, trademark applications and know-how related to business, product
and technology development. We plan on taking the necessary steps, including but not limited to the filing of additional patents as appropriate.
There is no assurance any additional patents will issue or that when they do issue, they will include all of the claims currently included
in the applications. Even if they do issue, those new patents and our existing patents must be protected against possible infringement.
Nonetheless, we currently rely on contractual obligations of our employees and contractors to maintain the confidentiality of our products.
To compete effectively, we need to develop and continue to maintain a proprietary position with respect to our technologies, and business.
The risks and uncertainties that we face with respect to intellectual property rights principally include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently, we only have
    provisional protection, which may not result in full patents being granted, and any full patent applications that we file may not
    result in issued patents or may take longer than expected to result in issued patents;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we may be subject to interference
    proceedings;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other companies may claim
    that patents applied for by, assigned or licensed to, us infringe upon their own intellectual property rights;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we may be subject to trademark
    opposition proceedings in the U.S. and in foreign countries;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any patents that are issued to us may not provide meaningful
    protection;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we may not be able to develop additional proprietary
    technologies that are patentable;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other companies may challenge patents licensed or issued
    to us as invalid, unenforceable or not infringed;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other companies may independently develop similar or
    alternative technologies, or duplicate our technologies;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other companies may design around technologies that
    we have licensed or developed;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any patents issued to us may expire and competitors
    may utilize the technology found in such patents to commercialize their own products; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">enforcement of patents is complex, uncertain and expensive.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is also possible that others may obtain issued patents that could prevent us from commercializing certain aspects of our products or
require us to obtain licenses requiring the payment of significant fees or royalties in order to enable us to conduct our business. If
we license patents, our rights may depend on maintaining our obligations to the licensor under the applicable license agreement, and
we may be unable to do so. Furthermore, there can be no assurance that the work-for-hire, intellectual property assignment and confidentiality
agreements entered into by our employees and consultants, advisors and collaborators will provide meaningful protection for our trade
secrets, know-how or other proprietary information in the event of any unauthorized use or disclosure of such trade secrets, know- how
or other proprietary information. The scope and enforceability of patent claims are not systematically predictable with absolute accuracy.
The strength of our own patent rights depends, in part, upon the breadth and scope of protection provided by the patent and the validity
of our patents, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
operate in an industry with the risk of intellectual property litigation. Claims of infringement against us may hurt our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success depends, in part, upon non-infringement of intellectual property rights owned by others and being able to resolve claims of intellectual
property infringement without major financial expenditures or adverse consequences. Participants that own, or claim to own, intellectual
property may aggressively assert their rights. From time to time, we may be subject to legal proceedings and claims relating to the intellectual
property rights of others. Future litigation may be necessary to defend us or our clients by determining the scope, enforceability, and
validity of third-party proprietary rights or to establish its proprietary rights. Some competitors have substantially greater resources
and are able to sustain the costs of complex intellectual property litigation to a greater degree and for longer periods of time. In
addition, patent holding companies that focus solely on extracting royalties and settlements by enforcing patent rights may target us.
Regardless of whether claims that we are infringing patents or other intellectual property rights have any merit, these claims are time-consuming
and costly to evaluate and defend and could:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adversely affect relationships
    with future clients;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cause
    delays or stoppages in providing products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">divert management&rsquo;s
    attention and resources;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">require technology changes
    to our platform that would cause our Company to incur substantial cost;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject us to significant
    liabilities; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">require us to cease some
    or all of its activities.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to liability for monetary damages, which may be tripled and may include attorneys&rsquo; fees, or, in some circumstances, damages
against clients, we may be prohibited from developing, commercializing, or continuing to provide some or all of our products unless we
obtain licenses from, and pay royalties to, the holders of the patents or other intellectual property rights, which may not be available
on commercially favorable terms, or at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have limited foreign intellectual property rights and may not be able to protect our intellectual property rights throughout the world.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have limited intellectual property rights outside the United States. Filing, prosecuting and defending patents on devices in all countries
throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States
can be less extensive than those in the United States. In addition, the laws of some foreign countries do not protect intellectual property
to the same extent as laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions
in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States
or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patents to develop their own
products and further, may export otherwise infringing products to territories where we have patents, but enforcement is not as strong
as that in the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
companies have encountered significant problems in protecting and defending intellectual property in foreign jurisdictions. The legal
systems of certain countries, particularly China and certain other developing countries, do not favor the enforcement of patents, trade
secrets and other intellectual property, which could make it difficult for us to stop the infringement of our patents or marketing of
competing products in violation of our proprietary rights generally. To date, we have not sought to enforce any issued patents in these
foreign jurisdictions. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert
our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly
and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in
any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. The requirements
for patentability may differ in certain countries, particularly developing countries. Certain countries in Europe and developing countries,
including China and India, have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties.
In those countries, we and our licensors may have limited remedies if patents are infringed or if we or our licensors are compelled to
grant a license to a third party, which could materially diminish the value of those patents. This could limit our potential revenue
opportunities. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant
commercial advantage from the intellectual property that we develop or license.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we are unable to obtain or defend our patents, our business could be materially adversely affected.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
patent position is highly uncertain and involves complex legal and factual questions. Accordingly, we cannot predict the breadth of claims
that may be allowed or enforced under our patents or in third-party patents. For example, we might not have been the first to make the
inventions covered by each of our pending patent applications and provisional patents; we might not have been the first to file patent
applications for these inventions; others may independently develop similar or alternative technologies or duplicate any of our technologies;
it is possible that none of our pending patent applications will result in issued patents; our issued patents may not provide a basis
for commercially viable technologies, or may not provide us with any competitive advantages, or may be challenged and invalidated by
third parties; and, we may not develop additional proprietary technologies that are patentable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result, our owned and licensed patents may not be valid and we may not be able to obtain and enforce patents and to maintain trade
secret protection for the full commercial extent of our technology. The extent to which we are unable to do so could materially harm
our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have applied for and expect to continue to apply for patents for certain products. Such applications may not result in the issuance of
any patents, and any patents now held or that may be issued may not provide us with adequate protection from competition. Furthermore,
it is possible that patents issued or licensed to us may be challenged successfully. In that event, if we have a preferred competitive
position because of such patents, such preferred position would be lost. If we are unable to secure or to continue to maintain a preferred
position, we could become subject to competition from the sale of generic products. Failure to receive, inability to protect, or expiration
of our patents would adversely affect our business and operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents
issued or licensed to us may be infringed by the products or processes of others. The cost of enforcing our patent rights against infringers,
if such enforcement is required, could be significant, and we do not currently have the financial resources to fund such litigation.
Further, such litigation can go on for years and the time demands could interfere with our normal operations. We may become a party to
patent litigation and other proceedings. The cost to us of any patent litigation, even if resolved in our favor, could be substantial.
Many of our competitors may be able to sustain the costs of such litigation more effectively than we can because of their substantially
greater financial resources. Litigation may also absorb significant management time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unpatented
trade secrets, improvements, confidential know-how and continuing technological innovation are important to our scientific and commercial
success. Although we attempt to and plan to continue to attempt to protect our proprietary information through reliance on trade secret
laws and the use of confidentiality agreements with our partners, collaborators, employees and consultants, as well as through other
appropriate means, these measures may not effectively prevent disclosure of our proprietary information, and, in any event, others may
develop independently, or obtain access to, the same or similar information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>International
intellectual property protection is particularly uncertain, and if we are involved in opposition proceedings in foreign countries, we
may have to expend substantial sums and management resources.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent
and other intellectual property law outside the United States is more uncertain and is continually undergoing review and revisions in
many countries. Further, the laws of some foreign countries may not protect intellectual property rights to the same extent as the laws
of the United States. For example, certain countries do not grant patent claims that are directed to business methods and processes.
In addition, we may have to participate in opposition proceedings to determine the validity of its foreign patents or its competitors&rsquo;
foreign patents, which could result in substantial costs and diversion of its efforts and loss of credibility with customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we are found to be infringing on patents or trade secrets owned by others, we may be forced to cease or alter our product development
efforts, obtain a license to continue the development or sale of our products, and/or pay damages.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
processes and potential products may violate proprietary rights of patents that have been or may be granted to competitors, universities
or others, or the trade secrets of those persons and entities. As our industry expands and more patents are issued, the risk increases
that our processes and potential products may give rise to claims that they infringe the patents or trade secrets of others. These other
persons could bring legal actions against us claiming damages and seeking to enjoin manufacturing and marketing of the affected product
or process. If any of these actions are successful, in addition to any potential liability for damages, we could be required to obtain
a license in order to continue to manufacture or market the affected product or use the affected process. Required licenses may not be
available on acceptable terms, if at all, and the results of litigation are uncertain. If we become involved in litigation or other proceedings,
it could consume a substantial portion of our financial resources and the efforts of our personnel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
rely on confidentiality agreements to protect our trade secrets. If these agreements are breached by our employees or other parties,
our trade secrets may become known to our competitors.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on trade secrets that we seek to protect through confidentiality agreements with our employees and other parties. If these agreements
are breached, our competitors may obtain and use our trade secrets to gain a competitive advantage over us. We may not have any remedies
against our competitors and any remedies that may be available to us may not be adequate to protect our business or compensate us for
the damaging disclosure. In addition, we may have to expend resources to protect our interests from possible infringement by others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have a limited operating history on which to judge our business prospects and management.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
company was incorporated and commenced operations in 2017. Accordingly, we have only a limited operating history upon which to base an
evaluation of our business and prospects. Operating results for future periods are subject to numerous uncertainties and we cannot assure
you that we will achieve or sustain profitability. Our prospects must be considered in light of the risks encountered by companies in
the early stage of development, particularly companies in new and rapidly evolving markets. Future operating results are expected to
depend upon many factors, including increasing the number of affiliates, our success in attracting and retaining motivated and qualified
personnel, our ability to establish short term credit lines, our ability to develop and market new products, control costs, and general
economic conditions. We cannot assure you that we will successfully address any of these risks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not be able to continue as a going concern.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has incurred substantial operating losses since its inception, expects to continue to incur significant operating losses for
the foreseeable future and may never become profitable. As reflected in the financial statements, the Company had an accumulated deficit
of approximately $23.2 million at March 31, 2022, a net loss of approximately $3.3 million, and approximately $2.9 million of
net cash used in operating activities for the three months ended March 31, 2022. The accompanying financial statements have been prepared
on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business.
The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or
the amounts and classification of liabilities that might result from the outcome of this uncertainty. The Company anticipates incurring
additional losses until such time, if ever, that it can obtain marketing approval to sell, and then generate significant sales, of its
technology that is currently in development. As such it is likely that additional financing may be needed by the Company to fund its
operations and to develop and commercialize its technology. These factors raise substantial doubt about the Company&rsquo;s ability to
continue as a going concern. The Company is seeking additional financing to support its growth plans. The sale of additional equity may
dilute existing shareholders and newly issued shares may contain senior rights and preferences compared to currently outstanding common
shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
management team has limited experience managing a public company, and regulatory compliance may divert our attention from the day-to-day
management of our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management team has limited experience managing a publicly-traded company and limited experience complying with the increasingly complex
laws pertaining to public companies. These obligations typically require substantial attention from our senior management and could divert
our attention away from the day-to-day management of our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Company may become subject to litigation, which may have a material adverse effect on the Company&rsquo;s reputation, business, results
from operations, and financial condition.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may be named as a defendant in a lawsuit or regulatory action. The Company may also incur uninsured losses for liabilities which
arise in the ordinary course of business, or which are unforeseen, including, but not limited to, employment liability and business loss
claims. Any such losses could have a material adverse effect on the Company&rsquo;s business, results of operations, sales, cash flow
or financial condition.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
the Company is unable to attract and retain key personnel, it may not be able to compete effectively.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s success has depended and continues to depend upon its ability to attract and retain key management, including the Company&rsquo;s
Chief Executive Officer and technical experts. The Company will attempt to enhance its management and technical expertise by continuing
to recruit qualified individuals who possess desired skills and experience in certain targeted areas. The Company&rsquo;s inability to
retain employees and attract and retain sufficient additional employees or engineering and technical support resources could have a material
adverse effect on the Company&rsquo;s business, results of operations, sales, cash flow or financial condition. Shortages in qualified
personnel or the loss of key personnel could adversely affect the financial condition of the Company, results of operations of the business
and could limit the Company&rsquo;s ability to develop and market its intellectual property. The loss of any of the Company&rsquo;s senior
management or key employees could materially adversely affect the Company&rsquo;s ability to execute the Company&rsquo;s business plan
and strategy, and the Company may not be able to find adequate replacements on a timely basis, or at all. The Company does not maintain
key person life insurance policies on any of the Company&rsquo;s employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
size of the Company&rsquo;s initial target market is difficult to quantify and investors will be reliant on their own estimates on the
accuracy of market data.</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
high growth crop technology is in an early stage with uncertain boundaries, there is a lack of information about comparable companies
available for potential investors to review in deciding about whether to invest in the Company and, few, if any, established companies
whose business model the Company can follow or upon whose success the Company can build. Accordingly, investors have to rely on their
own estimates in deciding about whether to invest in the Company. There can be no assurance that the Company&rsquo;s estimates are accurate
or that the market size is sufficiently large for its business to grow as projected, which may negatively impact its financial results.
The Company regularly follows market research.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Company&rsquo;s industry is experiencing rapid growth and consolidation that may cause the Company to lose key relationships and intensify
competition.</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
agriculture industry and various verticals within it are undergoing rapid growth and substantial change, which has resulted in an increase
in competitors, consolidation and formation of strategic relationships. Acquisitions or other consolidating transactions could harm the
Company in a number of ways, including by losing strategic partners and or customers if they are acquired by or enter into relationships
with a competitor, losing customers, revenue and market share, or forcing the Company to expend greater resources to meet new or additional
competitive threats, all of which could harm the Company&rsquo;s operating results. As competitors enter the market and become increasingly
sophisticated, competition in the Company&rsquo;s industry may intensify which could negatively impact its profitability.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Company will be reliant on information technology systems and may be subject to damaging cyberattacks.</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s operations depend, in part, on how well it and its suppliers protect networks, equipment, information technology systems
and software against damage from a number of threats, including, but not limited to, cable cuts, damage to physical plants, natural disasters,
intentional damage and destruction, fire, power loss, hacking, computer viruses, vandalism and theft. The Company&rsquo;s operations
also depend on the timely maintenance, upgrade and replacement of networks, equipment, IT systems and software, as well as pre-emptive
expenses to mitigate the risks of failures. Any of these and other events could result in information system failures, delays and/or
increase in capital expenses. The failure of information systems or a component of information systems could, depending on the nature
of any such failure, adversely impact the Company&rsquo;s reputation and results of operations.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has not experienced any material losses to date relating to cyber-attacks or other information security breaches, but there can
be no assurance that the Company will not incur such losses in the future. The Company&rsquo;s risk and exposure to these matters cannot
be fully mitigated because of, among other things, the evolving nature of these threats. As a result, cyber security and the continued
development and enhancement of controls, processes and practices designed to protect systems, computers, software, data and networks
from attack, damage or unauthorized access is a priority. As cyber threats continue to evolve, the Company may be required to expend
additional resources to continue to modify or enhance protective measures or to investigate and remediate any security vulnerabilities.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Company&rsquo;s officers and directors may be engaged in a range of business activities resulting in conflicts of interest.</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
certain officers and board members of the Company are expected to be bound by anti-circumvention agreements limiting their ability to
enter into competing and/or conflicting ventures or businesses, the Company may be subject to various potential conflicts of interest
because some of its officers and directors may be engaged in a range of business activities. In addition, the Company&rsquo;s executive
officers and directors may devote time to their outside business interests, so long as such activities do not materially or adversely
interfere with their duties to the Company. In some cases, the Company&rsquo;s executive officers and directors may have fiduciary obligations
associated with these business interests that interfere with their ability to devote time to the Company&rsquo;s business and affairs
and that could adversely affect the Company&rsquo;s operations. These business interests could require significant time and attention
of the Company&rsquo;s executive officers and directors.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company may also become involved in other transactions which conflict with the interests of its directors and the officers
who may from time to time deal with persons, firms, institutions or companies with which the Company may be dealing, or which may be
seeking investments similar to those desired by it. The interests of these persons could conflict with those of the Company. In addition,
from time to time, these persons may be competing with the Company for available investment opportunities. Conflicts of interest, if
any, may be subject to the procedures and remedies provided under applicable laws. In particular, if such a conflict of interest arises
at a meeting of the Company&rsquo;s directors, a director who has such a conflict will abstain from voting for or against the approval
of such participation or such terms. In accordance with applicable laws, the directors of the Company are required to act honestly, in
good faith and in the best interests of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>There
is no guarantee that how the Company uses its available funds will yield the expected results or returns which could impact the business
and financial condition of the Company.</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company cannot specify with certainty the particular uses of available funds. Management has broad discretion in the application of its
proceeds. Accordingly, a holder of Shares will have to rely upon the judgment of management with respect to the use of available funds,
with only limited information concerning management&rsquo;s specific intentions. The Company&rsquo;s management may spend a portion or
all of the available funds in ways that the Company&rsquo;s shareholders might not desire, that might not yield a favorable return and
that might not increase the value of a purchaser&rsquo;s investment. The failure by management to apply these funds effectively could
harm the Company&rsquo;s business. Pending use of such funds, the Company might invest the available funds in a manner that does not
produce income or that loses value.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
Articles of incorporation, by-laws and certain Canadian legislation, contain provisions that may have the effect of delaying or preventing
a change in control.</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
provisions of our by-laws, together or separately, could discourage potential acquisition proposals, delay or prevent a change in control
and limit the price that certain investors may be willing to pay for our common shares. For instance, our by-laws, to be effective upon
the completion of this offering, contain provisions that establish certain advance notice procedures for nomination of candidates for
election as directors at shareholders&rsquo; meetings.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
<I>Investment Canada Act </I>requires any person that is non-Canadian (as defined in the <I>Investment Canada Act</I>) who acquires &ldquo;control&rdquo;
(as defined in the <I>Investment Canada Act</I>) of an existing Canadian business to file either a pre-closing application for review
or notification with Innovation, Science and Economic Development Canada. An acquisition of control is a reviewable transaction where
prescribed financial thresholds are exceeded. The <I>Investment Canada Act</I> generally prohibits the implementation of a reviewable
transaction unless, after review, the relevant Minister is satisfied that the acquisition is likely to be of net benefit to Canada. Under
the national security regime in the <I>Investment Canada Act</I>, the federal government may undertake a discretionary review of a broader
range of investments by a non-Canadian to determine whether such an investment by a non-Canadian could be &ldquo;injurious to national
security.&rdquo; Review on national security grounds is at the discretion of the federal government and may occur on a pre- or post-closing
basis.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
limitations on the ability to acquire and hold our common shares may be imposed by the <I>Competition Act </I>(Canada). This legislation
permits the Commissioner of Competition to review any acquisition or establishment, directly or indirectly, including through the acquisition
of shares, of control over or of a significant interest in us. This legislation grants the Commissioner of Competition jurisdiction,
for up to one year, to challenge this type of acquisition before the Canadian Competition Tribunal on the basis that it would, or would
be likely to, substantially prevent or lessen competition. This legislation also requires any person who intends to acquire our common
shares to file a notification with the Canadian Competition Bureau if (i) that person (and their affiliates) would hold, in the aggregate,
more than 20% of all of our outstanding voting shares, (ii) certain financial thresholds are exceeded, and (iii) no exemption applies.
Where a person (and their affiliates) already holds, in the aggregate, more than 20% of all of our outstanding voting shares, a notification
must be filed if (i) the acquisition of additional shares would bring that person&rsquo;s (and their affiliates) holdings to over 50%,
(ii) certain financial thresholds are exceeded and (iii) no exemption applies. Where a notification is required, the legislation prohibits
completion of the acquisition until the expiration of the applicable statutory waiting period, unless compliance with the waiting period
has been waived or the Commissioner of Competition provides written notice that he does not intend to challenge the acquisition. The
Commissioner of Competition&rsquo;s review of a notifiable transaction for substantive competition law considerations may take longer
than the statutory waiting period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are governed by the corporate laws of British Columbia, Canada which in some cases have a different effect on shareholders than the corporate
laws of the United States</I></B>.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are incorporated under the Business Corporations Act (British Columbia) and other relevant laws, which may affect the rights of shareholders
differently than those of a company governed by the laws of a U.S. jurisdiction, and may, together with our charter documents, have the
effect of delaying, deferring or discouraging another party from acquiring control of our company by means of a tender offer, a proxy
contest or otherwise, or may affect the price an acquiring party would be willing to offer in such an instance. The material differences
between the Business Corporations Act (British Columbia) and Delaware General Corporation Law, or DGCL, that may have the greatest such
effect include, but are not limited to, the following: (i) for certain corporate transactions (such as mergers and amalgamations or amendments
to our articles) the Business Corporations Act (British Columbia) generally requires the voting threshold to be a special resolution
approved by 66 2/3% of shareholders, or as set out in the articles, as applicable, whereas DGCL generally only requires a majority vote;
and (ii) under the Business Corporations Act (British Columbia) a holder of 5% or more of our common shares can requisition a special
meeting of shareholders, whereas such right does not exist under the DGCL. We cannot predict whether investors will find our company
and our common shares less attractive because we are governed by foreign laws.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to the Ownership of Our Common Shares</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>New
laws, regulations, and standards relating to corporate governance and public disclosure may create uncertainty for public companies,
increasing legal and financial compliance costs and making some activities more time consuming.</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
laws, regulations and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result,
may evolve over time as new guidance is provided by the courts and other bodies. This could result in continuing uncertainty regarding
compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. If our efforts to comply
with new laws, regulations, and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related
to their application and practice, regulatory authorities may initiate legal proceedings against us and our business may be adversely
affected.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a public company subject to these rules and regulations, we may find it more expensive for us to obtain director and officer liability
insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These factors could
also make it more difficult for us to attract and retain qualified members of our Board of Directors, particularly to serve on its audit
committee and compensation committee, and qualified executive officers.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
market price of our common shares and Series A Warrants may be volatile, and you may not be able to resell your common shares and Series
A Warrants at or above the initial public offering price.</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market price for our common shares and Series A Warrants may be volatile and subject to wide fluctuations in response to factors including
the following:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual or anticipated fluctuations
    in our quarterly or annual operating results;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in financial or
    operational estimates or projections;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">conditions in markets generally;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in the economic
    performance or market valuations of companies similar to ours;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general economic or political
    conditions in the United States or elsewhere;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any delay in development
    of our products or services;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our failure to comply with
    regulatory requirements;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our inability to commercially
    launch products and services and market and generate sales of our products and services,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developments or disputes
    concerning our intellectual property rights;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our or our competitors&rsquo;
    technological innovations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general and industry-specific
    economic conditions that may affect our expenditures;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in market valuations
    of similar companies;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements by us or
    our competitors of significant contracts, acquisitions, strategic partnerships, joint ventures, capital commitments, new technologies,
    or patents;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">future sales of our common
    shares or other securities, including shares issuable upon the exercise of outstanding warrants or convertible securities or otherwise
    issued pursuant to certain contractual rights;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">period-to-period fluctuations
    in our financial results; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">low or high trading volume
    of our common shares due to many factors, including the terms of our financing arrangements.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if we fail to reach an important research, development or commercialization milestone or result by a publicly expected deadline,
even if by only a small margin, there could be significant impact on the market price of our common shares. Additionally, as we approach
the announcement of anticipated significant information and as we announce such information, we expect the price of our common shares
to be particularly volatile and negative results would have a substantial negative impact on the price of our common shares and Series
A Warrants.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, in recent years, the stock market in general has experienced extreme price and volume fluctuations. This volatility has had
a significant effect on the market price of securities issued by many companies, including for reasons unrelated to their operating performance.
These broad market fluctuations may adversely affect our stock price, notwithstanding our operating results. The market price of our
common shares and Series A Warrants will fluctuate and there can be no assurances about the levels of the market prices for our common
shares and Series A Warrants.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
some cases, following periods of volatility in the market price of a company&rsquo;s securities, shareholders have often instituted class
action securities litigation against those companies. Such litigation, if instituted, could result in substantial costs and diversion
of management attention and resources, which could significantly harm our business operations and reputation.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>As
                                            an &ldquo;emerging growth company&rdquo; under applicable law, we will be subject to lessened
                                            disclosure requirements, which could leave our shareholders without information or rights
                                            available to shareholders of more mature companies.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
as long as we remain an &ldquo;emerging growth company&rdquo; as defined in the JOBS Act, we have elected to take advantage of certain
exemptions from various reporting requirements that are applicable to other public companies that are not &ldquo;emerging growth companies&rdquo;
including, but not limited to:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
    being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act;</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">being permitted to provide
    only two years of audited financial statements, in addition to any required unaudited interim financial statements, with correspondingly
    reduced &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&rdquo; disclosure;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced disclosure obligations
    regarding executive compensation in our periodic reports, proxy statements and registration statements; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">taking advantage of an
    extension of time to comply with new or revised financial accounting standard;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">exemptions from the requirements
    of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously
    approved.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to take advantage of these reporting exemptions until we are no longer an &ldquo;emerging growth company.&rdquo; Because of these
lessened regulatory requirements, our shareholders would be left without information or rights available to shareholders of more mature
companies. We cannot predict whether investors will find our common shares less attractive if we rely on these exemptions. If some investors
find our common shares less attractive as a result, there may be a less active trading market for our common shares and our stock price
may be more volatile.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also a &ldquo;smaller reporting company&rdquo; as defined in Rule 12b-2 of the Exchange Act and have elected to follow certain scaled
disclosure requirements available to smaller reporting companies.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Because
we have elected to use the extended transition period for complying with new or revised accounting standards for an &ldquo;emerging growth
company&rdquo; our financial statements may not be comparable to companies that comply with public company effective dates.</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have elected to use the extended transition period for complying with new or revised accounting standards under Section 102(b)(1) of
the JOBS Act. This election allows us to delay the adoption of new or revised accounting standards that have different effective dates
for public and private companies until those standards apply to private companies. As a result of this election, our financial statements
may not be comparable to companies that comply with public company effective dates and may contain less or more modified disclosure than
those public companies. Because our financial statements may not be comparable to companies that comply with public company effective
dates, investors may have difficulty evaluating or comparing our business, performance or prospects in comparison to other public companies,
which may have a negative impact on the value and liquidity of our common shares.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>FINRA
sales practice requirements may also limit your ability to buy and sell our common shares, which could depress the price of our shares.</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
Industry Regulatory Authority, Inc. (FINRA) rules require broker-dealers to have reasonable grounds for believing that an investment
is suitable for a customer before recommending that investment to the customer. Prior to recommending speculative low-priced securities
to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer&rsquo;s financial
status, tax status and investment objectives, among other things. Under interpretations of these rules, FINRA believes that there is
a high probability such speculative low-priced securities will not be suitable for at least some customers. Thus, FINRA requirements
make it more difficult for broker-dealers to recommend that their customers buy our common shares, which may limit your ability to buy
and sell our shares, have an adverse effect on the market for our shares, and thereby depress our share price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
research analysts do not publish research about our business or if they issue unfavorable commentary or downgrade our common shares or
Series A Warrants, our securities&rsquo; price and trading volume could decline.</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading market for our securities may depend in part on the research and reports that research analysts publish about us and our business.
If we do not maintain adequate research coverage, or if any of the analysts who cover us downgrade our stock or publish inaccurate or
unfavorable research about our business, the price of our common shares and Series A Warrants could decline. If one or more of our research
analysts ceases to cover our business or fails to publish reports on us regularly, demand for our securities could decrease, which could
cause the price of our common shares and Series A Warrants or trading volume to decline.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may issue additional equity securities, or engage in other transactions that could dilute our book value or relative rights of our common
shares, which may adversely affect the market price of our common shares and Series A Warrants.</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors may determine from time to time that it needs to raise additional capital by issuing additional shares of our common
shares or other securities. Except as otherwise described in this filing, we will not be restricted from issuing additional common shares,
including securities that are convertible into or exchangeable for, or that represent the right to receive, shares of our common shares.
Because our decision to issue securities in any future offering may depend on market conditions and other factors beyond our control,
we cannot predict or estimate the amount, timing, or nature of any future offerings, or the prices at which such offerings may be affected.
Additional equity offerings may dilute the holdings of existing shareholders or reduce the market price of our common shares and Series
A Warrants, or all of them. Holders of our securities are not entitled to pre-emptive rights or other protections against dilution. New
investors also may have rights, preferences and privileges that are senior to, and that adversely affect, then-current holders of our
securities. Additionally, if we raise additional capital by making offerings of debt or preference shares, upon our liquidation, holders
of our debt securities and preference shares, and lenders with respect to other borrowings, may receive distributions of its available
assets before the holders of our common shares.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>An
investment in our Series A Warrants is speculative in nature and could result in a loss of your investment therein.</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series A Warrants offered in this offering do not confer any rights of common share ownership on their holders, such as voting rights
or the right to receive dividends, but rather merely represent the right to acquire shares of our common shares at a fixed price for
a limited period of time. Specifically, commencing on the date of issuance, holders of the Series A Warrants may exercise their right
to acquire the common shares and pay an exercise price of $6.00 per share (120% of the public offering price of our common shares and
Series A Warrants in this offering), prior to three years from the date of issuance, after which date any unexercised Series A Warrants
will expire and have no further value. Moreover, following this offering, the market value of the Series A Warrants is uncertain and
there can be no assurance that the market value of the Series A Warrants will equal or exceed their public offering price. There can
be no assurance that the market price of the common shares will ever equal or exceed the exercise price of the Series A Warrants, and
consequently, whether it will ever be profitable for holders of the Series A Warrants to exercise the Series A Warrants.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
Series A Warrants and contain a provision which only permits securities claims to be brought in federal court.</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
11 of our Series A Warrants states in relevant part: &ldquo;The Company hereby irrevocably submits to the exclusive jurisdiction of the
state and federal courts sitting in The City of New York, Borough of Manhattan (except for claims brought under the Securities Act of
1933, as amended, and the Securities Exchange Act of 1934, as amended, which must be brought in federal court)&rdquo;. Therefore any
claims with respect to our Series A Warrants brought under the Securities Act of 1933 or the Securities Exchange Act must be brought
in federal court while all other claims may be brought in federal or state court. Proceedings in federal court may be more expensive
than in state court due to more comprehensive rules on how discovery and motion and trial practice are handled. This provision may have
a dampening effect on claims brought under these securities laws or limit the ability of the investor to bring a claim in the jurisdiction
it deems more favorable. This provision is likely enforceable as requirements regarding bringing securities claims have been met, but
it may have the overall effect of discouraging litigation due to the circumstances described herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
do not currently intend to pay dividends on our common shares in the foreseeable future, and consequently, your ability to achieve a
return on your investment will depend on appreciation in the price of our common shares.</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid cash dividends on our common shares and do not anticipate paying any cash dividends to holders of our common
shares in the foreseeable future. Consequently, investors must rely on sales of their common shares after price appreciation, which may
never occur, as the only way to realize any future gains on their investments. There is no guarantee that our common shares will appreciate
in value or even maintain the price at which our shareholders have purchased their shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><B>Risks related to this
offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><B><I>Future sales or
other issuances of our common stock could depress the market for our common stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Sales of a substantial
number of shares of our common stock, or the perception by the market that those sales could occur, whether through this offering or
other offerings of our securities, could cause the market price of our common stock to decline or could make it more difficult for us
to raise funds through the sale of equity in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><B><I>Our stock price
can be volatile, which increases the risk of litigation, and may result in a significant decline in the value of your investment.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The trading price of
our common stock has historically been, and is likely to continue to be, highly volatile and subject to wide fluctuations in price in
response to various factors, many of which are beyond our control and may not be related to our operating performance. These fluctuations
could cause you to lose part or all of your investment in our common stock. These factors include, but are not limited to, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">price and volume fluctuations in the overall stock market from time
    to time;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">changes in the market valuations, stock market prices and trading
    volumes of similar companies;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">actual or anticipated changes in our net loss or fluctuations in
    our operating results or in the expectations of securities analysts;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the issuance of new equity securities pursuant to a future offering,
    including potential issuances of preferred stock;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">general economic conditions and trends;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">major catastrophic events,;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">sales of large blocks of our stock;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">additions or departures of key personnel;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">announcements of new products or technologies, commercial relationships
    or other events by us or our competitors;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">regulatory developments in the United States and other countries;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">failure of our common stock to maintain their listing on the NASDAQ
    markets or other national market system;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">changes in accounting principles; and</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">discussion of us or our stock price by the financial and scientific
    press and in online investor communities.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">These broad market and
industry factors may materially affect the market price of our common stock, regardless of our development and operating performance.
In the past, following periods of volatility in the market price of a company&rsquo;s securities, securities class-action litigation
has often been instituted against that company. Due to the volatility of our stock price, we are currently and may be the target of securities
litigation in the future. Securities litigation could result in substantial costs and divert management&rsquo;s attention in the future
attention and resources from our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="ba_005"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RATIO
OF EARNINGS TO FIXED CHARGES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we offer debt securities and/or preference equity securities under this prospectus, we will, if required at that time, provide a ratio
of earnings to fixed charges and/or ratio of earnings to combined fixed charges and preference dividends to earnings, respectively, in
the applicable prospectus supplement for such offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="ba_006"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated in a prospectus supplement, We intend to use to use a substantial portion of the net proceeds to redeem our July
2022 debentures. The remaining proceeds will be used for general corporate purposes. We will set forth in a prospectus supplement relating
to a specific offering any intended use for the net proceeds received from the sale of securities in that offering. We have significant
discretion in the use of any net proceeds. Investors will be relying on the judgment of our management regarding the application of the
proceeds of any sale of securities. We may invest the net proceeds temporarily until we use them for their stated purpose, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="ba_007"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
OF COMMON SHARES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are authorized to issue an unlimited number of common shares, at no par value per share. As of August 9, 2022, we have
15,555,118 shares of our common stock issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of the Company&rsquo;s common stock are entitled to one vote for each share on all matters submitted to a stockholder vote. Holders of
common stock do not have cumulative voting rights. Therefore, holders of a majority of the shares of common stock voting for the election
of directors can elect all of the directors. Holders of the Company&rsquo;s common stock representing a third of the voting power of
the Company&rsquo;s capital stock issued, outstanding and entitled to vote, represented in person or by proxy, are necessary to constitute
a quorum at any meeting of stockholders. A vote by the holders of a majority of the Company&rsquo;s outstanding shares is required to
effectuate certain fundamental corporate changes such as liquidation, merger or an amendment to the Company&rsquo;s certificate of incorporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of the Company&rsquo;s common stock are entitled to share in all dividends that the board of directors, in its discretion, declares from
legally available funds. In the event of a liquidation, dissolution or winding up, each outstanding share entitles its holder to participate
pro rata in all assets that remain after payment of liabilities and after providing for each class of stock, if any, having preference
over the common stock. The Company&rsquo;s common stock has no pre-emptive rights, no conversion rights and there are no redemption provisions
applicable to the Company&rsquo;s common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfer
Agent and Registrar</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for our common stock is VStock Transfer, Woodmere, NY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is currently traded on the Nasdaq Capital Market under the symbol &ldquo;AGRI.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="ba_008"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
OF PREFERRED STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s articles of incorporation authorize the issuance of an unlimited number of shares of &ldquo;blank check&rdquo;
preferred stock, no par value per share, in one or more series, of which no shares were outstanding as of March 31, 2022, subject
to any limitations prescribed by law, without further vote or action by the stockholders. Each such series of preferred stock shall have
such number of shares, designations, preferences, voting powers, qualifications, and special or relative rights or privileges as shall
be determined by our board of directors, which may include, among others, dividend rights, voting rights, liquidation preferences, conversion
rights and preemptive rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
stock is available for possible future financings or acquisitions and for general corporate purposes without further authorization of
stockholders unless such authorization is required by applicable law, the rules of the Nasdaq Capital Market or other securities exchange
or market on which our stock is then listed or admitted to trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting
power or other rights of the holders of common stock. The issuance of preferred stock, while providing flexibility in connection with
possible acquisitions and other corporate purposes could, under some circumstances, have the effect of delaying, deferring or preventing
a change in control of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
prospectus supplement relating to any series of preferred stock being offered will include specific terms relating to the offering. Such
prospectus supplement will include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    title and stated or par value of the preferred stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of shares of the preferred stock offered, the liquidation preference per share and the offering price of the preferred stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    dividend rate(s), period(s) and/or payment date(s) or method(s) of calculation thereof applicable to the preferred stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    dividends shall be cumulative or non-cumulative and, if cumulative, the date from which dividends on the preferred stock shall accumulate;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    provisions for a sinking fund, if any, for the preferred stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    voting rights of the preferred stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    provisions for redemption, if applicable, of the preferred stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    listing of the preferred stock on any securities exchange;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    terms and conditions, if applicable, upon which the preferred stock will be convertible into our common stock, including the conversion
    price or the manner of calculating the conversion price and conversion period;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    appropriate, a discussion of Federal income tax consequences applicable to the preferred stock;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
    any other specific terms, preferences, rights, limitations or restrictions of the preferred stock.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms, if any, on which the preferred stock may be convertible into or exchangeable for our common stock will also be stated in the preferred
stock prospectus supplement. The terms will include provisions as to whether conversion or exchange is mandatory, at the option of the
holder or at our option, and may include provisions pursuant to which the number of shares of our common stock to be received by the
holders of preferred stock would be subject to adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="ba_009"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
OF WARRANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may issue warrants for the purchase of preferred stock or common stock. Warrants may be issued independently or together with any preferred
stock or common stock, and may be attached to or separate from any offered securities. Each series of warrants will be issued under a
separate warrant agreement to be entered into between a warrant agent specified in the agreement and us. The warrant agent will act solely
as our agent in connection with the warrants of that series and will not assume any obligation or relationship of agency or trust for
or with any holders or beneficial owners of warrants. This summary of some provisions of the securities warrants is not complete. You
should refer to the securities warrant agreement, including the forms of securities warrant certificate representing the securities warrants,
relating to the specific securities warrants being offered for the complete terms of the securities warrant agreement and the securities
warrants. The securities warrant agreement, together with the terms of the securities warrant certificate and securities warrants, will
be filed with the Securities and Exchange Commission in connection with the offering of the specific warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
applicable prospectus supplement will describe the following terms, where applicable, of the warrants in respect of which this prospectus
is being delivered:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    title of the warrants;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    aggregate number of the warrants;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    price or prices at which the warrants will be issued;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    designation, amount and terms of the offered securities purchasable upon exercise of the warrants;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    applicable, the date on and after which the warrants and the offered securities purchasable upon exercise of the warrants will be
    separately transferable;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    terms of the securities purchasable upon exercise of such warrants and the procedures and conditions relating to the exercise of
    such warrants;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    provisions for adjustment of the number or amount of securities receivable upon exercise of the warrants or the exercise price of
    the warrants;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    price or prices at which and currency or currencies in which the offered securities purchasable upon exercise of the warrants may
    be purchased;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    date on which the right to exercise the warrants shall commence and the date on which the right shall expire;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    minimum or maximum amount of the warrants that may be exercised at any one time;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">information
    with respect to book-entry procedures, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    appropriate, a discussion of Federal income tax consequences; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other material terms of the warrants, including terms, procedures and limitations relating to the exchange and exercise of the warrants.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
for the purchase of common stock or preferred stock will be offered and exercisable for U.S. dollars only. Warrants will be issued in
registered form only.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
receipt of payment and the warrant certificate properly completed and duly executed at the corporate trust office of the warrant agent
or any other office indicated in the applicable prospectus supplement, we will, as soon as practicable, forward the purchased securities.
If less than all of the warrants represented by the warrant certificate are exercised, a new warrant certificate will be issued for the
remaining warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the exercise of any securities warrants to purchase preferred stock or common stock, holders of the warrants will not have any of
the rights of holders of the common stock or preferred stock purchasable upon exercise, including in the case of securities warrants
for the purchase of common stock or preferred stock, the right to vote or to receive any payments of dividends on the preferred stock
or common stock purchasable upon exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="ba_010"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
OF UNITS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
specified in the applicable prospectus supplement, we may issue units consisting of shares of common stock, shares of preferred stock
or warrants or any combination of such securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
applicable prospectus supplement will specify the following terms of any units in respect of which this prospectus is being delivered:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    terms of the units and of any of the common stock, preferred stock and warrants comprising the units, including whether and under
    what circumstances the securities comprising the units may be traded separately;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    description of the terms of any unit agreement governing the units; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    description of the provisions for the payment, settlement, transfer or exchange of the units.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="ba_011"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLAN
OF DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may sell the securities offered through this prospectus (i) to or through underwriters or dealers, (ii) directly to purchasers, including
our affiliates, (iii) through agents, (iv) via so called &ldquo;at-the-market&rdquo; or &ldquo;ATM&rdquo; offerings, or (v) through a
combination of any of these methods. The securities may be distributed at a fixed price or prices, which may be changed, market prices
prevailing at the time of sale, prices related to the prevailing market prices, or negotiated prices. The prospectus supplement will
include the following information:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    terms of the offering;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    names of any underwriters or agents;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    name or names of any managing underwriter or underwriters;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    purchase price of the securities;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    over-allotment options under which underwriters may purchase additional securities from us;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    net proceeds from the sale of the securities;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    delayed delivery arrangements;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    underwriting discounts, commissions and other items constituting underwriters&rsquo; compensation;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    initial public offering price;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    discounts or concessions allowed or reallowed or paid to dealers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    commissions paid to agents; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    securities exchange or market on which the securities may be listed.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agents,
underwriters, and dealers may be entitled, under agreements entered into with us, to indemnification by us against certain liabilities,
including liabilities under the Securities Act. Our agents, underwriters, and dealers, or their affiliates, may be customers of, engage
in transactions with or perform services for us, in the ordinary course of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Sale
through Underwriters or Dealers</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only
underwriters named in the prospectus supplement are underwriters of the securities offered by the prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
underwriters are used in the sale, the underwriters will acquire the securities for their own account, including through underwriting,
purchase, security lending or repurchase agreements with us. The underwriters may resell the securities from time to time in one or more
transactions, including negotiated transactions. Underwriters may sell the securities in order to facilitate transactions in any of our
other securities (described in this prospectus or otherwise), including other public or private transactions and short sales. Underwriters
may offer securities to the public either through underwriting syndicates represented by one or more managing underwriters or directly
by one or more firms acting as underwriters. Unless otherwise indicated in the prospectus supplement, the obligations of the underwriters
to purchase the securities will be subject to certain conditions, and the underwriters will be obligated to purchase all the offered
securities if they purchase any of them. The underwriters may change from time to time any initial public offering price and any discounts
or concessions allowed or reallowed or paid to dealers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
dealers are used in the sale of securities offered through this prospectus, we will sell the securities to them as principals. They may
then resell those securities to the public at varying prices determined by the dealers at the time of resale. The prospectus supplement
will include the names of the dealers and the terms of the transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Direct
Sales and Sales through Agents</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may sell the securities offered through this prospectus directly. In this case, no underwriters or agents would be involved. Such securities
may also be sold through agents designated from time to time. The prospectus supplement will name any agent involved in the offer or
sale of the offered securities and will describe any commissions payable to the agent. Unless otherwise indicated in the prospectus supplement,
any agent will agree to use its reasonable best efforts to solicit purchases for the period of its appointment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may sell the securities directly to institutional investors or others who may be deemed to be underwriters within the meaning of the
Securities Act with respect to any sale of those securities. The terms of any such sales will be described in the prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Delayed
Delivery Contracts</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the prospectus supplement indicates, we may authorize agents, underwriters or dealers to solicit offers from certain types of institutions
to purchase securities at the public offering price under delayed delivery contracts. These contracts would provide for payment and delivery
on a specified date in the future. The contracts would be subject only to those conditions described in the prospectus supplement. The
applicable prospectus supplement will describe the commission payable for solicitation of those contracts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Continuous
Offering Program</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
limiting the generality of the foregoing, we may enter into a continuous offering program equity distribution agreement with a broker-dealer,
under which we may offer and sell shares of our common stock from time to time through a broker-dealer as our sales agent. If we enter
into such a program, sales of the shares of common stock, if any, will be made by means of ordinary brokers&rsquo; transactions on the
Nasdaq Capital Market at market prices, block transactions and such other transactions as agreed upon by us and the broker-dealer. Under
the terms of such a program, we also may sell shares of common stock to the broker-dealer, as principal for its own account at a price
agreed upon at the time of sale. If we sell shares of common stock to such broker-dealer as principal, we will enter into a separate
agreement with such broker-dealer, and we will describe this agreement in a separate prospectus supplement or pricing supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Market
Making, Stabilization and Other Transactions</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
the applicable prospectus supplement states otherwise, other than our common stock all securities we offer under this prospectus will
be a new issue and will have no established trading market. We may elect to list offered securities on an exchange or in the over-the-counter
market. Any underwriters that we use in the sale of offered securities may make a market in such securities, but may discontinue such
market making at any time without notice. Therefore, we cannot assure you that the securities will have a liquid trading market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
underwriter may also engage in stabilizing transactions, syndicate covering transactions and penalty bids in accordance with Rule 104
under the Exchange Act. Stabilizing transactions involve bids to purchase the underlying security in the open market for the purpose
of pegging, fixing or maintaining the price of the securities. Syndicate covering transactions involve purchases of the securities in
the open market after the distribution has been completed in order to cover syndicate short positions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Penalty
bids permit the underwriters to reclaim a selling concession from a syndicate member when the securities originally sold by the syndicate
member are purchased in a syndicate covering transaction to cover syndicate short positions. Stabilizing transactions, syndicate covering
transactions and penalty bids may cause the price of the securities to be higher than it would be in the absence of the transactions.
The underwriters may, if they commence these transactions, discontinue them at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="ba_012"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the issuance of the securities offered by this prospectus will be passed upon for us by Jolie Kahn, Esq. of New York, NY.
If certain legal matters in connection with an offering of the securities covered by this prospectus and a related prospectus supplement
are passed upon by counsel for the underwriters, if any, of such offering, that counsel will be named in the related prospectus supplement
for such offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="ba_013"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated balance sheets of AgriForce Growing Systems Ltd. as of December 31, 2021 and December 31, 2020, and the related consolidated
statements of operations stockholders&rsquo; equity, and cash flows for the years then ended have been audited by Marcum LLP, as stated
in their report, which is incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference
in reliance upon such report given on the authority of such firm as experts in accounting and auditing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHERE
YOU CAN FIND MORE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
file annual, quarterly and special reports, along with other information with the SEC. Our SEC filings are available to the public over
the Internet at the SEC&rsquo;s website at http://www.sec.gov. Our SEC filings are also available on our website, <U>https://www.agriforcegs.com
</U>under the heading &ldquo;Investors.&rdquo; The information on this website is expressly not incorporated by reference into, and does
not constitute a part of, this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is part of a registration statement on Form S-3 that we filed with the SEC to register the securities offered hereby under
the Securities Act of 1933, as amended. This prospectus does not contain all of the information included in the registration statement,
including certain exhibits and schedules. You may obtain the registration statement and exhibits to the registration statement from the
SEC at the address listed above or from the SEC&rsquo;s internet site.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="ba_014"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INCORPORATION
OF CERTAIN DOCUMENTS BY REFERENCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is part of a registration statement filed with the SEC. The SEC allows us to &ldquo;incorporate by reference&rdquo; into this
prospectus the information that we file with them, which means that we can disclose important information to you by referring you to
those documents. The information incorporated by reference is considered to be part of this prospectus, and information that we file
later with the SEC will automatically update and supersede this information. The following documents are incorporated by reference and
made a part of this prospectus:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
    Report on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1826397/000149315222008083/form10-k.htm" STYLE="-sec-extract: exhibit">Form
    10-K</A> for the year ended December 31, 2021 filed on March 30, 2022 and Quarterly Reports on Form
    10-Q for the quarter ended March 31, 2022, filed on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1826397/000149315222013871/form10-q.htm" STYLE="-sec-extract: exhibit">May 16, 2022</A> and for the quarter ended June 30, 2022, filed on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1826397/000149315222022805/form10-q.htm" STYLE="-sec-extract: exhibit">August 15, 2022</A>; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Definitive Proxy Statement on <A HREF="https://www.sec.gov/Archives/edgar/data/1826397/000149315221020631/formdef14a.htm" STYLE="-sec-extract: exhibit">Schedule 14A</A> and accompanying additional proxy materials filed with the SEC on August 19, 2021;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    Reports on Form 8-K (excluding any reports or portions thereof that are deemed to be furnished and not filed) filed on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1826397/000149315222004882/form8-k.htm" STYLE="-sec-extract: exhibit">February 17, 2022</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1826397/000149315222009590/form8-k.htm" STYLE="-sec-extract: exhibit">April 11, 2022</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1826397/000149315222014793/form8-k.htm" STYLE="-sec-extract: exhibit">May 23, 2022</A> and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1826397/000149315222018639/form8-k.htm" STYLE="-sec-extract: exhibit">July 6, 2022</A>; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    registration statement on <A HREF="https://www.sec.gov/Archives/edgar/data/1826397/000149315221015987/form-8a12b.htm" STYLE="-sec-extract: exhibit">Form 8-A</A> filed on July 2, 2021.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also incorporate by reference all additional documents that we file with the Securities and Exchange Commission under the terms of Sections
13(a), 13(c), 14 or 15(d) of the Exchange Act that are made after the date of the initial registration statement but prior to effectiveness
of the registration statement and after the date of this prospectus but prior to the termination of the offering of the securities covered
by this prospectus. We are not, however, incorporating, in each case, any documents or information that we are deemed to furnish and
not file in accordance with Securities and Exchange Commission rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may request, and we will provide you with, a copy of these filings, at no cost, by calling us at (604) 757-0952 or by writing to us
at the following address:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">300
    &ndash; 2233 Columbia Street</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vancouver,
    BC, Canada</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">V5Y
    0M6</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 56 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$3,457,461</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGRIFORCE
GROWING SYSTEMS, LTD.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS
SUPPLEMENT</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>October
21, 2025</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%; text-align: center">Yorkville Securities</TD><TD STYLE="text-align: center; width: 50%">Cohen &amp; Company
                                            Capital</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"></P>

<!-- Field: Page; Sequence: 57; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>forms-3_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 forms-3_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %1!)L# 2(  A$! Q$!_\0
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M-U5O.H\Z@"SNHW56\ZCSJ +.ZC=5;SJ/.H L[J-U5O.H\Z@"SNHW56\ZCSJ
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MMANQ/[M&Q/[M/HJAC-B?W:-B?W:?2&@!NQ/[M&Q/[M+10 FQ/[M&Q/[M.I:
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M&%%%(WUH 6BF9&>>33ATH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHI#UH 6BFY![]*4'(H 6BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH #4<G^K:I#
M4<G^K:@"G%5V/I5&+K^-7H^E  _7Z5!(, D]#U%6#UJO+23:W"QBW>AVU^Q
M'EMZBLF3PI=(^$?>OOQ760?Z^KAZ&N.K@J55\S(=-,Y.R\**CB2X;)]*Z6WM
MDMT"QJ *G%!K:GAXPV",$A1Q2T@HS6Q8M%-X'>G"F 4AI:0]:+ %%)D=J3(!
MRQYJ;(+CJ6F< ]>33NO2GL M%-) '/-'7H<4[@.HIO'<T?CFE<!U%-X':ESG
MVHN M%)T]Z/QHN M%-_X%2Y]*=P%HHHH **9T!)Y%"G)!'2IN ^BBBJ ****
M "BBB@ HHIA.?8TF[ /HI@('N:?3N 44G>EH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH H3?
M\?+5-#T'UJ&;_CY:IH>@^M %FBBB@ HHHH 8]4YOO"KCU3F^\* L6H?]4*?@
MTV'_ %0J2@!HSFD-.[T47!:"%@!R<5&MQ$\A19%+#J :YSQMK8T3P_/*#B61
M2B?4UY1X=OM4\-^(+&^U&65K>]?G=G &,_UJK&,JRB[6/?BZ@]:4,#T-96HZ
MO;:7IC7\[@1!<_7-<%%\59)96DATF5[3/^MVM^?2E8MU()VN>H[UYYZ4;E/T
M]:X7PGX\_P"$G>^(MA"ELNX8.=W.*QH/BRUQ=RVL6E.\PDV;5W'CUZ46)56+
M.SO?%VEV&LQZ5+.HNI/NIW-;GVF%=NZ15+#(!->5:A<:=+X[TIKFP"74P4[M
MQX.:S?'HEN?'=M9BYDBBD10<-@ 8HL1*ND>S?;+;_GO'Z?>J3S$QG<,>M>86
M_P .;$3P2IK3%E(;;YO7]:I^*M;U*\UZW\,Z1*4'".^>:+![9]CUG[5!NV^<
MF?3=3]Z^HKRB;X:7UO8-/;ZK-]L4;CD\9Z^M6? OBJ^U"*_T?4VS=VH(!]0!
MFBQ7M7V/2C=0+UF08_VJ<D\4@RDBM]#7A'A_1)?$WB35+:;4)HQ$[,"&/'./
M6K-Y_:/@3Q)9PP:C)<13OM9&HL0L1W1[@74#)8"F?:H"<>:F?3=7E?C;Q+J%
MYK5MX?TF4Q/)_K7'4'/3]:>WPRODM?-AUB<7V,^V?SHL4JKELCU-IHT7<SJ!
MZDTS[7;_ //:/T^]7F7BZWU/3/A\(+JZ+7*L,N#CC-<QH>AZ5J.DP7=UKTD$
MK@;D+]#^=%A.LU+E:/=1<0L"1(I [@TXRQ@9+"N B\/FT\)LNG:H[!&9Q+US
MG'O6&DVM6O@]M7_M1YIS(%"E !UQ0-UK=#UW<H&<TF]3WKR>]\<W<GAB&.VW
M#4P LP(P .YKT'19I)=&M9)3EC&"Y]\4M"HUHLV,CUH+ =Z\^U_XCII>KMIE
ME9M=W ^\,'C\JN^&O&=QK4\\5WISV0A7)9@<?F10'MHW.TW#&<T,P52Q. .3
M7FNH?%!8KZ6WTW3I+PQG#,H;'Z"M3P_XYM?$EO<6Y0P7@0YB8$=O>G8;JQ.I
MM-7L+ZXD@MKE))8_O*.U72P'>O'? DQMO$^NS$%VCW<;O>NP\)^,V\375[!]
MF$9MCC.>O.*+"5:+=CLMP]:89DW[0ZY]*XB7QPT?BN70A:[C&C,&R>2,?XUY
MY<^,-7A\<F402$QO\ML,_-S18B5=*-TCV36_$NGZ"(C>S+&)#A2>]:5G>0WM
MI%<PL#'(-RGVKR_QIJ=O>>'M/O-4T_\ >228\LDC;R*Z6Z\4:=X8\+VDI3&Y
M (H1R>]%BHUDWJ=EN QSUHW#(&>37EL?Q7DCE0WNDRPV[<B4JW _*N@U_P 9
MPZ+H<>J6\0GBDQCFBPW6B=EN'K1D9QFO*#\6IO(6[71I&MR,NV&X_2NJ3QM8
MR>%VUK/[H#[O>D'MHG6A@<X/2C(]:\KA^*5]<D/'H3M;%@H==QSS]*](L;DW
M=G#.5*%UR4/:@J-2++@(-+3$QD_RI]!84444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 !IDG^K:GFF2?ZMJ *,77\:O1]*HQ=?QJ]'T
MH 4CFJ\M63TJM-2L.Y'!_KZN'I5.W_U]73TIM7$(*"?6CBANA]:76P+0 PQU
MK/OM7M;!E$\JJ3V-6)7$2F0G  YKCG3^V[ZYE>11'&"J@FN7%5I4G[FK(E42
MV.UBGCN(ED0@JPR#4@=2,@\5S7AN[W6\MJQR\)..>U5KC4-0U#47MK-Q&J]:
M:Q*]FI]P4KG7[AZBF&1<]>M<9<W.J6=S!;RS9Y'/K5C6[^\MY[=8)2'<#C'M
M42Q:L[)Z Y,Z#4;I[:S>6)=S#L*I:?JK3:8US=(8]O/-5@M]!I4TUQ/N<C(&
M!Z55AEDG\+2O(1N*\U,JVO;2^I/,S2_X26P.TB05>L=4M[Y6,39"]:Y32+S3
M8;-1.A9\GG;FM&\O($T26:P&T,P!XQ4TL4VKR:Z[#4F:=SK]C;2;&E!8<5-9
MZM9WQVQ2@L.U8FB:;:M9K<RH9'<\DU6URR33YDN;=_+.1\H[TU7JJ,:DDN5A
MS2.CO=6M; @3N 3TJJGB6P<@>: />L+7W,IL)6'7&X>V:L:B^EIIK$ ;RO&/
M6HEBJEY-6LA.<D['4QW$<D8D5P5/>L^Z\06-K)L:4$CJ!7.P3S6WAMMQ8,Q^
M4^@S6EHFE6YL$GF'FNXYS6BKRG-1AU&I2-:RUBSO3B*49]*@G\06<$YB+@L.
MHI\.DV]O<-/&N"1TKE'D2'7)7:$R>W6BI5K02NE<')K<ZB#Q%83R;%?DU9.J
MV8.//4'TK%TVZ@NKKRA8F,,N2Q4C%/>S@_MW 0X50<=C5*I6<;I(%._5'00W
M<$^?+D#8ZXH6YA=VC5P67@CTKE 9K74KBZB#%1A2O8YJQHJ2C4Y6FW>9(-Q]
MAZ4+$2Y8MK<<*BET-R_O%L;1IB,@=:33KY;VW6;&T'I57754:5-N&3CBN=T^
M+59[%&MYPD:YXXHJ8CDJ\O0)2:9W)90,DTGF+ZBN7T[5;B=+BTF_UL0/S52T
MVXU6^E91-\B.<].F:?UKWDD@YT=L64=Z-P]:YJ^&IO,$CO$C0#G)%5=/U.Y@
MU-;2:;S0?XJ/K:O9H.='7[ESC-&Y?6N/U*\OAK(AMY=H(%1S7NIZ;=P_:90Z
MR'I0\7OY![1':9'K5#4=06PM3,5W8/:L;5=7N5>*"S.))/6L[58M3AL-UU+Y
MB'&1Q6=?%V@W%7L)U.QUEA?+>VBSA=N?6K@=3T(KD#>RV/A^W, (W  G'2G6
M0OY6CE34%(SRIP*KZS;E5MQJ=SK@P)(!Y%+4,0Z9Y;')J:NU.Y84444P"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ2[!3J* &[ /K2XI:* &[>,"DV<<G)I]% #2O'6@(,Y//I3J* &JNW-.HHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****  TR3_5M
M3S3)/]6U %&+K^-7H^E48NOXU>CZ4 ./2JTU63TJM-0!';_Z^KIZ52M_]?5T
M]* #%!4,"#T-+10M (_)'!S\P[T&,YSN_2I**=P6@PQYQSTI&BW=3QZ5)14N
M*>X7(S$#W^M'E<8W?2I**7*KW C,0/>D\@;MV?FQC-2T4[:W C$(' /%.V#.
M>].HIVTL PH2,;J3R^?O<>E244"L,$>!R<TAB!R#R#VJ2BERJ]QC$C*K@L32
M[.G-.HHL@(GA#/NSCU]Z7RAZ_2I**8DDG<C\KKSP:4Q@E>>E/HI615QFSWH"
M8[T^BG8+C=O&,T%?0XIU% ANWWHV^].HI65[@(!CO05SWI:*8#=N*7:,4M%*
MR ;M]Z-OO3J*87&;,]Z7;QUIU%#U"XT+@YS3J** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK<J)V"%SA0>]</XPO38>+-&N5A>8A^54$G[OH*AU7Q"U_>V$9L)XF:0'>Z,
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MSA<\5T2KR>P'2E"MSR".PQ0!@:CHL]UXALM2210D#?,OKQBIM9TJ;49+81N
ML;!FW=^<UK^6 V[GWYI2.,@9S0!QMWX;OK/4;BYTN.VD6X8NPF4G!]J?J.A7
MDMK:R1FW>X@8NT9!V\^U=?C9T[#&*0GYNWN,=: ./TSPQJ$5Q?7%RUNAN8V
M2$$ 97%+>>'KY;/2Y+-XS=66T $':<>M=?DX/&TG\:7!/&<#H>* ,+^R;B36
MK?4I)$W!0' Z9Q39-#FDO[ZY\U,3HR*#VR,5T Z^P]J"<=^/I0!QEUX4N([>
MTEMS"]S;J%.\$J<5>M])U&;3KB.[%LDDF-ODJ0!BNCQQTSZFG%<#- %/3[9K
M33X8GY:--O%8NH:'>0:C_:>D2K',5 >-\[7_ "KI5QMW+GFE)_SB@#F[>SUF
M]BG_ +2>(%U(5$! Z4\>'GE\*VVEROMDA7Y6'J,UO,N]<$YR>U.&06XP.N:
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M!:*;O4C.1BEW#GGI0 M%(&!&<\4;AD#/)Z4 +129'K1D>M "T4A8#O02!U-
M"T4F0.]&1ZT +11D9QWHR* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ -,D_P!6U/-,D_U;4 48NOXU>CZ51BZ_C5Z/I0 X]*K359/2JTU $=O_
M *^KIZ52M_\ 7U=/2@!:*** "BBB@ HHHH **3('>@,"2 >E "T4@8'H:"0.
MIH 6BDWKG&:-PYYZ=: %HI,C&>U 8$9S0 M%-WKG&X9H#JQ.&!Q0 ZBDW#&<
MT;AZT +12%@.II"Z@9)% #J*0D#J:3>IS\PXZT .HI"P Y-!8 9)H 6BFAU)
MP&&:7</7K0 M%&1G%)D>M "T4FX<<]:6@ HI,C)YZ4H((R* "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** *$W_ !\M4T/0?6H9O^/EJFAZ#ZT 6:*** "B
MBB@!CU3F^\*N/5.;[PH MP_ZH5)4</\ JA4E !1110 4444 %-8X&?SIU(P)
MP/SH C/W?E/7UK'O_$NF:?YXFN )(NJ="Q[8K:VG&"HXZ5R6N^ ]/UO7K+4Y
MB8V@R61!D.<@@G\J )]#^VZHYU>[+)"_,$/3"]B:Z7 9?K34C\O:BX50.W>G
M*1_#T% &9X@OI+#2'D@P9"0BY]36#;>%%N[-+FZN)Q>2+OWK(V%/TS6_KFFM
MJ6F/$C8DR&7'J.E85OKVI6-J+.;3YI+I!L5U0E"?4F@"[>:S)I1AL8(?ME[C
M&S.WC'7-,A\4![6Y>[M##>6RG="&SD8R:IWJ7UCK$6M&T:5)$ ECC!9A@>E5
M$TZ\U.:_U<PM!E&2*(C!(([B@#0@\83$6]Q/IK164H'[[=G'X4^Z\2SC4Y+/
M3[(7+(%9W:0)@'D8S3=7L;J?P&+6*,FX^SA=H'>LS5XDAG@_T"X2Y\I +B",
MMDX'WCVH ZJ#6A+J45D\6R5XBY!/3%4;_6UGDU'3(U*R06XD9L],G%8[1:GI
ML]CJUU UU*L)CEP"6!)[ 5#86^HZAJVM7DUD84GM%2/@Y;YLX- %:V\2ZO8V
M^E0VMG]J69Y Y9\=#[UU+:A"-:1)(GCN?LK2,=Y*K@],5SS6=]8:9I=RUJSF
MW=P\: D\MP<5K3VMS>ZS]L2)EBDLV7:PP=Q/>@""/QE<21/=QZ:S64<ACDGW
M],=\5IZCXDCA2".U@-U-.-R1@[>G7FJ>E:?<0>$;NV: ><TCD)Z\BLN.UNM&
MELM1:(RA%=7C/WAGI@4 ;.G>*WO=7.F7-DUO<[-Q&<X_&NFZ=3C YKA-,U&X
MU;QTLY@\J)+8C!&&'/<>M=W@9(/- $E%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%%  :9)_JVIYIDG^K:@"C%U_&KT?2J,77\:O1]* ''I5::K)Z56F
MH CM_P#7U=/2J5O_ *^KIZ4 +1110 4444 %,<XY)P*?367=C(!% $>0$XX'
M7)KGM1\7Z?!:.;>433AB@B7[Q8<5T9CW@[P"",8KD8/ &G6GBTZ[&2KD#9$!
M\H;G)_'- &KH-E>)&;S4)2UQ+SM'116UTZ\U'N ;'0?H:?D*N ,B@#.U/5%T
MU[=&7<\[%5IEWJPM-5M;,KDS1ER?I5/Q5:W,UO;W-K'YDENVX+WK%^T:EK'B
M73KA;&2&WBA96>12ISD4 7V\5W,D]W'8Z>9UMY"KL6QC'MWINJ:Z+SP\ES;$
MJ97\L@=B#@U>\/V<EM-J;31#]Y<LRD]Q7-_8;BP\+J9T9&2]D?:!V+\4 .\2
M^&+.WL;:=7NO,DGC#L+AAP3SQFI==BA\*Z=I\EB9V#W&=K2%BW'2MOQ'!+>Z
M?9&W4NPFC8[>1@&D\0VL]P=+\N/>$N-SD=5&* &V'B66>[2RO+,VKR)F(EL[
M^,GZ5$==M[&SOYEB?]W<!&4L3DD=J76+"Y?6](EB0NL:OO;'(R.*SFTJ\:UO
MP823+>(Z[O[H% &A:>*)FO+6*\T]K6.Y(6"0ONW'&<>W%5K;5X]-UW7);R?"
M 1[$)SR1V%7=;L9Y[;1TB3YHI<L>X^6N>N_!\^J>(-2OI)9(W"QM#QPQ44 :
M^H7\^W3=3V/"LLBQE"?4UIR:Y-#+<B2UQ'"@?<&SD$XZ5B:A=7EWH^FPW<>R
M\%R@<#O[UU3:="ZEI/O.@1O<"@"J-<A>ZMX(U),P)/M6/\0G9=,MHQ,T227"
MAV5L<?6N@72[>*=9$0!AW]*PO'FE2ZOIEK;Q1&1?M"NW':@!^E:'HUH(;Z"Y
MD>6- 3FY+9X],TT^*YG4W-OIS2V ;#3;\%?PJQ9^$M,LK'%O"L5Q)&!N'4'%
M8UO<ZAIVE-H@TZ1Y3N42A3MP>^?QH V+GQ2K&"/38#>RS)O1,[?E^M+;^*X?
MLMP]Y$;>XMP#)%G)Y.!6-::=>>%[BVNO)DNHC;B.0(,LISV IESHE_K-S>:P
M8/)>2-%CB/!(4]Q0 :]XCOY+6UCDL7M8Y;B/9,&SD;O3M6M+XGFCO38V5C]I
M,?#L9=O\ZR]3U#4]9T^VLX=-DB9)XV=G4@84]J36X@ETXM]/GAO67"W$$9.?
MJ: .YC9I(5,B["P!QG.*G3.P9ZUGZ/\ :ETJ(79W2XY)ZUH@ # Z4 +1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MV378[\+&HWI!M&"/0GM4BZS?^(9H[*TG^RA5!DDQDDX]* .QAB2WA6%"0JC
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/6G4AXH 85&17GOBFT\6G7(+/3K@2Z?=<S$X78N<$?EFO0P.<@ 4C'!^7&:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M".W_ -?5T]*I6_\ KZNGI0 M%%% !1110 4444 %%%% !1110 4444 %%%%
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M "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4)O^/EJFAZ#Z
MU#-_Q\M4T/0?6@"S1110 4444 ,DZ9JE+RPJ\_W:I3<$4 6X?]4*DJ. YB%2
M4 %%%% !1110 4444 %%%% !28I:* &[!G/-&SYL\4ZB@!FSWHV>]/HIW'<9
MLYSFCR_>GT47"XS8>>:/+QWI]%%PN,";1P:"AQD$;O7%/HI"$48%+110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  :CD_U;5(:CD_U;4
M4XNM78^E4HJNQ]* ''I5::K)Z56FH CM_P#7U=[52M_]>*NT +1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!0F_X^6J:'
MH/K4,W_'RU30]!]: +-%%% !1110 UN1569,U<-1.F: (8)MOR'I5K.>G2JC
M1'&1UI5:11B@"W157S):7S): +-%5O,EH\R6@"S15;S):/,EH LT56\R6CS)
M: +-%5O,EH\R6@"S15;S):/,EH LT56\R6CS): +-%5O,EH\R6@"S15;S):/
M,EH LT56\R6CS): +-%5O,EH\R6@"S15;S):/,EH LT56\R6CS): +-%5O,E
MH\R6@"S15;S):/,EH LT56\R6CS): +-%5O,EH\R6@"S15;S):/,EH LT56\
MR6CS): +-%5O,EH\R6@"S15;S):/,EH LT56\R6CS): +-%5O,EH\R6@"S15
M;S):/,EH LT56\R6CS): +-%5O,EH\R6@"S15;S):/,EH LT56\R6CS): +-
M%5O,EH\R6@"S15;S):/,EH LT56\R6CS): +![5!/*%7 [TUGD(YJ,1DG+4
M$2U;3I4:)BI@,"@ /2J\HS5BF.N: *<9V2Y-7@=RY%56CW&E!=.!0!;HJMYD
MM'F2T 6:*K>9+1YDM %FBJWF2T>9+0!9HJMYDM'F2T 6:*K>9+1YDM %FBJW
MF2T>9+0!9HJMYDM'F2T 6:*K>9+1YDM %FBJWF2T>9+0!9HJMYDM'F2T 6:*
MK>9+1YDM %FBJWF2T>9+0!9HJMYDM'F2T 6:*K>9+1YDM %FBJWF2T>9+0!9
MHJMYDM'F2T 6:*K>9+1YDM %FBJWF2T>9+0!9HJMYDM'F2T 6:*K>9+1YDM
M%FBJWF2T>9+0!9HJMYDM'F2T 6:*K>9+1YDM %FBJWF2T>9+0!9HJMYDM'F2
MT 6:*K>9+1YDM %FBJWF2T>9+0!9HJMYDM'F2T 6:*K>9+1YDM %FBJWF2T>
M9+0!9HJMYDM'F2T 6:*K>9+1YDM %FBJWF2T>9+0!9I"V!582RYI&\Q^] $3
MG=(6[FK$(X%,6+!YJPBXH ?1110 4444 %& :** &D"DP/2GT4 1X'I1@>E2
M44 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E2
M44 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E2
M44 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E2
M44 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E2
M44 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E2
M44 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E2
M44 , 'I1M'I3Z* $ %+110 48%%% #<"DP/2GT4 1X'I1@>E244 1X'I1@>E
M244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E
M244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E
M244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E
M244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E
M244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E
M244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E244 1X'I1@>E
M244 1X'I1@>E244 ,VCTHVKZ4^B@!N!3A110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
I%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>forms-3_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 forms-3_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (<!*(# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@CUJI>ZK96"9N9@/:L/P7K9U/20LAWS)G=BN#N)%UGQS/9W\YCMT=@ 6(]*
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M<M>V[E)W^8X'>MO1M&CT'2EMX/\ 68R>^37*W_B#Q+I^IR)]CDFMR25*1]*
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M(6-B,8H [J/=M^:GTBGBEH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&^G:E8H$_>,$ />@".*!+2*.. 80=JF)R>!VIH96 ,; IZTCR)$?WDBJ#ZT
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MXX53SN/2@"*XLK2[($Z!PO3(JI_8.ED%OL<1Y[BKZS0.-L<R,1Z=ZD9CM!/
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M%X-')7J* $:-6/* T@7:/E4#Z4[<,>M( H.><T +QU(^:FE?,X=!BGYXS32
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M.EVDBW<J,1V%<I%IET_B,Z:=1G VD]J]$T,2-I=HP90 .!BN0A(/C\D]?+-
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MDAU*UN&V1W$;-Z T<\>C(NFRWG!(]>E(W8$<8JM>W2V-G)<S?,(QN.*PH_&
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MVI&7Y^G&.M1-=0+,(GE3S2>!FG37,=NGFS.J(.,M5787CV'  *%ZD]S3F5>
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M/(H^M59=5M8?O3(?H: -#--R*PI_$MC'U#'Z&JS>,K)1@0RG\:!I7.FR*0L
M:Y1O&MH 3Y$M5QX^LR2##(,>M7"DY;&-:HJ:U.S# T5R*>-[)_X''XU=@\56
M,I W;,]V-.>'G?8SIXJ$EN=#VI-PJG!J5K.OR3H?H:M*ZD<$$5A*:B^5G1":
MDM"3BCM3,J?6G$\?*:NZV"RN.'2EIJ;MOS=:=1L,**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%.HH 85/'-&#N ZBGT4 ,*X)(ZT@0\'H>XJ2B@"/9QDC+4!"65LD>H]:DHH
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MQ=3N*,UY]+XPN47.1^55U\<S Y./RK:E0G5CS(YZ^)C2GRL]()YI,UP47CU
M@,B,3["KUOX[L93AHI :7U:HB%CZ+=KG7YI<UB6WB73Y\_O0A_VC5]+Z"89C
MD#_[IJ)1DNAT1KTY;,N4M5UDR,@$?6GY]36=VMT7>^Q+14.XGIQ]:>.E5=!J
M/HJ-A0G H'==R2BF8S1M/K3'H/HIHH-(3'4444 %%%% !1110 4444 %%%%
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M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZZBXW.*NQC" 53@&9*T$7+ 5Y>?U>:T?ZV,<+'4N+\JC%/#F%MPIF.12GYF
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MTH7GK0 N:*='&\K8C4L?84/&\9PZE2>QH ;13F1D.&4@GUIM !1110 4444
M+3'Z&GTQ^AI= >YF7/\ JS5>W[U8N?\ 5FJ]OWKW\L_@L^:S;^,OZZ$U%%%>
MBMCR'N%%%% !1110 4444 %(P..G%+2C/X4-VU!-K8KE"I#Q-M8>E=EX:\4&
M-EM;IN/4FN3VC.143@HV\'!'I7)7PWM5<[:.+]C)<I[?%+'+$'!R#3\CJ>E>
M>>%?$K1$07394\#-=\L@D19 04/3%>#7I.E*Q]-1KJK!-;EFB@=**PN=-A:*
M0&EHO< HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDX ^M'0U[)YHZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[BN&\7ZCOF%LG08YKL;RX%O;22$XVBO++N=KR\=B<_,: $MUQS3VY>G !12
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M[P4?]?\ 45Z&6/\ >'GXM>Z=B*<*2@5]&]SR.HZBBB@84444 %%%% !1110
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M2NQT:R3R>7&#3[JWEMPB2Y#,P K4\-V;37$ER2GR<@$U8U71)PZW\CJ5$@(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% "-TIH'/X4\]*9@YS2Z@<?XQAW)$_H37(0'DUW_BB R:<9!T0$FO/H3B
M0BOGLRA^\/6P<M"T.M% '.**\YGH=0HHHI %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 49P**.IV]S
M3CN!4E;,@'O7H/A:+99JW]X9KS^-?.G^7L<5Z?H<7E:9!D<[:]7+(>]<\S&2
MTL:9ZTAI:"*]V^IYB6HZBBBF 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %(:6FMUH !63XAQ_9K9]ZU16;KJ[M,D]@36%;2#-(?&CS./+3'' S4
M[X5\;NU5H<^8V/6M[3=-BG@>XF)* '..M?.*ES5'\SW93M33,DL54$'(/>E9
MMN,')/:MNXT:.1(&MR=D@R W!I+W2(5M%DB8EP<8J7A)HR6(3,3.3SP:=@>M
M7I;(PV"SR*<D9( YK/P#@C.#ZUE*DX[F\:BD.I,>]+QG'I1BI->56N)C%''<
M4<YHR?2BYGRMB83TI"BGM3@,T-\O4BE9R'R\F_49Y*^E(8$I&N!432%CD&K4
M)]&3*G"UVQ7B4=ZB(QTH8GN:9N /&:OV=5Z7.*KCZ-%.VX[;ZTA8"C:[]*D6
M'^]6T(U:<=6>9+-N;9%6X.4JO <'%7;A0!BL\G9)7UV0XE\O(_ZU/E\Q=2I+
MF2+1ZT4#FBOJ3R->H4444 %%%% !1110 4444 %%%% !1110(****2&_A1%/
M]RNS\!#EOK7&3?=KM? (W+(P' .#7!CW[C/3RU?OD=^O2G4U#E:=7@'U(444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 'I49/.*>>E,_C%+[0%+58//T^2/'45Y=<+Y5VR>AQ7K;_,2IZ5YGX@M?LM^
MS8ZG->/F,?>N=V$EJ0*>:*;$0Z@YIYKQI[GL+82BBBI **** "BBB@ HHHH
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M+,ZBE/0^CRBFXPU_K0>M.I!UI:\V]SUTK!1110,**** "BBB@ HHHH ****
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M,<5< VBOF:L^>39]=AZ:IP0L9R*?34&!3JQCL= 4444P"BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"(^N*Z*-*525CGJ5U%">']!:683R(=OO7>11*D851@#I3+>)(4$:+@ 58Z#
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M8'H: 0>AJ!2I;S WM@=*3SD'5AN] : +.0:,BH=P."K#..F:595X#,N3V!H
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M<_Q0@35%L3ILQG+84;AUKAM*DOM(UR"_GL]J7+A2P4Y.X]ZZZXLK9OB3:O\
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MP:<8P3D<'VH C&2X 887J*>N/O'&3QFG! O3KZTNT<4 (,#)S3J;L'//6G4
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MT'P@.)[DG.>%[5RU,9&FK,[*6$E4>ABZ%X8N-1D5Y5(BZ\BO2[#3H+"!8HE
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MU>UC:(ZA 4E&UE\ODBL^^^*GV*9(_+4N" XYX]:;>>.)]0OX3 @$#'Y&'<T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)9/*5V4KUXYJ'5?&6JOX-M-3M;N,7LRDI%MY8^PK97X;0W5K;R2W4B.(@A0
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M*** "C%%% "8HQ2T4 )BC%+10 F*7%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 0>02Y<GYCQ^%.\D8V]JEHH :%(X/2C;CI3J* &[!G/>AD#C#
M4ZB@!NT@C'2DV'>3G@]J?10 T+QS08U))[FG44 ,=6( 4@?6D,$1()121W(J
M2B@"(1G))(SVIZA@!N()[TZB@"/RE/+ $]CB@1G=DGITJ2B@",QY;D_+Z4C1
MDDD'Z5+10!&(AO#G[V,4NTD$$T^B@!I4[< \TWRERIYXJ2B@!FUL\$4H7'2G
M44 1B+KFG>6NW%.HH ;M '%+MXI:* (FBW'<3R.E."'D'&/I3Z* &%#MP.OK
M3@O I:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
D@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>forms-3_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 forms-3_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +'!6T# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML>GZI>V@<J&6WN'C#?,.NTBO7\-&J@$;!QTZ5XA\:HI9]=TH11L1N0Y_X$*
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MWEU:-+.*$@A('W X.:]:BU.R>R:[2X0VJC)DSQBL:3QYX>ADVF_AQG&[=P*
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MJ,'G=EW<F@#3L]%TJUF,]M911R'JRKS6B<9SFN$\4>(+W3-3LH+74(+>.20
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M!I5E*9+:P@A;^\B\UD_\)OX>658HM1A:5R/E#<UJZAKEAI</G75S&B,.,G%
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MXJU10!C_ /"*Z'YGF'3+<MZ[:U(8(X(Q'$@1!T J2B@ HHHH **** "BBB@
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M0+6VL=!MA!$L2NH)""JNK^#]*UF\AN]0B:22%MR%6P :W((XX(4@C7Y N *
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M_AGH-G.EPBW)D3[N9R16UKGAK3/$%DMEJ$9>%!Q\V#0!PMC>Z%H7PLMKHQ(
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M;*$<'@5]"6.G6>G1^3:6T<*#L@K"M/ ^CV/B.76H8RMS*Y=R6ZFNH0*.@-
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M9KP3QC+J=U\2H-/M[IH_,W9Y.,9%3?$71+KP78Z=JMA=2_:I),.6<D' STH
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M>"!K>@+JM]?237,T?F[HI&4*<=Q4/P_\2:G;>(]0\/7LXNK>%1Y3(/NDGN:
M/8TFBG)1)DW*<%58&E>:)'VN\8;L"P!->'_#C4KJ3XI:G;33L8Q+)A6)I?'V
MI7:?%#3+:.Y98_M RH)&>#0![>TL<6 SQJ&Y^9@*1+BW9MB31?17!KQCXD+X
M@^WV,ENLUS:^5\R09!Z^M86CZA!9ZW9O*MUIS;QG[5*2#0!]$<(=W3Z5&9XS
M)M$J,QXV;A45I*EU9(RG>CKPP_B]Q7CWB<ZEX0^(EOJ0F<:9<R*C*Q)  R30
M![+)+# /WCI%GIDXIQFB2$-)*@'8LP%>&^)M?N?'?C/3]+T6YV684M,P)/S
M@]177>.?L@TNRL)-16*53@Q;R'?CM0!Z$MS;2,/W\+'T#@U))-%$H+2(H/ W
M'%?-?B=YO#<VGW6FB[MW.T$S2%@V374_%76+S_A!M$GBE:.:24@L#C/RB@#V
M9[R 1N5FC+ $X#@USWA[Q.^K:E<6CH@6,<$'D\US?@[PFD/ARVUN::62[>U+
M9\PXY![5Q?PSUF[_ .$A\1S2/N\B M'@=PQH ]X-Q$C,LLL4>#P"X&:>DJNN
M]9$9>^&! %?-=KKFI^)=>OFO+>[NTCD(6.W;:1Q73^#+CQ+#KLM@]A=Q:5*
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M+G@8 K'T"]CN-$M)89EE0)]X'.ZM@ $Y'4]10 JL&VGN>U/J-""Y"GIUJ2@
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MZ8KT+ H(!% '!7G@#[3\/8/#8N'!AC";\#)YK?\ "6A?\([H<=@&)VG))K>
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M">OO3Z;CG-+F@!:*3-&: %HI,T9H 6BDS2%B* '44P-2EJ$#=AU%,W&G Y%
MD[BT444#"BBB@!#TI,TK=*;FEJ+3J+FDS2!O:ER*+2"\0S2TVER!2]X/=%HH
MW"C<*?O![H44;A1N%'O![H8HQ1N%&X4>\'NABC%&X4;A1[P>Z&*,4;A1N%'O
M![H8HQ1N%&X4>\'NABC%&X4;A1[P>Z&*,4;A1N%'O![H8HQ1N%&X4>\'NABC
M%&X4;A1[P>Z&*,4;A1N%'O![H8HQ1N%&X4>\'NABC%&X4;A1[P>Z&*,4;A1N
M%'O![H8HQ1N%&X4>\'NABCI1N%,9@#1=K<:2>P^BFAOES3AS3NF)IH6DS2TF
M.:EWZ#0M(: <FC(--:!<:::<TXTTU7,A.I;H*G>GTQ#C-/W5+N]A<REJPHHW
M"C<*/>'[H48HW"C<*/>#W0Q1BC<*-PH]X/=#%&*-PHW"CW@]T**-PHW"CW@]
MT**-PHW"CW@]T,48HW"C<*/>#W0Q1BC<*-PH]X/=#%&*-PHW"CW@]T,48HW"
MC<*/>#W0Q1BC<*-PH]X/=#%&*-U&ZE[P>Z&*,4;J-U'O![H8HQ1NHW4>\'NA
MBC%&X4;A1[P>Z(11B@G-%->8*PF:,T8HZ46N/W4+BGCI41<#M4@Z4*-A)I["
MT444QA2-THS2%A0 F*,49HS2Y1>Z&*,49%&11RA>(H%&*3<*7<*/>#W0Q1BC
M<*-PH]X/=#%%&X4;A1[P>Z%%&X4;A1[P>Z%&,T;A1N%'O![H8HQ1N%&X4>\'
MNABC%&X4;A1[P>Z&*,4;A1N%'O![H8HQ1N%&X4>\'NABBC<*-PH]X/="BC<*
M-PH]X/="C%&X4;A1[P>Z&*,4;A1N%'O![H8HQ1N%&X4>\'NABC%&X4;A1[P>
MZ&*,4;A1N%'O![H49I"PS0'!-)26S#E["YI<\4G7I1CBJ$K]1":6D(HW<XJ4
MFRVAU-(I<YIO7O3O85VAI6G(,4T@^M*O'6GSWT0N=O1H?11NHW"E[P>Z%%&X
M4;A1[P>Z%%&X4;A1[P>Z%%&X4;A1[P>Z%%&X4;A1[P>Z%%&X4;A1[P>Z%&*-
MPHW"CW@]T,48HW4;J7O![H8HQ1NHW4>\'NABC%&ZC=1[P>Z&*,4;J-U'O![H
M8Q11N%&X4_>#W0HHW"C<*/>#W0HQ1N%&X4>\'NABC%&X4;A1[P>Z&*,4;A2$
MYHUZB]T-M)BE_&D_&AV&E$,4Y>E-S3D.10H]0]WH.HHHIC"BBB@"&YN(K:,/
M*P52<9/K54:I9_\ /5?SKGOB0[)X>MBK%2;Q1D''\#UY\K/Y8/FR?]]&NBCA
M)UM8G'B,9"B[2/8SJMF/^6J_G2?VI9?\]5KQ_>^/]9)_WT:3<W_/23_OHUV+
M+*EMU]YQO-*=]%^![%_:ME_SU6D_M6R_YZK7CVYO^>DG_?1HW-_STD_[Z-3_
M &75[C_M:EV_ ]A_M6R_YZK1_:ME_P ]5KQ[<W_/23_OHT;F_P">DG_?1H_L
MRJ+^UZ7;\#V'^U;+_GJM']JV7_/5:\?W-_STD_[Z-)N;_GI)_P!]&C^S*O</
M[7I=OP/8?[5LO^>H_.C^U;+_ )ZC\Z\?W-_STD_[Z-&YO^>DG_?1H_LVKW_$
M?]K4M[?@>P?VK9?\]1^=']JV7_/4?G7C^YO^>DG_ 'T:-S?\])/^^C1_9E7N
M']K4NWX'L']JV7_/4?G1_:ME_P ]1^=>/[F_YZ2?]]&C<W_/23_OHT?V;4[_
M (A_:U+M^![!_:ME_P ]1^=']JV7_/4?G7C^YO\ GI)_WT:-S?\ /23_ +Z-
M']F5>X?VM2[?@>P?VK9?\]1^=']JV7_/4?G7C^YO^>DG_?1HW-_STD_[Z-']
MFU._XA_:U+M^![!_:ME_SU'YT?VK9?\ /4?G7C^YO^>DG_?1I-S?\])/^^C1
M_9E7N']K4NWX'L/]JV7_ #U'YT?VK9?\]1^=>/[F_P">DG_?1I-S?\])/^^C
M1_9E7N']KTNWX'L/]JV7_/4?G1_:ME_SU'YUX_N;_GI)_P!]&C<W_/23_OHT
M?V95#^UJ7;\#V#^U;+_GJ/SH_M6R_P">H_.O']S?\])/^^C1N;_GI)_WT:/[
M-J=_Q#^UZ6UOP/8/[5LO^>H_.C^U;+_GJ/SKQ_<W_/23_OHT;F_YZ2?]]&C^
MS*O</[6I=OP/8/[5LO\ GJ/SH_M6R_YZC\Z\?W-_STD_[Z-&YO\ GI)_WT:/
M[-J=_P 0_M:EV_ ]@_M6R_YZC\Z/[5LO^>H_.O']S?\ /23_ +Z-&YO^>DG_
M 'T:/[,J]P_M:EV_ ]@_M6R_YZC\Z/[5LO\ GJ/SKQ_<W_/23_OHT;F_YZ2?
M]]&C^S:O?\0_M>EV_ ]@_M6R_P">H_.D_M6R)(\U:\@W-_STD_[Z-+O(7[\F
M3_M&FLMG]IBEFT/LK\#U]=3L\ "5<_6KBL&.Y6R"*\4W.K(PE?J/XC7K.@?-
MID;$DDCN:XZ]#V3L=V&Q/ME<U:0T=Z#7.F=+0@[TF, G-*":AN<K;L1Z52U#
MX40MJ5LCE&E (X(S3?[3M/\ GJOYUY1J<LC:S=?O'^_V8U79G_YZ2?\ ?1KM
MI8/G."OF5.EHT>P#4[,=95I?[4LO^>JUX]O?'^LD_P"^C1O;_GI)_P!]&M7E
MM3HSG6;TFKV_ ]A_M2R_YZK2?VK9?\]5KQ[<W_/23_OHT;F_YZ2?]]&E_9E7
MN-9M2>R_ ]A_M6R_YZK1_:ME_P ]1^=>/;F_YZ2?]]&EW-_STD_[Z-']F5>X
M?VO2[?@>P?VK9?\ /4?G1_:ME_SU'YUX_N;_ )Z2?]]&C<W_ #TD_P"^C1_9
ME7N']K4NWX'L']JV7_/4?G1_:ME_SU7\Z\?W-_STD_[Z-&YO^>DG_?1H_LVI
MW_$/[6I=OP/8/[5LO^>JT?VK9?\ /5:\?W-_STD_[Z-&YO\ GI)_WT:/[-J=
M_P 1?VO2['L']JV7_/5:/[5LO^>JUX]N;_GI)_WT:7<W_/23_OHT?V95[@LW
MI/9?@>P?VK9?\]1^=']JV7_/4?G7C^YO^>DG_?1HW-_STD_[Z-']F5>X_P"U
MZ7;\#V#^U;+_ )ZC\Z/[5LO^>H_.O']S?\])/^^C1N;_ )Z2?]]&C^S*O?\
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M]W)MY'9T445XY[P4444 <9\2_P#D7;7_ *_$_P#0'KS]?]6*] ^)?_(NVO\
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MI\[0R35M,9#%+8I'(1UP:P,AG..!GBNZM4BU:PD^VVGDN!UVA:XN\18IF"=
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MHR-WI6V\L-OH41N(V8  \?2E4G*4:=O,FG2A"I4\K&5ITVEZI-]G-C'&QZ$
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M=@HH\NY_Y]Y/RH\NY_Y]Y/RH]O0#ZIB.P44>7<_\^\GY4>7<_P#/O)^5'MZ
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M];U__D$R_2O)8TF.=L+L,]0*[\!-0F>9F5-U*2]1:*<4N/\ GWD_*@QW&/\
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M.:2]R]P;2'S'.2=@K:1C /#]]<:CH=O->1^5*5&><YXK3 [8QM_6FA41%15
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M.:Y;PIH5SHTUR;@@K)C&*ZFL9M-Z&U--;A1114*YT7T"BBBF2%%%% !1110
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M_P#H*5/>_P#(.F^E0?#_ /Y UY_U^O\ ^@I6-0VIG64445B;!1110!R?C_\
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MBLK@,C!EQU%+35A:A1112 ****H HHHI %%%% !1110 4444 %%%% !1110
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M--=@D9,APJ\DTIST'2JVIVTUW9O;Q-M9QC)K.,$G>YJV[6/.-<U6+6/$BP!
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M****8@HHHH **** "BBB@ HHHH **** "BBBA@%%%%"$R"]_Y!TWTJ#X?_\
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M:_Y#>G?]=#_*IGL7'<[J#_4)_NU)4<'^H3_=J2N1[G0(:0]*4TAZ4Q(R]?\
M^05)]*P/#7.D1CW-;^O_ /(*D^E8'ALXT>/ZFM*6Y%38U^ :4 DY49I%4$Y-
M,>:%6VM*J?4XS70]SGZ$F[L4I/H<49&,JP8>QS0,,.:+#3$7DE5.2: #R"/F
M%9>LWUQ8P"2UB9VX'"YKF[SQO=V,L*3V[!I&Q]RJ5.YG.I8[GD?<X]:"5_@/
MS5S%GXBU.YD7-MMB;N4KH1=VJH"\\:R'J"U)PL.,B8$YPPS[TN"?H*:&$L>(
MY$;/.5.:9YL 4AIE!7K\U2D7S$HRP.>".AI,-T(W4V.6&X4F.0$+P<&HS=6R
M/M:X13[M56!.Y,5QVQ12!E891PX]CFEI6"X4444K!<****+#N%%%% !1113$
M%%%% !1110 4444 %%%% !1110 4444, HHHH0F07O\ R#IOI4'P_P#^0->?
M]?K_ /H*5/>_\@Z;Z5!\/_\ D#7G_7Z__H*5C4-J9UE%%%8FP4444 <G\0/^
M0/9?]?R?^@O5FT_X\(_I5;X@?\@>R_Z_D_\ 07JQ:_\ 'C%]*UIJYE-:W"^#
M_89O*SYFP[<>N*\>N%\2B^W'S=^?O5[0WW:B:&)F#-$FX_[-=="HH)J2N<-6
MG*3]UE;2?M(TN+[4"TN!R:N.I8@$8I2K, 1@*O:@DLP9>:SYNJ.B&D&GN<)\
M1\?9H"I_>"1<53E\1:UI6B0GR76';]_/2NL\0: NO", [2C ]<=*N#2HFTI;
M&Y5&11@GK732K1C925SDE"3BSF?!N@1R2OJWF^<\H(/'3-5+^6Y\-^*C.TS?
M8YW^;T45O:/X:N-'O6GBG/V9LX0O_2JGCV>U326B9"UQ(I"8&3FIIUE*JT]F
M5*#4#*U#4;CQ-X@@M+"0F *'8KTXI_B_5+C3_LVFVTI1&.U@*U_!NA#2--6X
M<9GEY&>H!J_KOAVVUE$+';,.^<4*<(UEV""ERZG#W$&I+:PS:?;,CY7<RGKZ
MUZ%HEQ<3:7"+I2LN.2:PE\,:BJJB3)Y:D=6KIK=&@M$B."PZD55><)1M'N*E
MS<^I,P!&".*4$BDQ@#FBN2VIV2W$P,YH(!.3UI:*HD#SUHHHI( HHHI@%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1ZT4>M# R/$O\ R"#_ +R_SKHM
M"_Y!,5<[XE_Y!!_WE_G71:%_R"8JYJAT4S1I:2EJ$6Q#]ZHY_P#CVD^E2'[U
M1S_\>TGTH!G$>'Q_Q-]1_P"NO]*WQQ)M-<_H1QJNHD?\]?Z5T+=0WO71 YYG
MG?CE-:^W(+-I#%SP.U6? @U@3.+W>8\<!J[EUCD8AHU;/J* B0J!&JKGC@5U
MK$)4W"QS*C>7-<?@D-@8'I3=WS #K2E2O0T@P/F-<M..C;-I:(X[XE'&DC<_
M^<UN>'6;_A'(U')V9_2F>(-#&NVNPG]:NZ?9&TLA!G&%V]:Z92C[)13,*<6Y
MZH\]@AO-4\775F+MHX_,P5K<\16)T;PULMY,MO)W"M"Q\,BQUR74M^=[;N#5
M[7-*&M6'V96*G.>3BG4J1;31/(^5^IR<-FVH^"([NYF+.D><FJG@?0EU")IS
M)C9*W..N#79Z=HB6&B#2Y26!7;P<UC6?@^ZTNXS:W!$;/N*[_4TW65I>8HTG
MS)E+QK<SP:I811RF-,G@=Z7Q5K5Y";*TAE:(2J@9Q[@5MZQX8.L7$,DCX:'W
MJ?4_#<&KVL<;':\8"@YQTH4XV0I4Y)Z%/3_"44*1W37(D?KOQUJ+Q1?6=ND=
MM)(&D. $]:=:>'=2M)$C-R6B3_;)J;6_"L6KF.5G99X\8YP.*BG)<UV4X.UD
M<1JTMYI7DS6T1M=W)P>M='XHG-SX,MV<X)923ZFI;KP;<ZG"!<3+E.P:M6^T
M 7VAQZ>QQL(YSZ5I6JP=K$^R9SDFJS:1X!MVMV*LT?#"LV!;JYL1*L1EN7&0
M_<5W$?AJ#_A'TTR<[D"[<YY%9,7A.]L8RMI*I0GC>W-5"K3Y7=#]DRSX/FU1
M;>2WU(,64 !FKIZSM(T^:Q@(E8%R/FR<UHUS2:;T-J<;+4****DT"BBB@ HH
MHH **** "BBB@ HHHH ****3!;@>E!^Z?]TT'I0?NG_=-"V%U,3PQ_R,]_\
M[@_G7<UPWAC_ )&>_P#]P?SKN:Y9;G6M@I#UI:0]:0P[FN%\1C/BRRYQ^[;^
M8KNNYKA?$9QXLLO^N;?S%-:L4MC=SN"X':N?\:?VJOAFX.D;UNLC#)UQWKH#
M]U1TXHVD$*"K*>H/-=<59'+S:GS1HJ^,UUR$DSJ#+\Y]:^DK/S3I]MYZGS-G
MS$^M.6VM5N"RVT8..NP=:4[I'(. !TJ$FV:3DK:#MI>6//4'K7A?Q>>Y3QSI
MC6ZDRA3M _WA7NB94$EA@<CZUQ7B7P(OB/6K74Y'97AZ -COFE4C?8BG)]3"
MNX_'6LZ:NF2V\\-O-&%+YSP13SHK?"SP+=W%O(6O9"I+ 8(/2O3D#Q1+$>2J
M!1CM@55U+3K75M->RO5+HPQQS2C&R'*>IX!HLNI:[I\]Y-;M=7+%MKD\KSQ7
M??#6XU^WBO(=:$BVJGY7<\ 8I8?A?>:7(_\ 95R CDG$DG3-=)H'AN[LK6ZC
MU*4,KG'[ML]JE(MR1YO?7EAK>K72:=;+?.A.6!Z<TSX<ZYJD7CQM)GE>.'<P
M6(G@8%=-'\*Y]+U.6XTNX413D[M[\\G)J[H?PU71O$JZL)BTIR6)?/)JK"NC
MEO&5AXA/BEYKJ"2;3<#J>!70^ +[19+V6UM;A$EW8:,>N*O:OX0UR^O)/(N8
MC"W42/4WA+P#;>&KR2_E9GN9&W'!R,T*(FT=F%+[EZD#(IH.0!T(ZCUI^<N7
M/RDC&*:,@\CK6C6K]"6+111247H*X44455PL%%%%*XPHHHI@%%%% @HHHH *
M*** "BBB@ HHHH ****  =:Y_6O^0WIW_70_RKH!UKG]:_Y#>G?]=#_*IGL7
M'<[J#_4)_NU)4<'^H3_=J2N1[G0(:3M2FD[4[@C,U_\ Y!,GTKG_  V,Z.GU
M-=!K_P#R"9/I6!X:S_8R^G-7!.YG-7-4D!& Y..*\I\5IKYU5_*,AB!^0#M7
MK'RA=PY-,D6*7+/"I_X#7;3J*+NU<XYQ;T1S/@K^T18DWY9CGC=74_><X_*F
M\+&%C0*/84#*IGN:B<M;ETTUN.!8N$V\=:\\\>.6UK3@3TFY_*O0N4&XGFL#
M6_#2ZO<P3[N4;/6JI22ES,FK&YK0R+'I$3.VV,1<FN!FF@U&ZF-K&+EE_B':
MN_%FLEB+.1L*J;>M<I:^#9;.>1[.7"N>=S5=&HDVY$3BVM#-\%ZK=_VU<63R
ML4&[Y?[N!TJLWVS4O&$UG'=-'$,9Q73Z/X2_LG4VO2^6<'<,]S4D/A98=>;4
M]^-V. ?2M%5IIN2,X4YWU97U@'POH$TMN^^3<%+#C&:H:'H#:SI'VZ>],DK$
MG)'2NRO;2"_MGMY$RC>HKET\(W=JI@M+HK$Q.1OZ5C"5U[VY<TT]#/\ #&J7
M=KXEETV29IH@2!GMBO0.O-86B>&8=%F:=F\V5CDL3FMVE5DF^9&M&ZW"BBBH
M2LC1O4****!!1110 4444 %%%% !1110 4444 %%%% !1110 4444, HHHH0
MF07O_(.F^E0?#_\ Y UY_P!?K_\ H*5/>_\ (.F^E0?#_P#Y UY_U^O_ .@I
M6-0VIG64445B;!1110!R?Q _Y ]C_P!?R?\ H+U/:G_08OI4'Q _Y ]C_P!?
MR?\ H+U/:_\ 'C%]*VI:&<^Q.>@I?F\Z(-TIK?=ZXJ$W-LK*&G7</]JM%'FO
M8P510T9,-P9@1E:  H+)P!UI<X48((;O0V8QA1GUHBK1LPWU$.X#?GY>YI%,
M;_=.Y3U/K5'5=4@T>T,T[=>B_P#UJYR+Q1K&HPDV5HJQ'H6CQ3G%\MT1S)3Y
M3L>5&V4X3.1FJ=QI5I?W"S7$ D:,Y0GM7/P^,7M[I+35;=TW8 8)@5U0DB$?
MG>:H@;D$FJC!Q5QRDF["J,8 &=O ]J<0LG+#<:@CO+7)5+J'GU<4LUY#:P$2
M.H!'WL\5DX2<[H?/$G7&,$\>E"$ $#@5AZ1XFL=5FECC?:T;%?FXSBMB2=#"
MKR21HOKG%7*,E.S$N5:C^1SCCUI<[ON<U!%?02':EQ"3Z;A4Q]QCW%6T5>^H
MO;GKZ44?3I14, HHHIH HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "CUHH]:&!D>)?^00?]Y?YUT6A?\@F*N=\2_P#((/\ O+_.NBT+_D$Q5S5#
MHIFC2TE+4(MB'[U1S_\ 'M)]*D/WJCG_ ./:3Z4 SAO#^?[5U3C_ );?TKH<
M':/K7/Z#G^UM1 _YZ_TKH'!)4#UKH@<\QR@YSC\::O*C//--EFBCRLDJK]3B
MA&A>/]S(K$<\'-6VTS)1OU%Z.V>#GB@!@<%<@]Z,C&6ZU%<R-:VTDX.0JYIM
M<SY2N;D)MRID!\4T,'.6^;MBN)M?%^HW]Q/%:0(Q0X^9*U;#5=8N)=MU;QJ!
M_=7%/V$J=[D+$*<E8Z0*0V%_*D(P<L/FKCM,UZ[N?%MS9'A%DQ75R3V\+$/<
MQJ?1F&:7*^I,9KEEZDN'3+,.#WI%;D$')/>F0W$$P(699/96S2_:(D.PRQ*V
M?NL0#4.#3L:.:2)&SN/MU-( "N47//-1O)%#O:60+NZ$G IR-&^"KY&/X35V
M:0TU)7),XZ4W;DY?YCVI:*G8%9NPF.#_ 'CU-+SQD\444VN8E@0"V<<>E-P<
M<'OFG44]M NP/S'+<MZT444)6&@HHHH&%%%% !1110 4444 %%%% !1110 4
M444F"W ]*#]T_P"Z:#TH/W3_ +IH6PNIB>&/^1GO_P#<'\Z[FN&\,?\ (SW_
M /N#^==S7++<ZUL%(>M+2'K2&'<UPWB(9\667_7-OYBNY[FN%\1C/BRRQ_SS
M/\Q51W0GL;N<_,W((QB@*!\R+@TA8*RKCL*7:-K.6"J#W-;-MG/*UKBX);Z<
MT$#&XBH!<VQ;:LZDGC[U2X*CDY!K2SBC*,TW8 J!N1Q2[B2<].WM2DY(P.#Q
M7*^)/%,FD:A#:0Q[GD!/W<T13DS2;44=0&8D[6R>YH5L2+MZ <^]<A-XGU:S
MB$L]J/*QDE4[5N:+K4&N69DA.&'WJ)0:(C-,U,$Y_4T,> %X7O[U ]S:1X5K
MA%?/0M4JR"1,(RLH[BIY&BN=#B% &U<#O02 C \9/!J%[R"/AKB' ZC<,TY)
MXKAE\IPV?0T^5ASH>,$C<?QHW\L V<=*C:>'>4:>-6'8L!3#?6Q.%GBW+QPP
MH47<3FB<%7Y?EA2[CTZ^@IDLL=N%:61%W=,FC>NPLS+L/0@T-/0I3B/)"MR<
M#UHZ'GH>GO4#7<*6[2&:,Q+D_>&:QM/\5V5]?R0JX7RVP-W%7&,G?R(E.*.@
MS\W'*^M SSQQZU&9HBNXR*(SWS4?VRU,HB^TQE>V'&:CE'SHL8(ZC%%-4@CC
M..V:=0%[A11130PHHHH **** "BBB@ HHHH **** "BBB@ '6N?UK_D-Z=_U
MT/\ *N@'6N?UK_D-Z=_UT/\ *IGL7'<[J#_4)_NU)4<'^H3_ ':DKD>YT"&D
M[4II.U#0D9FO_P#()D^G]*P/#.?[%&>G-;^O_P#()D^E<_X:RND(>Q)K:#Z$
MR9K@#9CIS0P<(1F@D.0H&*CFFMXF*R3*#[M6C@V<[DDR7+@#Z4*,Q GK3499
M(]T;AA[&C[R@>E.I&ZL-.^PF YV@9;TI>0< 8QUJAK=Y<VFGF:TC#.G7CJ*I
M:!XBAUJ#!(2X3[ZMQ517NV(D[&Y@%LGD8ZT#&W:#^-<SJOBLVNH)96""5S][
MC.#6\ETJVZ&ZEC21NV<42@TN61*DD3Y).&ZCH:7(;[QRPJ%9X9/FCF1R.,*V
M:>TT43CS9$0GIN.*B5-*-HE>TB/W?,/F^;TH^4J0O4U ;VUW['GCSVPPITEU
M;KM+3Q(HYR6 I\LEOV&I)[DJ[5C*KPW>E(^0'J:8LJ7/^K=&3U4YICW5K&Y1
MYT0C^\P%*,9.%F#E&),%;J5P*,@]*CBFCE!\N0./8YJ3&*K6Y5TU=!1113$%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110P"BBBA"9!>_\@Z;Z5!\
M/_\ D#7G_7Z__H*5/>_\@Z;Z5!\/_P#D#7G_ %^O_P"@I6-0VIG64445B;!1
M110!R?Q _P"0/9?]?R?^@O5BT_X\(_I5?Q__ ,@>R_Z_4_\ 07JS9_\ 'A']
M*UIZZ&,_B&WH=K&81YWE#MQZUX_<6'B4ZAD+*>>E>STW9%OWF,9^E=E.HZ*L
ME<Y:M%3=VRII:SKI<(N01( ,@U=!(&\=?YT'>QS@;:4,K;EZ$]*R:3U9JERQ
MLC@/B)'(;BVG8$PAEW"NPT.:*;1X#:,!&5XQ4M[I]OJ-LUO=J"#T-<V/!DT!
M,=M>2+$>@\S&*MM2CRLYIP;GSE+XBSP20P0^8/M.]<>IYJS/>06'@ZW34\"0
MH>&[U;LO!L$=R)KN5YG7D;VW5H:UH4&MVA@E^7:,+CBM.>-HQ[!RRNV>?ZE$
M3IHO;?3C"H((E!ZUO:2CZ_X.<W4F["=35O\ X0N5[46SSMY(Z#?6QI.B1:39
M&T#$H1CKFKE4BK\I"IRNO,X/P1HT5_?W!9@!$[*/PKHO%&E:E/;0PV"O(B9W
M*M/'@Q[>^:YLYV16;<P#XK1O=%N+N$)%<.K#K\^*4ZJE/G-.1WL<IIDNFV=_
M%#>6RV]UC'S'DUZ*IS&H5LJ>@KE8/!<37B7%Q*S2)WW5U2!8W")DA:SJR3LT
M72;M9BX'88HI%R0Q/K2UA>\C:P444E)MWLAM:"T48HK30E!1112!A1111?4
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MJ+JVI:BSJ8G#P1LK;E*C!]L4^FI&L4:QIT4 4ZLFC:*"BBBDBPHHHH$%%%%
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MH **** "BBB@ HHHH **** "BBBDP6X'I0?NG_=-!Z4'[I_W30MA=3$\,?\
M(SW_ /N#^==S7#>&/^1GO_\ <'\Z[FN66YUK8*0]:6D/6D,.YKA?$?\ R-EE
M_P!<S_,5W7<UPWB(X\667_7-OYBG'=">QNGHOTI.YI1T&>PS3<JT32;@H4XR
M3BNE;G--ACC@TJYQRU0)=VTAVK<19]-XJ;@=\_2KEL3%W%."$VC<2>M)CYV#
M\8- !4_+U/'TKE]=\33Z5J]O:;582#DXSWI4DY.R)KV2.H)PI'3T-(P!C48R
M:(]KPH_.2H/-1S31PQ&65U4 XY.*S@GH:U&M?0D!R=@&,#FGJ0%P_*]C3$>.
M2+S$8%2.3FHHKF";=Y<@;9P<'-5*+DF*,HQ2)P<=^*!D @\[N:K"]LF!<7"
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M(Z4KCL%%%%4B0HHHH **** "BBB@ HHHH ****& 4444(1!??\@Z;Z5!\/\
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MQ76ZCX:M]2U*.\E9A(G0#I4FJ>&K34PC/N25.C+UITY03O(J=.;6AQ%QI6J
MP36%E) P(SCG/-=/KNIQ6.B01ZG'FZ?@(QP6.*5/"DJ8!O)]H(/WZTM3\/6^
MJV"03LQ:+D-WH<H<Z?0(PFHM'GNI6[)IZWL>F/;-P0Y/6N@L8QKG@HSW;;I4
M4E"?6KR^#8Y[?R)KF<QCH"U;&F:+!I^F_8$),0SUZT2G'H1[*I<X3P5HEEJ#
MW'G('>.3&?2O2HXTBC1$&57]*Y=?!L=M=/+:W$T8=MQ"M@5T]M&8;=8V).WN
M>IK*HU+8WA&2W)#UHHHK,T"BBB@ HHHH **** "CUHH]:&!D>)?^00?]Y?YU
MT6A?\@F*N=\2_P#((/\ O+_.NBT+_D$Q5S5#HIFC2TE+4(MB'[U1S_\ 'M)]
M*D/WJCG_ ./:3Z4 SA]  &K:B?27^E=""SOGI7/:!SJ^I#_IK_2N@;Y@!TP>
MU=$#GF>=^.M+UFYO%>V21X1G=MJSX#T_5;5V>\1UB(P-U=V<-PRAA[T@4*,*
M !Z"NKVMH<J1SJ-Y7'?,&(7D=A3"QP-W'-+@G.#UI2!L ')S7-3YM>8VE#0X
MSXD,7TM%SQC^M;OA]O+\.(RD#"9"_A2Z]H<6MVWDS%E"]-M6[&R6QL4@!RJ^
MM=%3E='E3U,(TW=GF4M]=ZMXBN+>XMWG5'PJ9K0L-/U>UUI)8;62WMFPI4UT
M^I^$[:\N#>12/%*QR=AQ19^')(+A)&NIFV\X9N*V5:/LTD92ISW1R/C/388M
M=MR"%,A.X>M;FH>%M-703<I& PBW8SWQ6SJWAJ'6+R.YD<JT9X&:OSV7GZ<;
M0D!2NT_2I=>\8)/;<'3=FF<#X&T>UU"VENIX<[,$<UZ,%"PJ%X0< 5EZ%H<.
M@0O%$S,K]=U:P7G.>/2LJDW)W-J=/DW"B@X!P>M'3[U9)=S:6F@44=%S^5)G
M YI];"%HH]O7I0<KUHN 44F?6ER*5P"BDS2YH<D@3N%%&:,';NXQ0G<+A129
MW?=!_&E'ZTP"BDSCK2CWI@%% /'.:48(]ZCF0["448(ZT51-PHHHI/8:W ]*
M#]T_[IH/2@_=/^Z:%L+J8GAC_D9[_P#W!_.NYKAO#'_(SW_^X/YUW-<LMSK6
MP4AZTM(>M(8=S7"^(SCQ99?]<S_,5W7<UPWB+_D;++_KFW\Q51W0I;&XXQAB
M?E(%97B&WN;G198[$D2$@\5JXP%YS]:#U/I74K(XYIO8\;TS0_$ UE7,4HB#
M<UZ] #%:1HPQ(!S4@11T4#Z4X=/6KG)20HIK<"=NTLV237FWC+:GBNQ^?((/
M\Z])7"DGJ3ZUSVM>$[?6KE)Y'=77H5-50:A*\B:\935HFXI(ABP<J$!/Y5RW
MC]W.B9MU.<C)'UJ;_A#Y2 HO[@ <?ZRM8Z+"^E?8)W9UQC<3DT1Y4U<)QF[V
M*.AR@^$69CSM.:Y_P9++]JU7S)/W9<[<_2M/_A"MB&**]G$)/(WUJV.BV^C:
M;,L66R.K=>E:.4>6275F3A/0X?PM8IJNM7<5TV] 6QGZFI-6A7P]XDM4L),!
M\Y0?6HO#6EMJ&LW@#S0GG!7CN:ZZP\(6]O>+<SRR32K_ ,]#G%74G3;=NPHT
MY62.?\4SS?\ "4:>VX@MY>5_"F>,]SZUIT:2XWJ=R_C75ZKX<@U/4HKR1F#Q
MXP%Z<4FI>&;;4KJWGE=P\0XP:2K07+Y(<J4W>Q@Z]X>M;'1$O0O[[;G=^%2:
M:-0U;P68HK@B5E&WCFNGU'3$OM-%D['9C&>]4[7PZMKI'V&"611@ -GFLE45
MMB^27+8XB.-=(5!K5DV2^!(QQ7HVF20/ID#VI!A9<@"L ^#4NF474\LBJV1N
M;-=-!;165M%!&,)&,"G7J*=N5!1A*+]XEHHHK"QMJ%%%%%AA1110 4444 %%
M%% !1110 4444 %%%% !1110 #K7/ZU_R&]._P"NA_E70#K7/ZU_R&]._P"N
MA_E4SV+CN=U!_J$_W:DJ.#_4)_NU)7(]SH$-(>E*:,<4Q(RM?_Y!4GTK \-
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MK TJ+5TNO]+D@:-3SL?-:%QK]A;.4?>3["A*VAHJJ2U+X(I>*J6VHVE\,P2
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M!3G -=NV6D.]CM'I35!+').RMW5O'D.54??YQ=H9V;=PQR!5>^;.F761QY9
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M(J=_"]@<E&>,$_P"M*QLHM/MQ#$2P'<]:N=;FC8J$6F3MUH%*>:*YS<****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MIC-0J;8>UB;@)+'(PO9O6@'KGBJ9U*%; 7N2;=AD;1DXK._X2W2\X?SE^L9
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MUS;^8IQW1,MF;W]WZ4G<TO\ =^E)W-=)S!1110 44450!1110 4444 %%%%
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MDB9MT8Q[<UA:@[W>AF=[Z(MR?+"\BO0;32(?[$M]/N1NV(!R,TQ?#&GQAD*
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MM[;A\&I<6MQJ:;T#[K<*>:!\O/6C.1QTHJ4VS40 9R32X(;(.?>C%%-J^Y*
MX)R4+'VI0W)W]#T%)TH//6ER1&("%SE3STH (Y)I>M%.R$%%%% !1110 444
M4 %%%% !1110 4444 %'K11ZT,#(\2_\@@_[R_SKHM"_Y!,5<[XE_P"00?\
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MB@ HHHH */6BCUH8&1XE_P"00?\ >7^==%H7_()BKG?$O_((/^\O\ZZ+0O\
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M\C99?]<V_F*<=T3+9F]_=^E)W-+_ '?I2=S72<P4444 %%%%4 4444 %%%%
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MOYT8']Y?SHN E%+@?WE_.C _O+^=%P$HI<#^\OYT8']Y?SHN E%+@?WE_.C
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MSWHP!5*=B'$Y5?#>H[!_IJ9^AI?^$:U'_G]3\C758Q12<V-01RO_  C6H_\
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M/R-=511SL.1'*_\ "-:C_P _J?D:/^$:U'_G]3\C7544<[#D1RO_  C6H_\
M/ZGY&C_A&M1_Y_4_(UU5%'.PY$<K_P (UJ/_ #^I^1H_X1K4?^?U/R-=511S
ML.1'*_\ "-:C_P _J?D:/^$:U'_G]3\C7544<[#D1RO_  C6H_\ /ZGY&C_A
M&M1_Y_4_(UU5%'.PY$<K_P (UJ/_ #^I^1H_X1K4?^?U/R-=511SL.1'*_\
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ME<Z#K<6FV$.2"1*QR/R]:+H+,]A9B#U_"G;E"]>*YC2/%^FWWAR/5))&C0*
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MO'THN@LSVTMMRH4TU<<+GKUJ.VF9[2%B.60$FO)M?\4ZMH'Q-M;>=C_9T\V
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M )YL9&?6O4+?PYI5KIDFFQVR?96&TQ;>,5-I>A6&D6;VMK;I%#(2611P<T[
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M_59;F/S)$(*>G7TKW:.SMH[$6:Q+Y(78%QQCI5'3/#.FZ*\TMA;1Q/+U*C%
M'B^L11Z=\8+=+<>6)(SD#@9)%97C:TU)/BDCRRB&V$@,4LHR@X[U[Y)X:TJ?
M45U&>TB>Y48#D<T_4?#NF:R@%]:12,.A89Q0!XA-X3&N:U:2MXGT][A&5@L
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M49P:S=*T.PT8-'8VD<,;]0HQ6H@&<XQ0 ^BBB@ HHHH **** "BBB@ HHHH
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M(]2NP6BD("[3CK7ST_@^ZF\"'Q8Y9YG02 GK6IXC\3IXLLM%T2/+E7B#K],
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M3EN>]>5_$3Q=?VND:5:V$K12WC!&D4X(RH-5KGPWKNG^$3J,/B*[DG9 S!F
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MHYXT;("R*& /N,TS4KY-.LFG,32*O4+UKR'7="UNP\&0:L->O(IHHPWE*1C
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M+B"$-)%(K*/4XH ]SU7Q!I^CV/VN]F6*/&1N.*Q/#_CFU\1NYM+&<1I_RT+
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MV4V[<ZOD@GV K5\3_#UO$MI;2S2(-4@5<2D?*<#TKT#>-IYSCUHSERN.V<T
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M_5K"'3)-5MO[.*C>NP[F4CIG-;&I_#>,^ FT#3I%CD9D9G;D'&:[6WO[6?\
MX]Y@ZKP0.PIEKJ]G?SR16TP,D;;66@#)\">'I?#'A:'3;B179&8EEXZURNE?
M#F\LOB3)XC-S&;=@X"8.?FQ7J P0<]*48QC'':@#S&;X=WK_ !'/B,W,1A^7
M" '/&:M_$;P/>^+GM6M[F*'RBI^<$]#FNQU'6[#2D0WDPBR<"LD^//#^2#=@
MG/'% '(_$#P]:MX<LDNP?M4)^24'"J0 ,UQUU?WTOA-[*?7;26- %6./(8_C
M7MD5UH_B>V*JB7<8&=KCBJJ^!?#J'S5TBV+$YV[: .,^">EW=GHKSW$90.S
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #6
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M;>K$B@#F;WP=IMSXDMM;57%W"Q8[6P"?<5T#*I(WJA&.I%2LF3E.">II2J$
M$9H C6.(#*QH/HHS3F4@?(1SZU)MX.#C-+MX% $(14^8JNX>@HV(OS(HR>I
MJ0QY;.>.XH"8;(.!Z4 -$:9QM!QZ\TCB-N'C!^HJ0+@D^M)LYY.: (RB[#P/
M^!<B@(%7" <\GTJ4H#P>GI2;,/D'C&,4 0^4BD,$CW'^+:*=Y*YY 8>A&:D\
MOGKQZ4;/>@!@C'RG 4+T XIV>I(]J>1FD*Y[T 1*@\UB54#UQS3FC5FR0#[&
MG[.OO2;..M #-JJ0 N#[<4KQ@X.T?ES3]O3GI0JD9R<T 1.BLOS+N [4_:NP
M#&!CI3\#.:3;Z\T 5U@AC/W%P.^*D 3=TRI'X5)L&T@C.>M((P/IZ4 1!(PQ
M"HJ@]>.M.\M"N% 7Z5(4!ZT%<C XH A,2DO\BYQP0.:YW1_!5AIFL3ZJJLUU
M*Q;+-G&:Z@ID@@D8_6@KD<'% &3=^'K&^O$N[A"\L9W+@]#6FBJ(PBKM IX3
M"XSSZTNWC&: (2@(^8*V.F1FGH"1R,8I3&,C'&*<1GO0 P@#.,'VIOE1K\XC
M ;Z5)M&12XYZT 1")1D[1EN.!3=@4%&7@_W1BK&!3=ISG<?I0!&((AAMN2.Y
MH(;=NR *D"X)YX]*0QY/)X]* (VC5SN"HP]QFG_+LVC R.E."!5VBFM'N7 .
M#ZT 95MH5E;Z@]\B8N'&&)]*U.0<]0?2G[!W'.,$T!,=#Q0!$(8P<[,D^O-(
M\$.X,(UX]!4^.>M &.E $8Y;.,#' IC(&;YT0GL2M3;/EP3GWI'CWQ[=Q'O0
M!$(U9\,JG'(P*<45CE5 8=R*D5 #GOC&:7 H Y'Q)X*T_P 12K/+YZS @920
MJ./I6+!\*=,:Y5[N661%/W/-->CA,# .*3RU))[F@"G:V4=G$L%MM$*J %(J
MPL21Y.Q3GT%2>6  !QS3L"@")8U4'  4]B*50JK@ 8[8%/*@]>:3R^F#C% "
MJ23[4ZC%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%!Z4 -W9XQ2].:I:EJEKI=N9[I]B#O6/IOC?1]3G\
MJWN0[9QC% '2@Y%(&YP17+ZCXZT:PNE@EN@K$XQ5V[\4Z7:V"WDDX$3#(- &
MV1VHZ"L+1_%NDZTY6TN-[CMBMW<,\T '(YI>*X_Q/\0M(\*WBV^H3;9&&0N,
MY%8B_&30')8R2!%Y)\LT >E@ 4M8GA_Q3IGB:U,^G3>8H.#QCFM@S1J<,ZJ?
M<XH ?131(C<A@1[4UYHD^](H^IH DHIJNK#*L"/8TGFQ[B-ZY'O0 ^BH_/B[
M2*?H:=O7&2P ]Z '45&L\3$A9%)'O3PP89'2@ Z@XI%)Z&J.JZDFF6C3R<(.
MIJOHFMPZO;&>)LQCN: -<$4M1+-$,GS%Q]:<LJ,NY6!'L: ''I2$XZ4AE0+D
ML /<XID<BLQPZM]#0!)U'2G5REUXZTJTUY=)DF_TILX3'I73K-&54[@-PR!F
M@"2D.<^U(SJOWF ^II!(I!8$;1WH 7BE!R>E5I[N&&!I=Z$*,GFL'PUXWTOQ
M->W%M83>8T.=W&,8.* .HHIAEC7[SJ/J:59%;[K _2@!U%)N&*89XEZR*/J:
M 'DCO2?7I432KL=B00O.0<US6E>.=*U76IM*AFW7,0R5Q[T =2,G/I2@YXKE
M+7QUI-UXGFT&*?-Y$^QDQWKJBP 'K0 X#!I:C$B%L;AN';-.:1$^\P'U- #J
M*9YJ%=VX;?7-()XFZ2(?^!"@"2FG(.:1I44$LP ]S3&GB"D^8OTS0 \GN!2@
M]S7/6GBFWNM:DTU.94;:16ZTB(_SN%&,\F@":D.*:LL;)N5@1[&L'4_&&CZ7
MJ,5A=W82>0@*O7K0!O*3GCI2\#KUK"\0>(;?0XHFD<;7Z$<UI07<=W9Q7"'Y
M6 .: +@Y%+48GBS@2+GT!I6D5>IQ0 ^BH_M$.<>:F?\ >%/+  '/6@!:*,T4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7:9K%U'?6T@NWM'.-XN7."<U[[IEP+C3HI1,DHQRR=#7CE_\,]8U^:&WOH3
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MB2,4 =(I8L"._45-40R).>,_K4M !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !BBBB@ HHHH **** #%%%% !1@444 &**** # /:BBB@ HHHH **** $
MP,8QQ2XHHH **** "BBB@ HHHH *,#THHH *,444 &**** "C ]*** $P,8Q
M2XHHH *,444 %&!110 8'I1110 48HHH *,444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 -+8[@4%L#GFF2
M %@-H--$@W89@I],T 2[LJ,=::S-D ?C30Q)X4'T.:#*BG#.H)[9H >&()R0
M?0"@O@@9%1G9_>"D]#FAMI8$*&]\T 2DG<#D;>])OSTZ4W<F?++C)[9I2".
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ME  ,XYH!S0<T>] !FDW4N3Z4A.!GTH 3<=X7VI06V\]:9N_C.!3F8;>O7I0
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MD).W'530!H6/QATW5+>7[%I]Y+(G\*+DUJ^%OB3IWB*_:P6&:WN%SE9>#Q7
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M6KWQ#M /@[9QQH01Y7R@>YH ]7TO5(-7L([NV.8GZ&H=;UVTT#2Y+^[;$2$
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MD0K(5\J/(8=/2OH?P]"]MHT*2%BV,_.<GFO$O#,;I\=[QRA"&63G'L*]]48
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MZ>KJZ6<"NH&&$8!_E6A10!GW.CV5WEI;6!Y#_$T8/]*6WT:QMF#16L*L.X0
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M6\2;^H"@ U?HH S#H.G-+YS65MYGJ(AS^E31:79V\WFPVL$;'J40#/Y5=HH
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MJ* *[VD30K#Y49B QL901^541X=TWS-QLK<8.?EC'^%:U% $$<'E@(JHJ#@
M#%.,6Y,,%.>H[5+10!E7'AW3+@[FLK??G.?+'^%7(;2.VC"00PQ@=D4 59HH
M H1:/9Q79NQ;Q"<]7"C/YU<6,*,#]:?10!0?2;22Y%RUO$9QT<J,_G5S8=H
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)** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>forms-3_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 forms-3_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" *3 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY K85BPSGBOJ:56-6',CP:E%T7J2J,"EID9R#3ZT(3OJ%%%% PHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ!'>)(KKE3FG'IS7+6.J- 0K'(KHH+J.=001F@"?@]Z.E)C'(I0<T +1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>N*,T=Z6G0H"N#UI,4M%  **** "BBB@ HHHH **** "BBB@!<@"DYHQ1DT
M*'QQ5RSOWMG'/%4J* .RM-02X49/S5=# UPT%S)#(&5B,5T-AJ:N ';)H V#
MFEIJL'7(-+0 M%% H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *0TM(: "BBBA"$[FJM]_QZ/]*M=S56^_X]7^E<^(^$TCN>=S@&
MX;'K5[103> , 15&;_7L1QS6CH9)O!S7P6#2^L14N_ZGNUGRQ?H:OB"*-;92
M%P:Y?(*5UGB+'V<9KD@,#-=&91A&L^4C!2;I-%BR17N$5O6NR98+.S5RHZ>E
M<99\W:?6NMU7_D$*?]FM\K@X4:E1J^C,<5']XEW*BZU;M(%V#KCI5G5(89=-
M,H7&1FN1MA_I*\_Q5U^H#.B >U=F$Q#Q-&49+8RJTG3E%+J<KIV%OT'4;JZ;
M6K5#9!U4=*Y6%REPFW@[J[&[S+HJGN5K#+^6>'E!K77\S2M!TJL/5&9X:MU=
MW9EXJ#Q):"*;<HZUM:!;^3:DYR235;Q'&6,+#L/ZUVU\-'ZE:VNAC[9_67\Q
M--A1-'9F7G![5S$I_P!(<CIFNRG"VVC_ %7^E<2Y+R[@< UY^:.$8QC;7_@&
M^#DW*3+6G_\ '^GU%>@0_<6O/=,R;]?J*]!A!**:[N'_ &2C*W]:&&.:;)57
MFGTF:7M7T:22T//2%%%(.E+5+8 HHHI@%%%% !1110 4444 %%%% !129]J6
M@ HI,TM !12 YH+ #)X%  2 .:0[NV*JSW\$:_>!/I65<ZVV<1\4 ;C3(@^=
MA52?5(8AP<USD^H2R?>8FJC.6ZF@#:N=:9LA*S9;V63)+')JMG'2D//6@&+N
M=CDFDSFB@9ZTFQI !@TI(I-P/ Y-!!'6A T%%&">U'3K5N<25384445&^P[6
M"BBBF&X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3D=HCD&F]:
M!UY- &WI^K$ !C6_%<)*!@BN&!(/'%;6D&9F^\<4 =&1Z4HZ4BYQS3J "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D-+2&@ HHHH
M0A.YJK??\>K_ $JUW-5;[_CU?Z5SXCX32.YYW,/WS?6M'0_^/L5GS?ZY_K5_
M1/\ C['UKX'#+GQD/5'NU%S1?H;/B(YMA7*?PUU/B$XM5)KE<C:.:Z,YAR5]
M'W(P=E398L?^/M/K76ZM_P @D?2N3L1B[3ZUU6JG_B5@>U=.7Z4*D[K9Z&.(
MO*K$Y"W_ ./A?]ZNQO\ _D!CZ"N/ML&X4#KNKK[X-_8@'?%;Y7*56,K:?\,3
MBXOGB<9TE4_[5=O:?Z3I03VKAW!W#V-=GX>D+6I!KGR67[YQ?]:E8U-)2-'3
MH?)M\'U-0:G;-<E,#@5/>7*VT0).!FGPS>;"KKR"*^NFH2C9'E\[UF9NN8BT
MQ5[XQ^E<?96KW<_E"NF\2S 1*I.#FN=T^\-I.7(XSQ7R^9RIO%J^VAZV&36'
MYEN[FW9>'FAG60G]:ZB-0JA2:P[77XIG5.,GWK=0!P&Q7LY;&BN;V9YM=RO[
MR)#1VI#TI17JKX3$4=*6@44UL(****8!1110 4444 %%%% !01D49%% "=!2
M DTC,%.3TJM<:A#$.'&: +1.?:H9+A(5RS#\ZP[G6RX*IQ67+=RR'ER: -^X
MUJ-<A.M9,^JSR$@' K/+D]J09[F@"1YF<Y+'-1\DYS00":,8H &HH!-% !11
M1V)[#K30F%%'\.[M3HT:5PB+NSW]*E>\]!MJ*O+09Q_$/RI0A)S&&/UJ:XGL
M=+4&YF5W/\!K-F\4QHP\FUV#L0:ZZ="3Z''4Q5..O,OO+A5_XU8?04APG3/X
MU0'BLEOWEKN'KFM&WU33[\88K$U.>"FE=)DT\PA+=H0'(S14LT#1+OQ^[/1O
M6HL5R6<79G;&2J*Z"BC.:*-QH**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ SB@#O2X]:%R7"XX- $UM$9GP!75V%H+>,''452TJQ"*)&6MG&1B@
M!1S2T@&* ,4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !2&EI#0 E+2=Z6A )W-5+_\ X]'^E6^YJK?_ /'H_P!*Y\0KQ*CN>=S?
MZYOK6AH?_'V*SY?]<_UK1T/_ (^Q7P>%FX8J*:ZK\SZ"MRQI:,UO$2YME [5
MRIZ#I7>WVG"\BP6QQ6'<>'!%$7W]/:O4S#+ZM6HZMM#BP5>G%VDS'L6/VU#Q
MU%=7JPSI@QCD5R5N%AOE7?WKM9+5;NQ5=_4567PA.E*FHZE8J=-U5*+T.'MA
MMNE.?XJ[&]8G1@?:J2^&D60.''!STJ[J8$&F^6>PK3#8:OAHS[7,<15A.<;,
MXP'ECWR:ZCPU+N4K7+$88_6M_P ,M^];ZUYF7UE2Q2;TU_4[,9R2AHS5\02!
M8 />K&COYFGI["LCQ/-M"BK?AN4M8M[5]!0QD/K4E?2[/-E37L;&7XG<M,JC
MUK"(^7%:NNS!K[;67G+-]:^7Q]13J.S/5P]E2BO,L:</].3ZBO0X3^[7Z5Y[
MI_\ Q_)]17H,/^K7Z5[V0SER,\_'N\B9NE':@]*.U?2O5(X.@HZ4M(O2EJA!
M1110 4444 %)WI:.M "45')*D0RQK.NM8C084C- &FSH@R2*S[G5HX@0#S6#
M<ZG+*3M)Q5)G+G+F@#3NM6>3[IK.:>1S\QJ/Z4<]Z #K1110 4444 %%%% !
M1110 4-R!CH.M% !R?>J3M<F701<F1<#*GC%&LZDFDQ_9HAF5Q@GTJW:!$CD
MG?\ U:*1^..*XJ[NI;N[DFDR=QQ]*ZLMP_-.YYF:XKEC8C<RS2-),^[/3G-,
M!VD@C.>E &T\'-*QVC@9->_&%G8^:G/F5Q-_."* "IW(<4O5?F%&,#(-:7Y5
MRA%>Y<Z#0=;P_P!EO#E3PI-:T]NT5P%SE3SFN((W  G$@.5KM--NCJ.BC=_K
MX@2WKBO%QN&M[Y[N68VZ]F-_B8#L:*!C:/7O17E'N)6"BBB@84444 %%%% !
M1110 4444 %%%% !1110 4M I.^* #)S6IIMB9W#$<54MK?SIE7UKK+*W6WA
M''- $R1B.,(.U2TWI\U.H **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "D-+2'K0 4A.!2TAX%+J 5%<1^9$P]JE)I#@#)J*J
MNBD>=:C;R6\[%E.,^E54<HPDC9@U='X@U&W4^7@%JYZ-&;YTC.#7PV+H1A7E
M[%-V7J>WAIS=/W[%G^U;OJ7;\Z'U.YD7:7/YU699"W*$4GDR'HIKE4L3):I_
MB=%.%%K= 2V[?@9]:L)J-R@P)#CZU#Y4GH:3RI,_=-3A_;0E>S_$CEIVM=%G
M^U;K/WV_.HIKV>489R1[FF^6X'W33 C?W353G7E*VOXB5.#=[H:"QZXJ2&XE
MMV)5L?0TTQ.?X:41,>"M9N$X/2+N:RJ4YZ-BSW$MR<LV?J:=#=SVZ%48@'T-
M,\ME/"TOEMW6K4ZT5\+OZ$2C1Y;#)'DE?<QR?4TF<#FI#&^.%-- \I@\B_*.
MM0H5)-7B_N*C*DHV1IZ#9/+<AR#CWKN5&%"FL/1;NVDB58L!JW1QR:^TR>$5
M3=CP\7)N0IH%!H%>I/H<_0<.E+2#I2U9*V T@)I:3!H&!.!302>O%-DG2,$L
M1Q65=ZPJC"&@#5DF2,<L*R[O5U0LJUBW&H23'[QJHQ8\DT 6I[^64GYC50NS
M'FD&:* "BBB@ HHHH **** "BBB@ HHHH **** "CM]**4'AJ3':XZ\;RM E
M8<9<"N+'2NVFC-UHLL0Y(;=^5<21AR/>O=RK1'RV<)N5@HHHKTXN\CS5"T0H
MHHH:YI7"+^R';/>ND\*/E+I/1/ZUS1]*ZCPS"8K>XG[,F*Y,PDO9V.K+Z3A6
M3_K<M$8=A[T49R2?6BOFS[!A1110 4444 %%%% !1110 4444 %%%% !1110
M A)Z4]%+$*!S3>>U;&DV)E8.PXH OZ18^6HD8<ULXIB((U"CI3Z "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0TM(
M: "BDH-) &.:K7LACMG8=<59[FJFH?\ 'F_TK#$-J.A4=SB;6'[?J>).5W5U
M<EG;6=OO*# ]JYK1R5U3'^U72:V_^@,A[UX&!Y%AZE5*[LSNQ,FZJC%V6AGM
MJ>GB3:(L^^VKEJ]C=-A(^?=:IZ1IEL]J&=06)/-;%OI\-L^] !7?AL+*HH5&
MK)HY:]10TB,GM;6*(LRH /6LMM1TQ."F3[+5OQ ,6#-VYKFK%[,P?O(,L>^:
MYZ[A3FX1CMJ;TX2E%,Z*VEL;HX54!/8BKCV%K&A9D4 >U<G:-%_:Z+$FT CC
M-=;J +6;X7M3P<Z592DX+05>$XR23,R6_P!-A)!0$CT%.MKS3;J0(J8)]5Q7
M,PLL<LC20%P,]ZDMS]KOX3:QE<=0*X:6(4ZD6H;NQK*BXJZ.U.GVP&[8N,9Z
M5E7-[IT#E#'\P]%K:!_<A3U"BN)O& U24>29!NYQ7=CDZ,XV@8T5*4K,VX-0
MT^; \L GU7%7;C3;:>T+!5P1G@5R%PRM,@6 ISZUVEJ,:9&,?PU.$G'$5)PY
M.A=:,H27*<EIY-IJVQ"<9KO%;* UP:<:X?K7=0\Q+]*URE2C5JQ>R>GW&>+6
MS) =U)D[L4#@TG.ZO73YK>IS2)1TH^E-!PN2:I76I1P @$9K41=>14&6(%9M
MWJJQ A"":QKK59)21DXK/=F=MQ- %RZOY)6.6Q]*I,Q;J:3K10 4'GO110 @
M&.]+110 4444 %%%% !1110 4444 %%%% !1110 4$8(ST-%!!8>PJ9#4U'<
MLV4JI(T)^XZD5RFL:>VGWAP"8G/RFNB8<!DZBK#+;ZE:B"X \P?=)]:]#"5_
M9GG9A@_;1YHHX:E8;>X/T-:&HZ/=Z?(24:2(]P*S3LC/W<9ZU[E*O!K0^9E2
MJ4V^87KTHP1U(_"@GY<A<BI[2RFOFVP1%6]:MU8P1G3ISJRO%6(X87N+A(HU
M)8_RKM8X1IVEK;+RQZU%I^FPZ+#YSD/.1^(HD+2,79LNW05XF-Q2EL?1X' R
MC[TV-'"BB@$G@C!'!HKS$[JY[#5G8****8@HHHH **** "BBB@ HHHH ****
M !>2<T<Y]J0]L4^-3(X4"@"Q8V[3S;<?+FNMMK=;>(*M5-*L1#'N8<FM.@
MQ2TG>EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCZE0YN;E0O;U?YC&.A6J\@'\J<-#M"/N\_2M>FXYH^I4/Y4#KU;WYC,_L2U
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(FCFZE+EJ.S-*BIYX0A#(P9&&<CMFH/6O,DG!GLQ49J]PHHHI7N4E;0****
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MF;B0-T KJ(UV(%'&* '\8P*,8%&*,4 *.E%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW;<#%>B:EIL6J6#V=VOF1N.<<4[3+"#3[06\2[54\"@#A/'EFEM::= "2$!
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MI==0NNHX.#1O&:3 V\4TE>]-^0/78>TBKUH$BFH9&1>685EWNO6MFAS(KX[
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MBZ?>;/7Z5Z'X.M-9M=,W:G>1W *C:J*010!UN\;L=Z=40W  CIZ5+0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4U@3C%.I"<4 ,!SNS
MTS7'?$/5KS2M,M!9'#S2E,YQVKL?N98G@UY_\6&:/2]/E0;G6?*J.YQ0!F2?
M\)9IFEQ:H)3,F S*\E=MX;UZ/7=$CO7=8CN*,"<#(Z]:X2&^\3:]I<&G):26
MJ.HS)(F013_%VC3:/X8TK3;6<0^9='S.N6R!F@#U&&\MY=PCE1MO!PP(%(NH
M6C2F,7$>X=MPKS74;$>$O"#26CR&XG*[V9B<'I3[OP4MKX;_ +4CN7%VB>>7
MWG!XSC% 'I<TJK"7W #U)XKA?'VMFUM-/^Q7(+M< ,%8=*Q+WQ'>WWA?2[-"
M4DN8@6D['FHO%/A*TTNSTBZA9S(TZE]SDYX!- 'IVDW0DTZU,CCS9$S@GDU=
M>>*,@,X!)P!FO-YKB:/QOX?12WE/&WR#OS4GBJYN+;Q=;LDVV$!"4H ]!FO+
M>W_ULJ)]6 K/U7Q!IVE6JW%S<*(V. 5(-<'8Z?)XU\1ZG)?3L+:TEVQ(K%2
M1[4GCGPI8VOAZ(?O9,2=I#Q0!Z)IVL6>I6BW%M,KQL,CD9J9=0M"^S[1%N]-
MXKSS0/#!L/!0GTIW%W<(&!9BP_*L#18+&"^5-:M;NWNO-SYKRD*W/I0![2LB
ML2 >E*KAQD55M71D00<Q8X;KFK*9R<F@!]%%% !1110 4444 %%%% !1110
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MNXX H ;4L4#2G:H-7;/2WF()'%=#:V"6XZ"@#,L=&P SULQ6T<(&!4P/84M
M#3D_2E&.U+10 4444 %%%% $9.,[%YKR0ZA>^'?&>JW9LRZ3S;@0">U>OU&T
M$+G+11L?4J#0!Q$&NR^*+6ZT\VOEEXCM.TCDUAZ5KVH^&+(Z-/8_/;#RXRH)
MW_6O5%AB0Y2)%/J% I&@A=MS11D^I44 >>>$?#MR-"OY;Q-LUTTA5.WS9(_G
M6'X3\(ZA+?:C9ZK"#!;MM@R<\8KV(*JC   ] * B@DA0">I ZT >2_#_ $'4
M_P"W+N358_W:,ZQY.?E!.*]#F\.Z5+<"633;=G8Y9B.:U@BJ<JH'T%.H XKQ
MQX:DU#38)-/0">WD5U4<<#M63;>/;^VMA%=6)%V@PP"D@GZUZ60#U%1&V@)R
M8(R?78* /*_%$^MZA!!>M&T5H67<B$G/X53TJTDN_&VD7-G8*EI%(2\A!!Q]
M*]B,4;+M,:%?0J,4+#$ARL:+]% H \_\-:?>0>-[J62 ) 4;#^]4O%!NM*\9
M66IM"S6T<A8LH).*]/"*#D* ?7%->*.3[\:-_O*#0!YA%%?^,O$<5S)!Y=E$
M P8Y!)'L:[;Q/;RW7AJ[@B7=*4P%]:VDBCC^XBK_ +HQ2D C! - 'CWA[Q-J
M>AV,MFNFAW\P]0:V=!T35=9\0_V_JJ^3&K!X8U.0*]$^S09SY,>?]T5(%"C
M  ]!0!YIH^DWX\0:DTT9$4L<J(WU! K TZS@\."73]4TI)67[K["V_ZU[2$4
M'(49^E-:"%SEXHV/J5!H \ZUS2WOO!Z'3K18=DZ2^6HQD YK;\'ZZ^J6K6[P
M&-X@,Y4C-=9L0+MV+M],4B11Q_<C1<_W5 H 1>G)-2444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %-?E<>M.HH CVY38:YGQCH$WB"
M"R2$D>3-OKJJ* *%E:M;:?! Y.Y%QN[UA>+_  _<:Z-.\HD&WG$C<]JZRB@#
MG->\/?VSX>;3G)1^,,.O%<D^A^+;FV72)<+9_=:42?,5Z=*]0HH X75? WF>
M'+6RLI6$]J@5'Z$\YK$O_#WBK7#8Q72+%!:R Y63)8#BO5:,4 <#X@\+ZC)<
MZ?J.F'?=6B$*C' Y/K69!X5UW4]>BU+4CM1=H*!LCBO4:,4 >;WOA[7=)UJ[
MO-"02PW3[Y$=]H7Z5K?V!J&J>&Y;;4V,=R=Q4*<X)Z5V6** //\ 0]&\26>D
M'2YL)'$ L4ROEB*S-2\.>)?$#PVVHV<,$44H(N(Y,N0*]3HH S].LO[.LH+)
M)&D6,8WMU-7E(/2G44 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 1R-M*U3OKN.UMFF9L8'%7)1G'%>?^,-58/]G1OE[@5C7J*$=-SFQE
M;V-+F6YSVM:Q+JEW(Q8A%/ K')[BD8[C1FO!J5.>6I\Q.4JKYI!M+')-+@!L
M49-!&"*S?8S<(.+\A$662588AEVXKU7PSH<6G62L4'FM\Q)KDO!FG+=:J9G7
M*J017J"Q!5V@<5ZF"P]O>9[&5X5-<\AAC5FR!D=ZX/QEH \LWML@4@\@5Z"%
MV]*JW]LMQ:R(RYRIKMKT(S@TCT\7152#1X?]\$]UZT$[4W"K>HVIL]2N(<8'
M:J8X3 Z9KP9)PERH^8DG"3BA>HW=Z=&Y!R."*;2YXQ42WM(E/FW.S\*:Z5<6
M\K>PKT* ATW \&O#;>9[>99$."#Q7K'AW4C>:<N6!<8!KU<-632B>UE]=?"S
M=0\D4[O488BEW&O3;Y=SUZBZD@ZTZHPQR*?F@?06D)[]J,DGBJ&H7@MXR%/-
M %75K_8FQ#S7-NQ=MQ/-/N)GED+9XJ,X- "$^E%'2B@ HHHH **.G6EZ]*
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MSM)[&@"2BDR<4F[':@!U%-SP33=Y&!C)/<4 245"TC%MH^4^IJ3=[\4 .HJ
MSJ 6# J#CCUJ8=* %HHHH **** "BBB@ HHHH **** "BD8X&:;OP>N0>U #
MZ*C:0#@D GUH#D@$'CN: )**ADG\M2V. ,YJG;:O;7EG)<0SH57()STQ0!I4
M5E:9KMIJ:3_9I5E-N=LA4]#4EGK%O?RLENX;9U(- &C141E,>2W*]0?2JUK?
MK>H6B(&TD$&@"]144DP2,N?N@9JEI6LP:M 9H 0@<IDGJ10!I45$TRAMA.UC
MTSWJ.:Z$%O)<2<1H,G- %FBLO2M:M=91I+297"?> .2*;=:]96=\EK+.BS.0
M!&3SS0!K45%&[,S9& .F:-Q8#:PZ\T 2T4T,6)P,8[^M-WG)_E0!)14'F.5.
M",_RIXD^3)&#0!)14?F8&3T/?TI-[+G//?(H EHJ-'++NQCV[TI<9SD 4 /H
MIA8] >::9@%R#N]<=J ):*C602'Y'!IV[G'>@!U%%% !1110 4444 %%%% !
M1110 4444 5[R<6\!D/0"O&M8N6N;V5B<C<<5Z?XME:/1WVG!*G'Z5Y!([/*
M3[UY6-J6DT>+FM7W>4;D@XQUI:#S@>E%>4M6>-%VB% R0:*1R1C'3-:)7DAQ
M6AZ+X&MC%IOFD<L*[=#E :YOPIM_L*WP.HK?C)VG-?08=>XCZG"14<.K$H.:
M:YXQ21\YH/)(K?R.BG[T=3R[QO;B'63(!@.:Y<\ CWKLOB!CSX!T;<:X[.'
M/I7SN+]VJ['S&+BE6E;S"BEQ25AO(XZ>MP'/X5UW@R^,=\(&/RD$UR/09'XU
MI:',T-XCYYW ?AFM:,^6H=.&J<M0]F RH/K013('$D*D>E2U]#)W2/JF^:*8
M@'(IYYXIO0YHDD$:%C5=!]".YN%MXB2>:Y2_NFGD//>K6J7IE8A3Q6022<T
M+G:,4F,4=:4G- "4444 %% YI<9/!H 0 ]ZDBB>5MJBI;:SDN''&!736.FI
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MKB,+(]N9 0V<9%;EUX>N;O\ L]M\:M; [L+@'Z5-=^'9;O5?M1=0OD>41^%
M&!\/SK4K;[R1GCXY+9KT<8)SWKC="TO5M)U2:#S$-F#A %Y ^M=B!M7W- #@
M<BEIJ9V#/6G4 %%%% !1110 4444 %%%% !1110!RWCB0IIB ?Q!OZ5Y7CJ?
M>O4_'*YTU&/0!L_I7E;9W?C7B8[^(SYS,[NJU_6P?Q&EI'X.>U RQP!DUQQ7
M8\]I\MD+2$;DQWZTNUP,E33=P5<YYSC%+WE):#UC#4]%\"W_ )]F;4GYHQ7:
MJ/EQ7C>@:N=(OQ)G"N>:];L[^&[MTD216W#/%>[AJJY4KGT.7UU.CRMEI!@T
MV4[5S3P5]>:P_$&LPZ?8R-YB[\8"YYKHE-13;.N<U3A<X/QM="ZU9HU/"&N<
M;J,>E2SW+7DKW#\,WK4.=JYZG-?.UFYU=#Y:<W4K.WF.S24A5AU!%+]:F47&
M5S/E<+W =ZL63;+F+_?'\ZKG@58LQNGBQUWC^=.WO)E4_C3/9]/;=:H?:KAQ
MBJ6G#%FF?2K8(/>OHX_ CZZ'P(=CN:QM6O=@**:O7MV((F&<'%<I<RM-+DGB
MJ19&268EC3#UI6.1@4E, HHHH ***<B%VP!0  ;^!UJ_I^EO(^6Z5;TW2]Q#
M.N*WXH4B7 % $5O:1P@?*,U9/'2C&:3/.,4 .%%%% !1110 4444 %%%% !1
M110 4444 %%%% %>6WAF8-)&&93D$U(ZJ5RW3N*4_-V[TC*22.QH YOQ)X:3
M4K%([<8,;^:$'0FL2R\+7USJ%O=WD*VPM^BH<[J[XEC]T8 ]:;Y7[P..AZ@T
M 11VT44.U8EP1AAZU')I]E+:B&6VC: #[A'%7&3(&/7-((AN+=SVH KQ:?9Q
MQA8X45!T %+]FB0L@@01O]XU+Y7.6R3[4I0'C#<^] ''>(?#$EY>K>6B[]H
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MW YI,^U+WH ;C/+*,TN<=J#R0<\4N>: #%1)\A*ERQZ\U(3G.".*;R!VSZT
M9U_I=GJAVW,",Z_=8BG6&C6%BVZW@1&Z9 J[C+CD C]:=P3M'6@ );=PHY[T
M9VMM_&E^?GD4FX=QGWH <P)Z&CDCD4F%Z]*=Q0 G3M1@^E)D9."..M.)P.M
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MO"CY=@/IZT >R1NKQAEZ&G52TFXENM,AFFC,<C9RA&",$BKM !1110 4444
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M, 4Z^\&,9XY;"Y>V*H$)C YQ77E3M)'?I3L87(H XV_\&27UM;E]0E,T(X?
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MVJ6HG<*X' )[GO0 [=D<<D4UC@$YX[^U)C+8 (Q5+7;V2PT:ZN8P"T<9(XH
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MW3,Q.<T 0-R<T@H"]S3HU+R!0* 'QPM(P*]!UKI-+T]85\TCD\U'IFGJH+2
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MJ,#Z5JZ3HMGHD/E6R-S]XGDGZT ::KANG&.M/IJ=*=0 4444 %%%% !1110
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MZ38F60,X.VNGBC$2A5'% #@H10 .E*2Q[4'@YIH&3D&@!WU'-)G!YH5\DY&
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M;);Q@ 5..:3!IU #6![4Q7!R,8:GLNX@YZ4FUN2,9H H7NK6>G^6M[.(S(<
M'O5N)UN(5:,Y0C*FN?\ $7@ZV\0W%M//+*KP/N 1R >*W;2 6UK' N=L:XYZ
MT 4/$+R1^';]D)$JQ$J:X?0/#+ZCH\UVUZWVC[X;'(XSBNX\1K)/X<ODB4EW
MB(6N*T/Q!+IVCR6+6-P;@_*&"<=* +FB:W</HM];ZC.WFVZ$^8>N,UK7'BNV
MTK3K./>)9IHPR _Q#UK$MM"NH?#FH7-RA:[NHRNU1P.<CBH=3M+1=$L4O+6Y
M>X2$;3$.E '42>*+>VT@7]P N[.T>IJI9>,([Z3[-<1"WDFC9XN?O+CK7(RW
M5X/#T+ZA!B%&8HH7!_&K*R2>([RPCL[1X8X[<AI"F.?K0!I^';\6+WL\C;EP
M<9[\UJ:5XMM+^>2"X81ORR1^JCO7,RC4M+MG\FV+K)E7!3/'M67INF7%UK:2
M0P31YB8L7!'/M0!W4/C6&ZOQ#;1AX"VWS/3UHO\ QG9VMUY<6V7:<.<]#6/X
M=U>*RL1ILNFR?:C(W[SRN.3ZUSPTF*WU>^.IV]T_GS;D\K. * .[O_&5E;QH
M5579^%7U-9T?Q"MYU=([<&6)MK+D\55@T;[+K%L(H7:W)4CS!DBI=.TZ2.]U
MLR6J8>?,9"=L4 ;ESXLLH],ANPZDRL45?4CM26'BVSO;6=G(1H3AE]Z\_OM%
MO!86DTT<IB2Y9BB Y K<TG2K1M/O+BS@N4=G!(ESSQ0!?C\=V\KI(( D+R&,
M29^\1VJN/'4W_"1I8+:@1N3M;/44R33)7\+VZ&V <3L>$Y%5\/I>KZ9)<6;2
M1B,C*)D]>] '<:CK,.EVJW%R^PN,*OJ:R-.\8P7EUY,BB)B"5_VJC\7VDUW9
MV5W#&S""02LF.HQTQ6(]VWB+6;#['9-;"-")"T>W)H H:=J+:QX]G^V68FC1
M0%+'[N">:]'O;R+3K!YM@5$^[[USVB6<B^*+B26!53R0H(7'-6O&MS?6NC$6
M<(D'&1MR: #2?&,&HWKV<BB&6-=V <Y%5)_'L,=[=10P"1;9]DC9^Z:Y31;2
M67Q-+<16\RAK=0Q8=^];]EI;BQUA3;@M)("I*\GB@#6U#5[6YM;*X6[\I9)@
M  .I]*34/&4-G>?8H5$SKPY]*Y[^R[QM*TZ)X6S'>[^G09K3LK"0>)=0EE@!
M5G)&5]NU #X_B!:3*DJ*&MM^PR^C#J*V-3\11VUG#<Q1"9)5W+S7*Z;I<R>%
M+F(V@WFZE(&SG!)JA?MJ"6.FV,]O(UL(R&*+\P_&@#:U+Q!%K>@I-"VTK*5(
M';%=7X?.=$MBQR2G->8Z#IMX='=1;RHOGM@,ISUKT_0E:'1X(W4AD7!XH TE
MQT%.ID9+#)%/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "D[\4M-! X'6@!3GUIA^\
M1NQ2[L'!!HX/TH @FM8+@;IXP^. 31%:0P#$,813UQWJ8[@P'&VE9MHX[=:
M*RVUM#*9HXU#]R*F"J_S$Y]#Z4@Z[DP0W4&G,, 4 "HJ E1UZFH;BV21TD"
MD'DU.I)%"C()8\^U ",F5RG!'2HI;6"X(::,,P[FI\[4R*">F * &86,*JG
M["H)[&"=A))&&?N3Z5:;ID 9J,]LYQ0 B01)'L50%/04YHT(PW4=#Z4I;GW'
M04-O!XQCOF@""6VCF*"2,2XZDU(8XV &!M7I3\8Q@\'UI#DMCC;0!'-!'.RM
M*@91T)I)[>*6,)*H=.P/:I"&#*@Y2G855(SGVH 9#$((S&BX4<"ECMH88VCC
MC"JQRP'?-.&-@QGGUI6'?VH CCM88598D"YZXI<*T>U3M&>?>G!CL!'XTI4;
M,'CZ4 5TLK=9&>*,(Y_B%2"$*>&P_4FG[1M"\X]:<>&Z=J '*<@'.:6@=.**
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI"<
M F@#-U>X\JWV@_>XKE0#(3ZYK3U>Y,MP4!R%I--L/-F&>G6@"[I.GX =AS6Z
M!QCTIL<8C4 4[I0 HZ4444 %%%% !TJ,'!(QP:D(R,4P$$[<&@!A7 *,,J:C
M6UAW;A$!BIP&SSTIU $/S;F+<H1C%-DAB9074'TI[95EXX)IRK@D'G- &7J^
MBPZI;QP$[44YQBK-C91Z?;I;1#@#&:M<EFXZ#BG $@9H C*A_D,8*TB0QJV5
MC"L.E2X(&%H YR>HH @^S1[S)Y0W#H:5H(IBIDC!;WJ8\&EW#('K0!&5& 0O
M/2@1@< =>6-.(PQ(--*G9@'DT ,>)9%*%<H:6.!8T\M5 7O4A;'RXI,[OE';
MK0 W8@&"/E]*3R$E/SH"%^[4F%?Y?2F$%V 4X"T /"YCVL,CIBHEM88SNCC
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MVV' )5O;'6N$LX1HWC/[+;2LT<I)*EL@8%6K3Q,(-)FN?+Q*;AXQM7@8/4T
M=V,8/.*8"KON49[9KSI->UVXUNPBFEMVMIP3^[ZX]Z=>>.+S[;)%:"/R85YR
MO)(ZT >BC[S#.?:C=Q\WRUYU=^-[^2SL1!#Y;7*Y,DB84?C3O%.J:VN@6DEM
M- 96E ++TQ0!WL]W!: ,Y ![T_S-\0=!O!KAGU._M-(LSJ.QBR\[12OXEU2^
MF,>F(GDQ1[B67TZB@#MU#YY;;GH*D4D]17GDWC:\DM(5@C O .0R\ U?TGQ'
MJW]NK8ZHL>UX@X,:XZT =NO2EI%QM&*6@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5=/O)M.BM8M,\^';@<_<J.W\*WX\+FWGE8W"2F6-2/R%=[R<  !?2E)&>.:
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MEW _=(_PIJN&;((/:@"7 S2*BJ, 8IU% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4C#(I:* (9(!)(K$_=/2I0H'2EHH 0#%
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-%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>forms-3_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 forms-3_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 'R W@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW2@*OE;QG(.*AX.D.6*J]SKAXF?=M)_&E7Q.[;L-TKDPC+E]X(';-"*[,54
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MI85:12,$M42=0TY*=S0\1>([];^T2W5A$Y4@8ZDCI6R_BB>WN+2S:!DDE'S
MUEZOH6I?8[*98E,T+ XW>@J36]+U._?3;^*)5N$0EE#=3FE'V@<M(UM4\4KI
M^L0:<8BPD"G</4UGWWC.:#59+&"UDD>-MH"XYJE<Z5K.KZ_;7L]G%$(@@(5N
MN.]7]/T*ZC\9S:C/$GV=I"1S5?O">6F6+_Q%=65O%*]C*'8C*\9J"S\5C55O
M+=HVCE!P%)YJ#Q-I>L3:WYT1W6^T +NZ50TOP_?Q:I+.8@"YSUH_>#Y*9I^"
MIWG%QYC$_O''7WKHM2U&#1[-[F13\@XYK%\(Z5=Z>TXF0#+LW7U-7_$VER:I
MI<D:D9(X -5'VEC*:I\QAP^.2DHEDM9!%(VS<2,5;U+Q6MK-!';0._G>AZUS
MT.@:I(D,$ENGDQR!L[JUKC0;J37;*:.-?(B)SSTH;J&L(TRQ:>,&_M$V=S9R
M1,Z<;B.]8D&KWEAXKO8X(WN%$G"K6KKFA7=UXE@N[=!Y*QJ&.>XJ;2]%NK7Q
M/=WS1J8F?*Y-%ZA35/8L:'XI.I&XADA99H@S[3UXK+N?',UM.96M)-JGGI4>
MG>'-5AUF^N%55\Q'V_-ZYK,_X1_59K2X@GC!;INW9I7J$\M,Z.Y\7)9:?'<1
MQEVE8# ]Z@/C">WN(DN;22*.4_*S8P:H2>&M3?1[>/R8_DF4YW<XJ]XCT2[O
MH+"*W0-)#G(8X%%Z@<E,NZCXG6SECBM8'FFD4':IYP:=IWB"3-S)?64L0AY^
M?'%8][HFHV&IV]W;HLLBQ*"&/&:M-8:QJT5Y]KB2#S1T1\YIWD1[.EV*Y\<-
MYCS1P.8@VW/&*N7WBY+.QL[J*,OYN3Q7/V^@:K;1/:+;1NC,3EFQ5W4_#-])
MIEE$D:CRLY /2G>7<'3I=C1/BJXMH?M%Q92HCCC..]06/BR2ZN@HB9D8]JTM
M6L9;S0(;>&)7F0+D-QTKE8M#U)IH]B"':>=IIJ33,Y0A;0]"+#RU<*59AT-)
MTIENOEV\<<K,SA1DFGUUPGH<4XI/0.O:D/%+2&KNNYD[]!M(:=2&G="M(2DI
M:#THN@M(;28I:*JZ)M(;1111=!:0E'%!ZT=J5T.W<0XI***=T%@IM.IM%T)H
M*#12471D[W"CBB@]*=UW-(KN'5A5S21_Q.[,_P#3453'WU^E7=(_Y#5E_P!=
M17/BVO9[G5@G^\T1[,E25&G! J2OENK/L([(****!A1110 4444 ,E563#=*
MP[VP>.3S(AD5O$ CFF,!C!'%4F1):G.I-')\AX<4K1LG)K5GTV"3YE 1O452
M;3I(@=DS2'T:BUR6VBN,$4A&T;AS[5FZGJMUI8.ZT1AZ\USTOC.<@@6I'N%-
M7R*6A#G*.J.R9@5+.=H%8&K:_##$T,# R'C@US%UXAO;@8 D /8 UFO/(H\Y
MX6)'))4UW8>E&.YYN)KUGHBV\K2LQE/S&F '&T'!]:S[?68[NZ,:QG=GNIJ[
MYYSL,3AAS]TUZT,3""L>3+#UJCNT2[BB<LK[." *,&-N" 6&:A$[C.(&YZ_*
M:7SY&8%H7R/]DU/UFCW']3K]OP)R26C4C&.N12;L_.#\H..*B-Q(3_J7/_ 3
M3?.D"E1 V/3::?UFAW%]4Q"Z?@6-PC(D*[XSZ=J4$F4L!@$=/:JZW,@79Y#;
M?3::7[5)G/DMZ?=-9O$T;[C6$Q&_Z#;JQMK\#SXRPC^[S5H*FU5RNU1@ #I5
M?[5(!Q"W_?)I!<./^6#?]\FFL30[E_5<1_2+09G)1CC;T-.4J@VN-YZU5^U2
M'K"W/^R:7[4^<^2V?]TT_K-#N1]3K/<L ?OU^7"L>!0&(R4(&#@C%0?:Y#@^
M2_'3Y32?:6'_ "P;_ODTOK%$M8.H6GP2K8!(ZXITC+)M?:>.*J?:W'_+!O\
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M"UT7AERV6 ':G)\H.6!?H!6?_:9QC[.W_?)H_M(YSY#9_P!TT?6H">!K[V_
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M+_\ ?)H_M7)SY+_]\&CZS /JE<T"LI?:\J<CJ!BD! 1XR04!ZBL\ZH#UA?\
M[Y-']IC:5\AL'ML-'UF ?4ZYHE2OW2"<=_2DWLJ*P*@_2J']K'.1"^<8^Z:3
M^U#_ ,\&_P"^31]:@'U2N:#*5.XNH!%(NU.2C,I[YJ@=4+#!@8_\!-+_ &FV
MW;Y+8]-II_6H$O!5^Q>/RMQC8>V*-J@XQQV/I5#^TF(_U#?]\FD.J-T\AO\
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M[#_G@OY"J9U^#?L!YQFFOXBMXB/-=5!]ZGV=0I8JF7O['L?^>"_D*/['L?\
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MQCWH^KU1_7J!M?V-8_\ /%?RI#HUC_SQ7\A6.WBR$,%&"Q&::?&-HD3/*P7
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ME?\ /%/RH_X0[2O^>*?]\TWF,P_LNFNIP7]I6WK^M']I6WK^M=[_ ,(=I/\
MSQ3_ +YH_P"$.TK_ )XI_P!\TO[1F']F4^YP7]I6WK^M']I6WK^M=[_PAVE?
M\\4_[YH_X0[2O^>*?]\T?VC,?]F4NYP7]I6WK^M']I6WK^M=[_PAVE?\\5_[
MYH_X0[2O^>*_]\T?VC,7]ET^YP7]I6WK^M']I6WK^M=[_P (=I7_ #Q7_OFC
M_A#M*_YXK_WS1_:,P_LNGW."_M*V]?UH_M*V]?UKO?\ A#M*_P">*?\ ?-'_
M  AVE?\ /%/^^:/[1F/^S*7<X+^TK;U_6C^TK;U_6N]_X0[2O^>*?]\T?\(=
MI7_/%/\ OFC^T9A_9E+N<%_:%MZ_K2?VC;>OZUWW_"'Z5_SQ3\J/^$/TG_GB
MG_?--9C,'EE+N<#_ &A;>OZTG]H6V>OZUW__  A^D_\ /%/^^:/^$/TK_GBG
M_?-+^TIB_LREW. _M&W]?UI#J%MZ_K7H'_"':5_SQ3_OFC_A#M*_YXI_WS5?
MVE,?]F4NYY]_:%MZ_K1_:%MZ_K7H/_"':3_SQ3_OFC_A#M)_YXI_WS1_:4P_
MLREW//OM]MZ_K1]OM_7]:]!_X0[2?^>*?]\T?\(=I/\ SQ3_ +YH_M*8?V92
M[GGGVZV]?UH^W6WK^M>A?\(=I7_/%?\ OFC_ (0[2O\ GBG_ 'S2_M*8?V93
M[GGAOK?U_6D-];>OZUZ+_P (=I/_ #Q3_OFC_A#M)_YXI_WS1_:4Q?V72[GG
M/VZ#L?UI/MT/K^M>C?\ "&Z5VA3_ +YH_P"$.TK_ )XI^5/^TIA_9=+N><_;
MH?7]:0W\/K^M>C_\(=I7_/%/^^:/^$-TK_GBG_?-']I3%_95/N>:F^A]?UI/
MML/K^M>E_P#"&Z3_ ,\4_P"^:/\ A#=)_P">*?\ ?-']IS["_LNGW/-/ML/^
M31]LA/?]:],_X0W2?^>*?E2?\(9I7_/%/RH_M2IV*_LNEW/-/MD/K^M(;R''
M7]:]-_X0W2O^>*?]\T?\(;I/_/%/^^:/[5J=B'E-/N>8_;(J/MD5>G?\(;I/
M_/%/RH_X0W2?^>*?E1_:<^P_[*I]SS#[7%33=Q5ZE_PAND_\\4_[YH_X0W2?
M^>*?]\T?VG/L']E4^YY9]KBH^UQ5ZG_PAFD_\\4_[YI/^$,TG_GBG_?-/^TG
MU3#^RJ?<\M^U1&C[3%Z_K7J7_"&Z3_SQ3_OFE_X0W2O^>*?]\T?VD^S#^RJ?
M<\L^TQ4W[5%7JO\ PANE?\\4_P"^:3_A#=)_YXI_WS369RZ(3RJGW/*_M45(
M;J*O5?\ A#=)_P">*?E1_P (;I'_ #Q3\J?]IR%_95/N>5?:8J3[3#_$#^=>
MK?\ "&Z1_P \4_*@>#=)_P">"'\*/[3D']DP[GE)NH4.54_G4^GR"XU2V*@\
M.*]0_P"$-THC_CW3\JE@\*Z=;RK)' @93D<5E5S"4T52RR,)&I8*PA3)!XJY
M4,:E"H"@"IJ\[F<M6>M""@K(****904444 %%%% !1110 4444 &*0@4M(:
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M?\#H@ 1Z&@C KG_^$EC+D%%&!1_PD\'3 -5["?8S^NX=/?\  Z 'CI1C/M6
M/$:GHH_.FMXE3.U@ >U'L9]AO&X=]?P.A&"<8-!7+<$5S_\ PD9 ^=%"^N:5
M?$<1;( I>QD"QE#O^!T&.:0=^1[5@?\ "2*I(=5%(/$T/.Y1M'4T>QEV']<H
M=_P.@ P,DYH) 7/6L!O$L2L!M!4TC^(T1@50$&CV,NP?7</W_ Z' (R#2X!Z
M&N>/B2+.$4>]*?$<2#@ GTH]C(/KN'[_ (&\<8SB@8;V^M87_"0C;N*KCTS5
M>3Q?8QS1Q2,%=^U'L9=@^N4._P"!TIP#[4$BL#_A(XP^% 88SS2'Q)$3]U:/
M8R[!]<H=_P #>SCK2;23D$8K"_X25&^ZBX'6AO$L17(4"CV,NPGBZ'?\#?V8
M%&.*P%\1J1RHQ]:0>)HF.!CBG]7GV%]<H+K^!T (;@#!IVT#J:YW_A)XF.U5
M&:4^)H5X=1D4O82[!]=P_?\  Z$A0:0@ Y!XKG_^$D1N0BX^M)_PE$"C+*,"
MCV,NP_KE#O\ @= RGL12,VT< D^U<\?$\49,L@ C S3%\76MQ$LUL0X]*/8R
M[!]<H=_P.DP2!@\TXC!]JYO_ (2F'=N"CD?K3CXG0*H*+DT_83["^NT._P"!
MT1&![T@'4'DBN<?Q3'P1&.#S2MXGB.2@&T]Z7L)]BEBZ'?\  Z)>0>,&A2"3
MD]*YQO%4&X("OF8SMSVI!XIB.%V+D]:?L)]@>,PZZ_@=(#['ZTN !ZFN6?QG
M:F<0!@& SBI?^$KC!SL7%'L)]A/&X?O^!TF!ZTA R#G KF?^$LB5^5'-*?%:
MB3:T*;3WS3^KU'LA+&8=]?P.FVY'!%!ZUR[>+H44@JBG/'-./BU%&/+0CUS1
M]4KOH5]<PZZ_@=/@8HP,URW_  F"#_EDOYT?\)>G_/-?SJOJ=?L9O'8=/?\
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M>:W_ !3ILFKV420C[LH.!5#7M#N;_1K2S2/#0@BJ]_L2O9=1;_Q7<P:A:6Z
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MJ/[1@_NM7HO_  BND_\ /M'^5)_PBNE?\^T?Y4?VA4[C_LRD>>#48/[C4O\
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M-*_Y]H_RI?\ A%=+'_+M'^5']I5.X?V73/+3=Q?W'H^UQ?W'KU+_ (172_\
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M>Y<TM#'9Q*?[M7ZAC4*5 Z#H*FKS[MZL]**25D%%%% PHHHH **** "BBB@
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M4%_:5)_"=KN'K1D>M<6OC!#U0#\:</&"$$[!@>]3]1J%?VA [+*T97UKC?\
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M#\Z?U&MV'_:5 [?(HR*XC_A-5_NC\Z/^$U7^Z/SI_4:W8/[2H';Y%&17#_\
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M-[<>=F&P/K2G,B*&*JQ'3I6+J/B*'2)[>#R@)9B.,]C7-R>*+MO%AMPA*!B
MN:/:Q-8X>9WA42-M&[Y1G(IJE65D+8^IYKG;GQI%;WQM4MU$NP':#UJE=:PT
MNJV$KN8&92?)'1J7UF"T&L-)L[)21"2O(Z<]:2)\[5WH6[BN$@\5WTGB9K<Q
M%8MH'E9X'^U5W3M01_$]P)+@@(_W/2CZS#L:2PLK'7HV\G<,;: "^7X KEY_
M'$0GDCM;19D3(9\GC'6K0\5V<FCM=QXQ&/G]J:K1EL8O#R6Z9O*Q&1L_'%
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M]DH_X1[3?^?9*/K\T.>60/*_M:=?)DS]*3[6@_Y92?E7JO\ PC^F?\^R4?\
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M(O7%9<GC P2>7*O/N:(4Y3V)GB%3.W#C&:7>,XKA6\9JO;CZTK^-HHHO,=@
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M/G'O2?\ "2Q/&7##<.,9H^K3ZH?U^D=47 I#( >17,?\)+%Y8.\4G_"3QE,
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M>N]9U0I>/Y?V?IC'.:TO%HN!H=S-;?*RCGWJYHM@VF:6L'F\_2I-3MWOM+>
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MJSTXQY58****8PHHHH **** "BBB@ I#2TE  *6DI,\]* %--)Q2DX%9][J
MB3$?S-GG%-(ELMR2QK]YP/QJI+JD$7&"WT&:R7)N7W24X!4QM7FGH3[Q<.OP
M <0S#_@!IJ:S$Y^Y*/\ @)J S2$\M2&1B*<7$)7>QB^+M6:2!+>!&_>=>*Z#
MP_9+9:9&JJ S#<?QJE/;0SE6=1N'>H)[R]T\%T<R)C  [5JES:1.>;Y-9'4%
M1NZTI7(X(KSX^+ID?#$Y^O2G)XOF+D G@9ZUHL'4ET,)8^E32N]#OUW#CBI
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MTLBE\ YIP<;@"N>.PKEM.\3SW5N]Y<V3QVJC(D)XJ&/Q9?2>9+!I\C6H;_6
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M*#STIQ\0MI^FV1\LN7<@<]>*?UFFR?J,SI]@"]#FFE@>@KFF\3W,5_$EY;M
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MMG-;*D['(\5+G/,E\-ZF]W&(AY8!!/.!6OJ?A^]L[RVO[<"2X!R><C-=ONW
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M_O@U[/\ V;:_\\1^5)_9UJ/^6(H_M"8?V93/&_/G_P"?>3_O@T>?/_S[R?\
M?!KV3^SK3_GBM']G6G_/%:C^T:H?V;3/&_.GY_T>3GK\AH$\^,?9Y,?[AKV3
M^SK3_GBM']G6G_/):/[1K!_9L#QT7$Z]+>3_ +X-+]JG'_+L_P#WP:]A_LZT
M_P">*TG]G6O_ #R6FLQK!_9M,\?-S.3DVSY_W#2BZN/^?>3_ +X->O\ ]G6O
M_/):4:;:_P#/):?]I5?Z0_[.@>0_:[C.?L\G_?!H^U3_ //M)_WP:]@_LZU_
MYY"D.FVG>):7]I52EEU,\@-W.>MO)_WP:47DX_Y=Y/\ O@UZ[_9UI_SR6C^S
MK3_GDM+^T:H/+:9Y']LFQ_Q[R8_W#1]MG_Y]Y/\ O@UZ[_9MG_SR6C^S;/\
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M7_GDOY57]H3%++8'BWF7!.3;R9_W#2>9/_S[2?\ ?!KVG^S;3_GBM']G6?\
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M\/ZG)J,!,JE">F>]6-6U--$L);F<^85^Z@X-:.HC#ZM.]KE]D"D9)YI/+RP
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M #[-_P!\FC%Y_P ^S?\ ?)KVC[%;_P#/)?RH^Q6__/)?RH^NL2RVD>+XO/\
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M31M- "4E.VTNV@!E%/VT;: &44_;1MH&,I:=MI-M "44NTT;32$)12[31M-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
,@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>forms-3_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 forms-3_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %:!;P# 2(  A$! Q$!_\0
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MO(/^&C?"'_0.US_OQ%_\=H_X:-\(?] [7/\ OQ%_\=H ]?HKR#_AHWPA_P!
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M1?\ QVC_ (:-\(?] [7/^_$7_P =H ]?HKR$?M&>$"0/[.UO_OQ%_P#':/\
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M^@=KG_?B+_X[0!Z_17D'_#1OA#_H':Y_WXB_^.T?\-&^$/\ H':Y_P!^(O\
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M_0#B_.NZQ1B@#A?^%/\ @C_H!Q?G1_PI_P $?] .+\Z[K%&* .%_X4_X(_Z
M<7YT?\*?\$?] .+\Z[K%&* .%_X4_P""/^@'%^='_"G_  1_T XOSKNL48H
MX7_A3_@C_H!Q?G1_PI_P1_T XOSKNL48H X7_A3_ ((_Z <7YT?\*?\ !'_0
M#B_.NZQ1B@#A?^%/^"/^@'%^=)_PJ#P./^8)%^==WBD;@9]* .%'P@\$'KHD
M0_&E/P@\$GIHL6/K787MY#8VS7-P^U%]ZR]'\6:7KDS16DX9UZC(H P_^%/^
M"/\ H!Q?G1_PI_P1_P! .+\Z[K'O1@>M '"_\*?\#_\ 0$B_.D_X5#X('']B
M1?G7<9R3D]*Y_5O&>E:-/Y-U*$<=B>: ,?\ X5!X(SG^QHOSI?\ A4'@AO\
MF"Q?G4Q^)GAT#<;D9],BM#2?&>DZY+Y5I,&;T!&: ,G_ (4_X''_ #!(OSH_
MX4_X(_Z <7YUW P,#)IW'K0!PO\ PI_P1_T XOSIG_"HO _*_P!BQ;QVS7>\
M=C487YB3]XT <.WPB\$^6"VBQ CWIW_"H/!!Y_L2(_C6GXK\8V/A.&-KP.=^
M,;1GO6SI&IP:QIT=[;[A&_3<,4 <G_PI_P $?] .+\Z/^%0>"/\ H!Q?G7=8
M]Z1O7/2@#A3\'_ P_P"8+$/QI1\(/!(Z:-%^=:VK^-=(T>;RKJ8*WH2*IQ_$
MCP].RHMT 6..2!0!3/PA\$Y)?18OSI1\(/!"CG18N?>NMCU*VFL_M,,JRQ*N
M25.:YK0?B%INOZU/IMNLGF1>JX'7% $'_"G_  1_T XOSH_X4_X(_P"@'%^=
M=R!QR>:7 ]: .$_X5!X'S_R XL?6@?"#P3G*Z+%^==G=WEO9Q[[B>.)?5V _
MG2B1)XD:)PRGNIH XO\ X5'X)YSHT0/UI#\(O!!;/]BQ'\:M^)_B#H_A5Q%=
M,\DG]V,;C^57O"OBJU\361GMHI4&3CS$Q0!C?\*B\$D[?[#B&?>G?\*?\$?]
M .+\Z[<?,,MP?:GX'K0!PO\ PI_P1_T XOSH_P"%/^"/^@'%^==UQZT<>M '
M"_\ "G_!'_0#B_.C_A3_ ((_Z <7YUW7'K1CWH X7_A3_@C_ * <7YT?\*?\
M$?\ 0#B_.NZQ[T8'K0!PO_"G_!'_ $ XOSH_X4_X(_Z <7YUW6*,4 <+_P *
M?\$?] .+\Z/^%/\ @C_H!Q?G7=8HQ0!PO_"G_!'_ $ XOSH_X4_X(_Z <7YU
MW6*,4 <+_P *?\$?] .+\Z/^%/\ @C_H!Q?G7=8HQ0!PO_"G_!'_ $ XOSH_
MX4_X(_Z <7YUW6*,4 <+_P *?\$?] .+\Z/^%/\ @C_H!Q?G7=8HQ0!PO_"G
M_!'_ $ XOSH_X4_X(_Z <7YUW6*,4 <+_P *?\$?] .+\Z/^%/\ @C_H!Q?G
M7=8HQ0!PO_"G_!'_ $ XOSH_X4_X(_Z <7YUW6*,4 >2>./AEX4TGP9JM[8:
M5'%/# 65@>AR*Y[]FAF;_A* >@^R8_\ (U>I?$@ ?#O73SS;'^8KRO\ 9F_Y
MFG_MT_\ :U 'O]%%% !7@/[2^-WA;ZW?_M&O?J\"_:7Z^%A[W7_M&@#V3PZ'
M_P"$<TO'W?LL?_H(KSKXJ>.KS3)5T?2W*W,Q*Y4]#7I'AKCPUI@_Z=D_]!%>
M$?$Y)-,^(\%_<H3:F4D''&* -;2?A)J6MV(OM5U(BXD&]0RG/-=!X,\(Z_X=
MUTI)?O)8QL,C;P17>Z'JUE>:3;203QD>4/XAQQ4IU.TF>2&&YA:=.J*X)- &
M!XG^(>D>&I-EQ.C/CA,XYK!T;XSZ/J=\+:Z5;7<<*S-UKSKP[:6VN_%"ZBUV
M0A$9RBR'@X/'6NK^,.BZ':^'C<6:P0W$2DIY6 2: /1_$GBNU\/Z"NJLPDB9
M@ <XX-<3+\:M*-LL\$0E/\:AJY?6;JYNO@M$TP+,)D W>E;_ ,)?#.D77A>&
MXN+99))5^;<N0* .O\&>/]-\7%DMRL<JYS%G)X[U7\5_$W2/#5PUK)(DLXX,
M6[!KRW2(%T?XN/;VS&.)E?Y4.!UK8\4>#=1@\:2:Y;?9+J,L&\J9P?TH ZGP
M[\6-.U[54LO)$$I&02V>*T=9^)%KI?B2#1?(\UY7VY#5QFC>-=,M/$,-KJFE
M6UO=-\JF&''?%8?C=EC^+UA.WRQF<$=NQH ]L\0>(8]"T(:DZ97 ^3-<W'XL
M@\6>!-1NK:/R<0DXSGN*;\1;VV'P_.9HB6 P-P]*Y+X= #X8:CGIY)Z?44 9
MOPLU Z5;ZO>E3*4E<=?8UC6?Q0O;?QB]Y,6-N7&(2>N*Z3X.11R_VNLBAH_,
M?Y2/8UAZ+9V+?%R:"6&,P>8N%<# ZT >I>(->TG5/!#:IJE@)+8LH\MF[FF^
M%-;T?3_ \NJZ79B"UB0MY8;KS47Q7AMH? <T5LBJHD7 4<5R_AH8^"%VW\0B
M?CMU% &W'\:](>W>;RE,J'&S?S6QX4^)^D>*;OR%D2.;^&/=DDUQ'P8\.Z=?
M6-W=W-O'*_F;<.H(Y%8OB'3X-$^,MHEBHA0S+\J# Z&@#V_Q1XJL/#%@9[V5
M0W9"<9KAK'XW:3/+*LD(CB ^4E^M<7\49I[[QII4-X[+:E!D9X/S"O3-8\-^
M&H_!<FR*U4K#E77;DG H M>$/B%:^+;R:*WCV)$Q4<YS[UVQ .,=J\#^"*1I
MK]^L?*"4X_*O? 1UH <,YYI:;GYA[TZ@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ I#TI::V<<8H \S^-$LB>%)3'D$(<$5P?@;X9_\ "4Z%]LFOMCY
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MSQNS7 W_ (*U/2O%D^IV8LKQ" 2DSAL?A6SX5\::1_PE":==Z9#;7S9^:&'
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M:187NKZ>LWG)N3+8V\UQ'P@LK"7Q3J7VF&!U!8*' ./F-;GQQB2+2[%(@!&
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MJ.E:=<6RDGS-@=J]5\!^(--U_0TDTZ$0[%&55=HH [%,#C&#3Z:HZ$]<4Z@
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MD[+'&9&/"\F@"0'/X4O-102I-$LL9RK#-24!849S2T@ZTM 6L%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2,,CI2TC' H XWXA^
M&KGQ1X?>RMGVLRD=,TOP_P##MQX9\/&RNFWON!'&*ZX'*]:8)$?)#@XX(!H
MKWUC'?V4UNQ'[U<9KR2V\ >(O#^K3MI%Z8H)G+'"9ZU[( ""G;UH!&=IY]Z+
M!='C$'POUA?&UCKEU>><T<H=_DQG@UUOCCX>6_BV))5D6&ZB VOCGCFNXW*,
M@D_)R3445W%/OD1@ AVG)Q0*Z/%H_AIXLO5CL[G6F:T!QC8>E=-XK\ W.H>$
M8-&M)=SQLA+@9SBO1?M=JZ86>(9]'%*TD<:#+X4_Q9HL%T<(_@N\D^&_]@^9
MB?8R[L>N*7PAX,N=%\)7>ERS?O90<''L17<I<1$JJ31MS_>&:D>9(\EW1?\
M>(%%@NCSKX9^![KPJ]_]J;S!," ,8[YK#\0?"K4U\1MJFB7OV=Y26;:N<9KU
MY+F*4;1+'N]F%/:3R_O,H3'))HL%T><:OX/UC4_!*:1<SF:Y&[,FWUK4\/\
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MD48I:!0*P8YS32A/4T^B@H8 0#@\FD9=P S3\C-& .: $5<#^5($/\1S3Z*
M&[<# XI<<TM% #=G4'H: I'?BG44 )MR: ,4M% #-IW=>/2E6,+G%.HH ;M.
M>3Q2&-3U%/HH ;MSUI2,TM% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% '*?$K_DG.N_]>Q_F*\J_9E_YFG_MT_\ :U>J_$K_ ))SKO\
MU['^8KRK]F7_ )FG_MT_]K4 ?0%%%% !7@?[2O+^%O3-U_[1KWRO OVECAO"
MWUNO_:- T>S>&^/#.F@]/LR?^@BKDUQ:VP#2.J[NA-4?#R@^'-,.3G[*G'_
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MD0",H05'RD?=Q2F'<NUL$=^*FHH'8B6( Y"@<8Z4]%V\=J=10 4444 %%%%
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MGM[JWC6%F5D!;V-.MKF31M;O#):OY<V K9KLS&A;)49]:9);PRD&2-6(Z9%
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M9;)&9IU6*3:.P%=HL$2-N6-0?4"G-&CXW*#CIF@.1G(7\%[8Z)&;6-A(0/-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *3O2TAH *K7L1EM9(U&21@59IDC*B[V;
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M8W Y"RN-4N-"M[:.UD7*CYSTQ1=:1=VK1KY3W5NQY1.,'O78Q0I;1(B_<08
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M!\G '3K2E^?:@!U%,$@(%!D53SF@!]%,+,">F,<4H8D T .HINXCKTH+8'-
M#J*CCEWCD8-.)P,T .HI@9L#.,]Z5G"C)Z4 .HIF_(!6EW?-B@!U%-#$CM35
M<L6 '0T 244TL ,GM2!]PROZT /HIN[YMM&>>,8H =132X7&>]&XC.<8[4 .
MHIN3QC%!8]J '44TL1SVI%D#4 /HIN3[8H#@CC]: '44W=S[4;QD#UZ4 .HI
M <]*,G'O0 M%(#2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!_:8Z^%OK=?^T: /:/#G_(L:7_U[1_R%:C' .*R_#G_(L:7_ ->T?\A6KZT
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M /0Q@'Y03[T-@?>Y/M7!V-]J\\;P1$%0"Q=FP0*U?#UU&D[137<DDN>0_04
M=*TFT$L-J <DU5FU2R@5&,R_-]WGK1JXQI<Y#D90\BN*NKG['IND-Y?G$H>H
MS0!V]MJEC._E17",^,[0:N  'KUKC["">\U%+F&W2&(*,GH:ZX 95E;(% #Q
M][%.IO.[C%.H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I.]+
M2=Z #M4<K*B%W(4+W/:I.U4]3 _LZ?/3;02RH=;TL$JUW"2#5N&>.XB\R%U=
M>V*XO0KO2HH[D7%NTC^;@'R\UJZIJ\5E';PV:A&F;: 1B@R;+]QHEA<3>>XY
M/WAGO5^SLX;./R88\(*YJVUBXM+G[/=(&+J7!7FF:9J&JZEJ$ZD*L2#(PU [
MHZO.5?$BDJ<\=O:H+6]6Z8XC(*]1ZUROAN._^WZC++,SQK*1@MTXJW'KCP&Y
M41() OR8[GWH'S(ZN-, DXYYQZ4@*J!MX&>M<A<W6M6VG_;2J'<1\N[C!JTM
M[>W^DQ2(8XVR=WSXH#G1T@SAPQ&#T/M6.^@Z9<.92I9@<DAJS+'6[EYWT^4*
M7*,58'/051\*B_'VJ2:5G09(!;WH%S(ZW398'62&!-BQ':1ZU;:($Y.&4<@>
M]<H-=>.TNRL*)*)0HV]ZD^T:K8>5<3A?+8Y8;N@]J!IHZE5X^88!IQ(Q@$9'
M)%<=-J^H7FJQ06@4Q2*3DM@U>TJ_NX]4EL;Q5W!0<@YZT%1:-Z:=(X#+(1&H
M[FJ=GJEE=RLD-S&6_N#K47B':-'E4MSD$#UKF?#DB7MWYSQ);%/PW8^M FTI
M'>$E<?W<<U6AO+:[D98Y4D*]5':G23;D91]UE."*\\TB.[TN^DO(I&DB:0AP
MQZ#- 2DCT3S[<3K$9%$F.%J7^+./F_I7(-<QW'B:RN(9&(,;';VK1T+5+B_6
M>610-I90 ?0T!&2-V3:JG+ 9ZFD5L $$,#QQ7%:GJM[>Z=JB)B-H)0H93S4]
ME/?Z;X=>5G\R0J2N\]Z YT=5=S?9H&FQG'2B&5)XMY7:".M<Q!J&H_\ ",&]
MNXT+L 57=D&EO->=8H;:%%$K %@>  :!<Z.K4+A5X8'H:4@$84CCM7*V&LS6
M]ZMK.-WF E2.<8JK97^LZG!/<(B(D;L!ANN#0/F1V9=57<V$4>M*0&X!&>M<
M7JE]>7GAF4H^R:, .0>]68[Z^TG086E EGD(&2<\&@.9'5$ +D ;A[4-&&(+
M8V]<>]8&DR7<LZ2R2*5;EEWUI:K>+8Z=+(6P<';GUH#F1-'>VLUR\$<JM+$<
M,HZBK1&5KSNQ_P"):\&M-/N-S\\RENAKHM0UN6&^MXXE!24*3D^M N9'0<,
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MMUXB4+<?\2TC<RX/7ZUV%I;+:1&WA&Q%&$S5CR]LF\,3G^'M3]H)P<@GI[4
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M **** "BBB@ HHHH **** "FL,BG4U\XXH :<8)'+>E1QHJ-M1-N[YB?>I.
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M_E5]ZG/>K%SX>LYI]Z HY.3SUJY:7<5[#OC)(5B.1W%,U#4XK!5,@.6&1Q0
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M<Z[_ ->Q_F*\J_9E_P"9I_[=/_:U>J_$K_DG.N_]>Q_F*\J_9E_YFG_MT_\
M:U 'T!1110 5X#^TQU\+?6Z_]HU[]7@/[3'7PM];K_VC0![1X<_Y%C2_^O:/
M^0K5[UE>'/\ D6-+_P"O:/\ D*U>] "T444 %%%% !1110 8'I1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1BBB@ HHHH **** "BBB@
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M7A2TC%G);JX=&!.6SVILL-SIU^UQ]D>Z#YP%'2NJ5@1@[3CT--DDC& 6Y]J
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M'9,NG((XK"?Q'*+B&*VA5@Z9.[@"G7GB<6[?9D53<K]\9X'XT ;RVL!@,3(
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .4^)7_).==_Z]C_ #%>
M5?LR_P#,T_\ ;I_[6KU7XE?\DYUW_KV/\Q7E7[,O_,T_]NG_ +6H ^@****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^\?RH^LT.X>T1T&*,5S_ /PEMC_>/Y4?\);8_P!X_E1]9H=P]HCH,48KG_\
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M ,*@\'ZTT?,W/&.E.;IG=368CDB@!Q"MQV%)@Y8COTH/"@KWZBE(+9 .V@
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MMM7FL_,DN6_>$$A36G9^&A:7,US]KDDEE4 L0,KBE7PO#]J,\]PT^5(PX]:
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M;B6)1,,X2@#HN6(YP.XHS\I'IUK/L+V2^T[[5(@BR-PQZ5AZEX@NY+"Z>V@
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MXU;<$4'U I##$3DQH3ZE13Z* $"A1@  >U+110 4444 %%%% !1110 4444
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M]F7_ )FG_MT_]K4#/H"BBB@ KP']ICKX6^MU_P"T:]^KP']ICKX6^MU_[1H
M]H\.?\BQI?\ U[1_R%:I&X$&LKPY_P BQI?_ %[1_P A6KWH -HQBC S2T4
M-5 H/OZTZBB@!"H-($ )/K3J* #%)M!&*6B@!I0$8-.Q110 F!G-&!C%+10
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M\*2^'G_0O?\ D[<?_'*/^%)?#S_H7O\ R=N/_CE '.?\-%^&_P#H'WGZ4?\
M#1?AO_H'WGZ5T?\ PI+X>?\ 0O?^3MQ_\<H_X4E\//\ H7O_ "=N/_CE '.?
M\-%^&_\ H'WGZ4?\-%^&_P#H'WGZ5T?_  I+X>?]"]_Y.W'_ ,<H_P"%)?#S
M_H7O_)VX_P#CE '.?\-%^&_^@?>?I1_PT7X;_P"@?>?I71_\*2^'G_0O?^3M
MQ_\ '*/^%)?#S_H7O_)VX_\ CE '.?\ #1?AO_H'WGZ4?\-%^&_^@?>?I71_
M\*2^'G_0O?\ D[<?_'*/^%)?#S_H7O\ R=N/_CE '.?\-%^&_P#H'WGZ4?\
M#1?AO_H'WGZ5T?\ PI+X>?\ 0O?^3MQ_\<H_X4E\//\ H7O_ "=N/_CE '.?
M\-%^&_\ H'WGZ4?\-%^&_P#H'WGZ5T?_  I+X>?]"]_Y.W'_ ,<H_P"%)?#S
M_H7O_)VX_P#CE '.?\-%^&_^@?>?I1_PT7X;_P"@?>?I71_\*2^'G_0O?^3M
MQ_\ '*/^%)?#S_H7O_)VX_\ CE '.?\ #1?AO_H'WGZ4?\-%^&_^@?>?I71_
M\*2^'G_0O?\ D[<?_'*/^%)?#S_H7O\ R=N/_CE '.?\-%^&_P#H'WGZ4?\
M#1?AO_H'WGZ5T?\ PI+X>?\ 0O?^3MQ_\<H_X4E\//\ H7O_ "=N/_CE '.?
M\-%^&_\ H'WGZ4?\-%^&_P#H'WGZ5T?_  I+X>?]"]_Y.W'_ ,<H_P"%)?#S
M_H7O_)VX_P#CE '.?\-%^&_^@?>?I1_PT7X;_P"@?>?I71_\*2^'G_0O?^3M
MQ_\ '*/^%)?#S_H7O_)VX_\ CE '.?\ #1?AO_H'WGZ4?\-%^&_^@?>?I71_
M\*2^'G_0O?\ D[<?_'*/^%)?#S_H7O\ R=N/_CE '.?\-%^&_P#H'WGZ4?\
M#1?AO_H'WGZ5T?\ PI+X>?\ 0O?^3MQ_\<H_X4E\//\ H7O_ "=N/_CE '.?
M\-%^&_\ H'WGZ4?\-%^&_P#H'WGZ5T?_  I+X>?]"]_Y.W'_ ,<H_P"%)?#S
M_H7O_)VX_P#CE '.?\-%^&_^@?>?I1_PT7X;_P"@?>?I71_\*2^'G_0O?^3M
MQ_\ '*/^%)?#S_H7O_)VX_\ CE '.?\ #1?AO_H'WGZ4?\-%^&_^@?>?I71_
M\*2^'G_0O?\ D[<?_'*/^%)?#S_H7O\ R=N/_CE '.?\-%^&_P#H'WGZ4?\
M#1?AO_H'WGZ5T?\ PI+X>?\ 0O?^3MQ_\<H_X4E\//\ H7O_ "=N/_CE '.?
M\-%^&_\ H'WGZ4?\-%^&_P#H'WGZ5T?_  I+X>?]"]_Y.W'_ ,<H_P"%)?#S
M_H7O_)VX_P#CE '.?\-%^&_^@?>?I1_PT7X;_P"@?>?I71_\*2^'G_0O?^3M
MQ_\ '*/^%)?#S_H7O_)VX_\ CE '.?\ #1?AO_H'WGZ4?\-%^&_^@?>?I71_
M\*2^'G_0O?\ D[<?_'*/^%)?#S_H7O\ R=N/_CE '.?\-%^&_P#H'WGZ4?\
M#1?AO_H'WGZ5T?\ PI+X>?\ 0O?^3MQ_\<H_X4E\//\ H7O_ "=N/_CE '.?
M\-%^&_\ H'WGZ4?\-%^&_P#H'WGZ5T?_  I+X>?]"]_Y.W'_ ,<H_P"%)?#S
M_H7O_)VX_P#CE '.?\-%^&_^@?>?I1_PT7X;_P"@?>?I71_\*2^'G_0O?^3M
MQ_\ '*/^%)?#S_H7O_)VX_\ CE '.?\ #1?AO_H'WGZ4?\-%^&_^@?>?I71_
M\*2^'G_0O?\ D[<?_'*/^%)?#S_H7O\ R=N/_CE '.?\-%^&_P#H'WGZ4?\
M#1?AO_H'WGZ5T?\ PI+X>?\ 0O?^3MQ_\<H_X4E\//\ H7O_ "=N/_CE '.?
M\-%^&_\ H'WGZ4?\-%^&_P#H'WGZ5T?_  I+X>?]"]_Y.W'_ ,<H_P"%)?#S
M_H7O_)VX_P#CE '.?\-%^&_^@?>?I1_PT7X;_P"@?>?I71_\*2^'G_0O?^3M
MQ_\ '*/^%)?#S_H7O_)VX_\ CE '.?\ #1?AO_H'WGZ4?\-%^&_^@?>?I71_
M\*2^'G_0O?\ D[<?_'*/^%)?#S_H7O\ R=N/_CE '.?\-%^&_P#H'WGZ4?\
M#1?AO_H'WGZ5T?\ PI+X>?\ 0O?^3MQ_\<H_X4E\//\ H7O_ "=N/_CE '.?
M\-%^&_\ H'WGZ4?\-%^&_P#H'WGZ5T?_  I+X>?]"]_Y.W'_ ,<H_P"%)?#S
M_H7O_)VX_P#CE '.?\-%^&_^@?>?I1_PT5X;_P"@?>?I71_\*2^'G_0O?^3M
MQ_\ '*/^%)?#S_H7O_)VX_\ CE '.#]HKPW_ ,^%Y^E)_P -$^&L_P#(/O/T
MKI/^%)?#S_H7O_)VX_\ CE'_  I+X>?]"]_Y.W'_ ,<H YO_ (:*\-GKI]YC
M\*3_ (:*\.9_X\+S'X5TO_"DOAY_T+W_ ).W'_QRC_A27P\_Z%[_ ,G;C_XY
M0!S1_:)\-[LC3[SWZ4']HGPV#QI]Y^E=+_PI+X>?]"]_Y.W'_P <H_X4E\//
M^A>_\G;C_P".4 <W_P -$^&CUT^\_2E_X:*\-_\ 0/O/TKH_^%)?#S_H7O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
>**** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
